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Helicobacter pylori is a globally significant human pathogen and is the 
causative agent of a wide range of diverse gastroduodenal diseases such as 
gastritis, peptic ulceration and gastric adenocarcinoma. Antimicrobial 
resistance is a growing problem, with H. pylori recently listed as one of the 
top ten antibiotic resistant pathogens of global concern by the World Health 
Organisation. This species has been shown to be a globally diverse 
pathogen expressing large genetic variation, even within geographically 
clustered sub populations. Furthermore, individuals infected with H. pylori 
are thought to harbour unique and diverse populations of quasispecies, but 
diversity between and within different niches of the human stomach and the 
process of bacterial adaptation to, and infection persistence within each 
niche are not yet well understood.  
 
This study utilises whole genome deep population and single colony 
sequencing to quantify and characterise the within- and between-niche 
genetic diversity of H. pylori populations from paired antrum and corpus 
biopsies from the stomachs of individual patients. This revealed extensive 
genetic diversity both within and between different niches of the same 
stomach. Subsets of highly variable genes including outer membrane 
proteins, restriction modification systems, DNA repair, chemotaxis and 
virulence associated genes were observed.  
 
In addition, this study investigated the between niche (antrum versus corpus) 
antimicrobial resistance profiles of individual patients. The within and 
between niche (antrum and corpus) diversity of two sequential datasets were 
also investigated and results from the same patient before and after failed 
eradication therapy were compared. For one sequential dataset there was a 
big increase in H. pylori allelic diversity both within and between niches of 
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1.1. Important highlights 
 
Helicobacter pylori is a Gram negative, helical shaped, fastidious microorganism. The 
natural reservoir of H. pylori is the human stomach. Infection has occurred at least since 
anatomical modern humans migrated from Africa over 58,000 years ago (Linz et al., 
2007).  
 
This co-evolution has continued to the current day with approximately 50% of the global 
population infected by H. pylori with almost all infected individuals presenting some 
degree of gastritis (Kodaman et al., 2014). Other clinically important diseases are 
further attributed to H. pylori infection that include but are not limited to peptic ulceration 
and adenocarcinoma. 
 
Helicobacter pylori was categorised as a class 1 carcinogen in 1994 by the International 
Agency for Research on Cancer, making this the first and presently the only known 
bacterial carcinogen (Møller, Heseltine and Vainio, 1995). In 2018, stomach cancer was 
second only to lung cancer in total cancer deaths worldwide (Ferlay et al., 2018). 
 
The World Health Organization (WHO) listed clarithromycin-resistant H. pylori in their 
list of high priority organisms for which there is an urgent need for antibiotic research 
and development (World Health Organization, 2017). 
 
Extreme genetic diversity as a result of a high mutation and recombination rate, immune 
evasion and development costs have hampered vaccine developments to date.  
 
1.2. History of Helicobacter pylori discovery (and rediscovery) 
 
The history of Helicobacter species and in particular the discovery of H. pylori, has been 
a complicated series of discovery and re-discovery. Among which, observations and 
hypotheses were made that were often written off by the scientific community that today 
are well recognised attributes of H. pylori infection. Furthermore, while Helicobacter- 
like organisms had been described prior to 1983, it was not until the work of Warren 
and Marshall (1983), that the stomach was disregarded as a sterile organ. This coupled 
with contradictory experiments over the past century, the incorrect notion that gastric 
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acidity was the cause of gastric ulcers, and the difficulties in culturing H. pylori largely 
contributed to the complex history of H. pylori discovery and its role in human disease.  
 
Perhaps the first observation of Helicobacter- like organisms was by Bottcher and 
Letulle in 1875 who reported bacteria within gastric glands and gastric ulcers of animals 
(Kidd and Modlin, 1998; Bottcher, 1875). Astonishingly, Bottcher and Letulle are 
thought to have been the first to hypothesise that gastric ulcers were caused by these 
bacteria, however this was not widely accepted within the scientific community at the 
time (Kidd and Modlin, 1998). 
 
The next notable discovery came in 1893 when ‘spirochetes’ were described to be 
colonising the gastric glands of canines (Bizzozero, 1893; Marshall, 2001). These 
Helicobacter- like organisms were most likely to be one or a combination of 
Helicobacter bizzozeronii, H. felis, H. salomonis, H. heilmannii and/or H. canis species 
(Van den Bulck et al., 2005; Hänninen et al., 1996; Wilcock, 2013; Canejo-Teixeira et 
al., 2014; Prachasilpchai et al., 2007). The work by Bizzozero was taken further by 
Salomon who ground up gastric epithelium from dogs infected with Helicobacter- like 
organisms and showed that these could infect mice (Salomon, 1896; Marshall, 2001). 
This represented the first time Helicobacter- like organisms were experimentally 
transferred into an uninfected host and to this day, mouse models are still used to study 
H. pylori pathogenesis. The work by Salomon was repeated a full 24 years later, in 
1920, by Kasai and Kobayashi reproducing the results of the original experiment (Kasai 
and Kobayashi, 1919).  
 
In the early 20th century, Krienitz identified three types of spirochetes by microscopic 
evaluation of the gastric contents belonging to a patient with gastric adenocarcinoma 
(Krienitz, 1906). However, no link was described between the presence of the bacteria 
and the gastric adenocarcinoma of the patient.  
 
The first high prevalence of Helicobacter- like organisms were recorded in rhesus 
macaque monkeys from all gastric mucosa samples in a study by Doenges (1938). 
Additionally, Doenges investigated gastric samples taken from human autopsies in the 
USA and found that 43% of the humans sampled were infected by Helicobacter- like 
organisms (Kidd and Modlin, 1998). Freedberg and Baron followed up on these reports 
by investigating gastric specimens from patients who had undergone partial resection 
surgery and found that 40% of their patients were infected with spirochetes (Kidd and 
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Modlin, 1998; Marshall, 2001; Freedberg and Barron, 1940). However, it is worth noting 
that Freedberg and Barron did not associate an etiopathologic role of this infection due 
to histological inconsistencies and difficulty in identifying and culturing the organisms 
present (Kidd and Modlin, 1998). Despite these two confirmatory studies of the 
presence of spirochetes in human gastric specimens, an investigation by Palmer 
(1954), 14 years later of over 1,100 human gastric biopsies identified no Helicobacter- 
like organisms. Palmer concluded that the previous studies had isolated Helicobacter- 
like organisms as a result of post-mortem colonisation from cross contamination of the 
oral microbiota. With greater than 50% of the population thought to be infected at the 
time of the study, it is not known how such a result was attained (Marshall, 2001). 
However, a different staining technique was used in comparison to the earlier studies. 
It is argued that this study alone may have set back research into the human gastric 
microbiota by around 30 years (Kidd and Modlin, 1998).  
 
In 1967, Ito published the first electron microscope picture of Helicobacter- like 
organisms colonising within a parietal cell gland (Ito, 1967). Further electron microscopy 
images of Helicobacter- like organisms were published in the years following this study 
(Lockard and Boler, 1970; Steer and Colin-Jones, 1975). However, it was the work by 
Steer and Colin-Jones (1975), that further noted adherence of Helicobacter- like 
organisms to the gastric epithelium and imaged the phagocytosis of these organisms. 
Furthermore, these authors suggested that white blood cells were actively recruited to 
these colonised areas of the gastric epithelium. However, despite these observations 
the authors were unable to culture the organisms present, as with all other studies 
previous.  
 
It was not until the work of Warren and Marshall (1983), that the significance of 
‘unidentified curved bacilli’ were realised in the role of human gastritis. By realising the 
similarities between these organisms and Campylobacter spp. they were the first to 
successfully culture H. pylori from human gastric samples. However, it must be noted 
that Warren and Marshall’s first publication did not came without controversy with an 
initial submission emphatically rejected by the Australian Gastroenterology Association 
(Kidd and Modlin, 1998). 
 
In order to complete Koch’s postulates for the ‘pyloric Campylobacter’ and confirm that 
this organism was a disease causing agent, Marshall orally ingested a bacterial culture 
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isolated from a patient in 1985 (Marshall et al., 1985). Infection and gastritis were 
subsequently confirmed by gastric endoscopy approximately four weeks later.  
 
Despite Helicobacter- like organisms being observed prior to the work of Warren and 
Marshall (1983), these were largely just that – observations with little to no etiology. 
However, their work not only associated infection with gastritis and peptic ulcers but 
went on to successfully culture and prove that H. pylori was responsible for disease. 
This was a paradigm-shifting discovery and, in 2005, Warren and Marshall were 
presented with the Nobel Prize in Physiology or Medicine for their work (Pincock, 2005). 
 
To complete the complex history of H. pylori, it wasn’t until the advent of 16S rRNA 
gene sequencing that the taxonomy of this bacteria was resolved to Helicobacter pylori 
and has previously been referred to as Campylobacter pyloridis, Campylobacter pylori 




The transmission routes of H. pylori have not been fully elucidated and are often 
debated. However, it is clear that infection with H. pylori is highly prevalent across the 
world with over 50% of the global population thought to be infected (Hooi et al., 2017). 
Therefore, it would not be unreasonable to suggest that there are multiple transmission 
routes leading to infection. 
 
It has been reported that up to 90% of adults are infected in developing countries while 
less than 40% are infected in more developed countries (Leja, Axon and Brenner, 2016; 
Kayali et al., 2018). This deviation has been associated with differences in 
socioeconomic status, overcrowded living conditions, sanitation and hygiene (Bardhan, 
1997; Cheng et al., 2009; Ahmed et al., 2007; Breckan et al., 2016). 
 
Infection is thought to occur during early childhood with infection persisting life-long in 
the absence of eradication therapy. 
 
Perhaps the most prevalent mode of transmission is person-to-person, particularly 
between close family members (Rothenbacher et al., 1999; Didelot et al., 2013; Krebes 
et al., 2014). Some studies have found that mother to child transmission was more 
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prevalent than father to child transmission (Osaki et al., 2015; Mamishi et al., 2016). 
Sibling to sibling transmission has also been identified between siblings of close age 
(£4 years), with transmission from the older sibling most frequent (Goodman and 
Correa, 2000; Kivi et al., 2003). Spousal transmission has been reported, however, this 
is thought to be relatively rare (Linz et al., 2013; Gisbert et al., 2002; Kivi et al., 2003). 
Environmental sources of infection are also thought to play a role in transmission of H. 
pylori from a range of sources including food and water (Zamani et al., 2017; Goodman 
et al., 1996; Aziz, Khalifa and Sharaf, 2015). 
 
Person-to-person transmission routes include gastro-oral (transmission via gastric juice 
such as vomiting in early childhood), oral-oral (through saliva) and faecal-oral (poor 




Helicobacter pylori has a specific tropism for gastric mucosa and epithelium of primates. 
The majority of the H. pylori load are contained within the gastric mucosa but also 
colonise the underlying epithelial cells. Colonisation of the antrum is thought to occur 
primarily and is often the most predominant colonisation niche, but colonisation can 
spread to or even become dominant in the corpus. Corpus predominant colonisation is 
associated with long term proton pump inhibitor (PPI) use, predisposed by the reduction 
of acid secretion by parietal cells (Mukaisho et al., 2014). Corpus predominant gastritis 
is more associated with the formation of gastric ulcers (Kusters, van Vliet and Kuipers, 
2006). Pangastritis can also develop and encompass both the antrum and corpus 
stomach regions. Colonisation of H. pylori and the different local effects are depicted in 
figure 1.1. 
 
A recent study by Ailloud et al., (2019), revealed that intra stomach migration occurs 
within the stomach and is more frequent between niches of similar epithelia such as the 
oxyntic corpus and fundus. However, the ability to colonise as a lifelong infection is not 
fully understood, especially in the face of gastric mucosa flow and replacement, acidity 
and the host immune system.  
 
Here, essential H. pylori colonisation attributes are discussed.  
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Outer membrane proteins (OMPs) play a predominant role in bacterial adhesion to the 
gastric epithelium. Helicobacter pylori harbours a comparatively large number of OMPs 
comprising around 64 genes (Alm et al., 2000a). These are made up of five main OMP 
families, namely the Hop, Hof, Hom, iron-regulated OMPs and efflux pump OMPs.  
 
While there are many characterised OMPs, perhaps the best characterised include; 
adherence-associated lipoprotein (AlpA and AlpB), blood group antigen binding 
adhesin (BabA), outer membrane inflammatory protein (OipA), sialic acid binding 
adhesin (SabA), HomB and HopZ (as reviewed by Oleastro and Ménard, 2013). 
 
Outer membrane proteins also play a role in outer membrane vesicle formation and the 
OMP AlpB has been shown to impact biofilm formation and adherence to AGS cells 
(Yonezawa et al., 2017). 
 
The lipopolysaccharide also contributes to the adhesion of H. pylori to the gastric 
epithelium, particularly through Lewis x mimicry in the O antigen side-chain (Sheu et 
al., 2007; Edwards et al., 2002). 
 
The high number of OMP protein families and the extensive number OMP genes 
consisting within them and the LPS play an important role in gastric epithelial 
attachment and persistence of infection (preventing clearance by mucus flow).  
 
1.4.2. Urease, motility and chemotaxis 
 
Gastric juice within the stomach provides a harsh environment and barrier to bacterial 
colonisation, particularly due to hydrochloric acid and bile salts. In order to survive 
passage into the stomach, H. pylori must first survive the highly acidic conditions. 
Survival is facilitated by the secretion of the urease enzyme and pH-gated urea 
transport mechanisms. The pH-gated urea transport mechanism channels gastric urea 
to the cytoplasmic urease enzyme that hydrolyses urea into ammonia and carbon 
dioxide (McNulty et al., 2013; Weeks et al., 2000). This ultimately creates a more neutral 
micro-environment around H. pylori cells. 
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As a result of urease activity, the viscosity of the surrounding mucus is also reduced, 
facilitating the motility of the bacteria (Huang et al., 2016a). 
 
The motility of H. pylori is mediated through 4-8 unipolar flagella (Gu, 2017). 
Colonisation and persistence of infection have been shown to be drastically reduced by 
non-motile mutants (Eaton, Morgan and Krakowka, 1992; Eaton et al., 1996; Foynes et 
al., 1999; Kim et al., 1999). Another study has linked increased H. pylori colonisation 
density with strains that are highly motile (Kao et al., 2012). These studies suggest that 
motility is essential to gastric colonisation and persistence of H. pylori.  
 
Motility appears to be directional, with chemotaxis playing a major role. Four 
chemoreceptors have been identified within H. pylori, namely Tlps (TlpA, TlpB, TlpC, 
and TlpD), a CheA kinase, a CheY response regulator and additional paralogous 
coupling proteins (Abedrabbo et al., 2017).  
 
Many studies have used chemotaxis gene mutagenesis to show the inability of H. pylori 
strains to colonise animal models (Howitt et al., 2011; Foynes et al., 2000; Terry et al., 
2005; McGee et al., 2005), demonstrating that chemotaxis plays an essential role in 
gastric colonisation. 
 
Chemotactic and mechanistic details of chemotaxis systems of H. pylori have not been 
fully elucidated. However, chemoattractants such as urea, arginine, bicarbonate and 
host-derived molecules as a result of host-cell injury have been identified to date 
(Cerda, Rivas and Toledo, 2003; Nakamura et al., 1998; Mizote, Yoshiyama and 
Nakazawa, 1997; Aihara et al., 2014). Chemorepellents have also been identified such 
as low pH and energy depleted associated environments relating to bacterial 
metabolism (Croxen et al., 2006; Schweinitzer et al., 2008).  
 
Chemotaxis is also thought to play a role in gastric localisation within the stomach. A 
study by Rolig et al. (2012), found that H. pylori are attracted to specific niches within 
the stomach facilitated by unique chemotactic signals. They also found that localisation 
to the corpus was required by chemotaxis, but subsequent proliferation was not 
dependant on chemotaxis. Proliferation was dependent on chemotaxis in the antrum 
but localisation by chemotaxis was not. This suggests that nutrients are not limiting in 
the corpus in comparison to the antrum and that localisation might be determined via 
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chemotaxis to specific niches and not just towards the gastric mucosa, epithelium and 
glands.  
 
Chemotaxis is thought to change during acute and chronic infection. Chemotaxis 
towards the antrum is thought to occur during acute infection, after which chemotaxis 
mutant strains are thought to shift towards corpus colonisation (Rolig et al., 2012; 
Johnson and Ottemann, 2018). Furthermore, chemotaxis mutant strains have been 
shown to colonise the gastric epithelium less abundantly and might play a role in 
inflammation (Williams et al., 2007). 
 
1.4.3. Helical structure 
 
The cork-screw helical shape of H. pylori is thought to assist movement into and through 
the thick gastric mucus layer. Mutants with loss of the helical cell shape have attenuated 
stomach colonisation and reduced motility in gel-like media mimicking the gastric 
mucus layer (Sycuro et al., 2012). 
 
1.4.4. Antrum and corpus niche differences and Helicobacter pylori colonisation 
 
As previously mentioned (section 1.4), H. pylori colonisation is thought to first initiate 
within the antrum. Antrum colonisation can persist life-long, however, in some cases 
colonisation can progress to other stomach niches such as the oxyntic corpus or 
fundus. In this case, an antrum or a corpus predominant colonisation often develops 
during the course of infection.  
 
The antrum and corpus are specific niches within the stomach due to specific 
differences between these environments. The antrum possesses gastric glands that do 
not contain acid secreting cells but instead harbour somatostatin (D cells) and gastrin 
(G cells) and mucus producing cells (figure 1.2). Corpus glands contain parietal cells 
(acid secreting), chief cells (produce pepsinogen), mucus cells and enteroendocrine 
cells (D cells, G cells and enterochromaffin‐like cells that release histamine, serotonin 
and atrial natriuretic peptide). Furthermore, the glands within the corpus niche are 
generally deeper than those in the antrum (Park and Kim, 2015; Fung et al., 2019). 
 
The differences in gland cell makeup and pH between the antrum and corpus are 
reasonably well understood. However, the compositional matrix and concentration of 
 11 
nutrients within specific niches of the stomach are not fully elucidated (Keilberg and 
Ottemann, 2016). Furthermore, it is not fully understood what promotes or limits H. 
pylori proliferation within the stomach. Studies have reported specific H. pylori strain 
differences between isolates taken from the antrum and corpus relating to virulence, 
antibiotic resistance and colonisation (Seo et al., 2019; Arévalo-Jaimes et al., 2019; 
Carroll et al., 2004; Rolig et al., 2012). While specific strain differences have been 
reported, the full extent of between niche H. pylori population diversity has yet to be 
studied in detail.  
 
Figure 1.2 Diagram of the human stomach and niche specific glandular structure 
 
 
Figure adopted and adapted from Testerman, McGee and Mobley (2001). Schematic of the 
human stomach and niche specific glandular structure and cell composition.  
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1.4.5. Immune evasion 
 
Despite the strong adaptive and innate immune responses, H. pylori is able to persist 
as a chronic, lifelong infection of the stomach. Helicobacter pylori is able to escape, 
disrupt and manipulate the host immune system facilitating survival and long-term 
infection. Virulence factors also play an important role in immune evasion. Immune 
evasion by H. pylori is expertly reviewed by Mejías-Luque and Gerhard (2017) and 
Karkhah et al., (2019). 
 
Helicobacter pylori avoids or dampens down the innate immune system through a 
variety of ways. Detection by Toll-like receptors is reduced due to host cell antigen 
mimicry by OMPs, as previously mentioned. Furthermore, the LPS and flagella are less 
immunogenic than most other bacteria due to structural modifications (Stead et al., 
2008; Mejías-Luque and Gerhard, 2017). Phase variation of antigens are also thought 
to aid in the evasion and modulation of the host immune response (Bergman et al., 
2006). 
 
In the face of high inflammation and phagocyte chemotaxis, H. pylori survive killing by 
reactive oxygen species by producing catalase and superoxide dismutase (Odenbreit, 
Wieland and Haas, 1996; Spiegelhalder et al., 1993). A recent study by Lekmeechai et 
al. (2018), have shown that outer membrane vesicles play an important role in reactive 
oxygen species neutralisation and thus immune evasion. 
 
Immune clearance of H. pylori by phagocytosis has been shown to be independent of 
vacA and cagPAI negative mutants (Rittig et al., 2003). However, others suggest that 
vacA and cagPAI status play an important role in phagosome survival (Ramarao et al., 




1.5.1. The cag pathogenicity associated island and the role of cytotoxin-
associated gene A (CagA) 
 
The cag pathogenicity associated island (cagPAI) is either present or absent in H. pylori 
strains. When present, the island is either complete (consisting of ~30 genes) or 
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incomplete (<30 genes) (Nguyen et al., 2010). Some of these genes encode for a type 
IV secretion system that ultimately translocates the effector protein CagA into the 
gastric epithelial cells (Odenbreit et al., 2000).  
 
Once translocated, CagA undergoes phosphorylation-dependent and phosphorylation-
independent cell signalling modulation by interacting with over 25 host cellular binding 
partners (Backert and Tegtmeyer, 2017). These interactions effect the host cell in 
numerous ways including proliferation, changes in the cytoskeleton, formation of 
pedestals, and stimulation of IL-8 (Kao, Sheu and Wu, 2016). CagA has also been 
shown to downregulate B7-H2 expression which allows H. pylori to evade Th17-
mediated clearance (Lina et al., 2013).  
 
1.5.2. Vacuolating cytotoxin A (VacA) 
 
Inflammation, induced in part by CagA, results in the recruitment of white blood cells to 
the site of H. pylori colonisation, as previously mentioned. VacA is an excreted pore 
forming toxin and is translocated into host cells by endocytosis (Karkhah et al., 2019b). 
This toxin has many host cell interactions such as cell damage by cellular vacuolation, 
cell proliferation, apoptosis and induction of IL-2 secretion by T cells (Amieva et al., 
2003; Cover et al., 2003; Cover and Blaser, 1992). 
 
VacA is also involved in immune evasion such as the prevention of phagosome 
maturation (Zheng and Jones, 2003). The interruption of the calcineurin signalling 
pathway by VacA has been shown to block the proliferation of T cells and down 
regulates IL-2 transcription (Gebert et al., 2003). Furthermore, VacA is able to bind to 
mitochondria resulting in cell apoptosis and the proliferation of T cells (Talebi Bezmin 
Abadi, 2017).  
 
1.6. Prevalence  
 
The global prevalence of H. pylori infection is around 50% but varies across the world 
(figure 1.3) (Hooi et al., 2017).  
 
The prevalence of infection in the United kingdom was last reported by Vyse et al. 
(2002), revealing infection rates to be around 13%. However, it must be noted that this 
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was determined using serum serology from people aged between 1 and 84 years. 
Therefore, the prevalence of active infection might be different to that reported due to 
serological testing methodology that is not able to discriminate between active and 
current infection. Furthermore, the testing of children of such a young age might mask 
the true infection rate as infection in these patients might develop later on in childhood. 
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Figure adopted from Hooi et al., (2017). Global overview of H. pylori prevalence.
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1.7. Clinical manifestations 
 
Clinical symptoms of H. pylori infection include; dyspepsia and acid reflux that has not 
responded to antacids and lifestyle changes, abdomen pain, nausea, loss of appetite 
and weight loss.  
 




All H. pylori infected individuals develop some degree of gastritis, but most remain 
asymptomatic. Gastritis can be diagnosed by symptoms but often corelates poorly with 
histological or endoscopic gastritis (Sugano et al., 2015). Gastritis is therefore best 
diagnosed by gastric endoscopy (described below).  
 
Gastritis is often a result of inflammation, intestinal metaplasia and atrophy with H. pylori 
being the leading cause of gastritis (Sugano et al., 2015). 
 
Gastritis is often reported as three different types; pangastritis, antrum predominant, 
and corpus predominant (figure 1.1).  
 
1.7.1.2. Ulcer disease 
 
Helicobacter pylori is an etiological agent of both duodenal and peptic ulcer disease 
(Serin et al., 2015). 
 
Different virulence factors and combinations thereof can increase the risk of ulcer 
disease. These virulence factors include; cagA, vacA s1/m1 genotype, dupA, iceA1, 
oipA and babA as recently reviewed by Chang, Yeh and Sheu (2018).  
 
1.7.1.3. Gastric adenocarcinoma 
 
Infection with H. pylori is the strongest known risk factor for gastric adenocarcinoma 
(Correa and Piazuelo, 2011). Gastric cancer is multifactorial with H. pylori infection and 
the action of bacterial virulence factors, disease precursors and progressions, host 
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genetics and environmental factors thought to play a role (Correa and Piazuelo, 2011). 
Furthermore, gastric cancer is suspected to be a multistep process over the period of 
infection. 
 
The human model of gastric carcinogenesis has been updated multiple times, but H. 
pylori is an etiological factor in each progression to adenocarcinoma (Correa, 1988b; 
Correa and Piazuelo, 2012). The first stage in the multistep cascade to gastric 
carcinogenesis is H. pylori infection and gastric inflammation (figure 1.4). The following 
step is to non-atrophic gastritis, potentially exasperated by H. pylori specific virulence 
factors (figure 1.4). Progression of atrophic gastritis may develop further as a result of 
H. pylori virulence factors, environmental factors and host genetic factors (figure 1.4). 
Atrophic gastritis is antecedent to intestinal metaplasia. Intestinal metaplasia can be 
slowed by the eradication of H. pylori infection, but healing can take many years or may 
not heal at all (Zullo et al., 2012; Walker, 2003). Gastric lesions associated with atrophic 
gastritis and intestinal metaplasia are the last step in the cascade to carcinogenesis 
(Correa and Piazuelo, 2012; Park and Kim, 2015).  
 
Helicobacter pylori virulence factors such as vacA s1/i1 isoforms and cagA status are 
important risk factors of gastric cancer (Winter et al., 2014; Park and Kim, 2015). A 
recent genome wide association study (GWAS) by Berthenet et al. (2018) identified a 
number of individual gene presences, paired gene presences and specific gene 
polymorphisms that increased gastric cancer risk. This study identified both virulence 








Gastric precancerous cascade adopted and adapted from Sipponen and Maaroos (2015).  
 
1.7.1.4. Mucosa associated lymphoid tissue lymphoma 
 
As with the development of gastric cancer, development of mucosa associated 
lymphoid tissue (MALT) lymphoma is thought to be a multistep progressive process 
starting from H. pylori infection and chronic gastritis (Farinha and Gascoyne, 2005).  
 
Physiologically, the stomach does not contain lymphoid tissue. However, chronic 
infection with H. pylori and persistent gastric inflammation results in the formation of 
MALT in the gastric mucosa. Specifically, H. pylori infection results in the recruitment 
of B lymphocytes, T lymphocytes and neutrophils to the site of infection. B cells 
proliferate due to reactive T cells, cytokines and activation of the CD40 pathway by H. 
pylori. Continuous stimulation and prolonged growth of B cells coupled with the 
presence of reactive oxygen and nitrogen species results in the acquisition of genetic 








– Low vitamin B12
– High homocysteine
– Impaired methylation cycle








Atrophic gastritis in antrum,
corpus, or both (pangastritis)
Intestinal metaplasia




In approximately 75% of cases, MALT lymphoma regresses after H. pylori eradication 
suggesting that H. pylori infection is required to maintain malignancy (Hatakeyama, 
2019).  
 
1.7.1.5. Extragastric diseases 
 
While H. pylori infection is localised to the gastric niche, there is a growing body of 
research into H. pylori associated diseases far from this primary site of infection. These 
have recently been reviewed by three recent publications (Ražuka-Ebela, Giupponi and 
Franceschi, 2018; Gravina et al., 2018; Franceschi, Covino and Roubaud Baudron, 
2019). 
 
In brief, H. pylori infection has been associated with extragastric diseases including; 
neurological diseases, cardiovascular diseases, pulmonary diseases, haematological 
diseases, autoimmune diseases, kidney diseases, metabolic syndromes, hepatobiliary 
diseases, pancreatic disease, inflammatory bowel disease, colorectal cancer, 





Patients presenting symptoms of a H. pylori infection such as dyspepsia and/or acid 
reflux that has not responded to antacids and lifestyle changes, usually follow a ‘test 
and treat’ strategy in the UK.  
 
Diagnostic tests include both invasive and non-invasive tests. Patients are often 
diagnosed by non-invasive techniques due to the high sensitivity and specificity of some 
of these tests and the increased comfort these types of tests afford the patient 
undertaking them. However, non-invasive tests do not allow for the culture of the H. 
pylori infection and thus offer little insight into the active infection.  
 
1.8.1. Non-invasive tests 
 
1.8.1.1. Breath test by Isotope labelled urea 
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Patients are often diagnosed by non-invasive techniques such as the heavy isotope-
labelled 13C-urea or 14C-urea breath test that takes advantage of the H. pylori induced 
enzymatic breakdown of the 13C-urea/14C-urea to ammonia and carbon dioxide by 
excreted urease. Enrichment of 13/14CO2 expelled in the patient’s breath is an indication 
of a current H. pylori infection. The sensitivity and specificity of this method are high, at 
96% and 93% respectively (Ferwana et al., 2015). However, false negative H. pylori 
infection results are increased if the patient has not stopped PPI drug administration 
two weeks prior to the urea breath test, due to reduced urease activity as a 
consequence of higher gastric pH caused by these drugs (Graham et al., 2003).  
 
1.8.1.2. Stool antigen test 
 
The stool antigen test comprises of two versions, an enzyme immunoassay and an 
immunochromatography based test. Both have high sensitivity and specificity in 
identifying H. pylori infection, but the enzyme immunoassay has been shown to be the 
superior of the two methods with test sensitivity and specificity as high as 94% and 97% 
respectively (Gisbert and Pajares, 2004; Shimoyama, 2013). The stool antigen tests 
are thought to be more affordable than the urea breath, but patients have a much higher 
preference for the urea breath test than for the stool antigen test (Shimoyama, 2013; 




Diagnosis of H. pylori infection by the non-invasive blood and urine serology tests are 
falling out of favour across the world. This is due to the need for a secondary 
confirmatory test to diagnose a current H. pylori infection, such as the urea breath or 
stool antigen test. Since antibodies can persist long after a H. pylori infection has 
cleared, serological tests are not suitable for eradication confirmation after therapy. 
Serological based tests are usually performed by the enzyme-linked immunosorbent 
assay (ELISA) and can target a range of anti- H. pylori antibodies. However, the 
sensitivity and specificity of the blood serology test are low at 50% and 54% respectively 
(Kazemi et al., 2011). Therefore, it is no surprise that this diagnostic test is not preferred. 
However, a study by Stratton and Laczek, (2013) has shown that before the blood 
serology test was revoked as a diagnostic test within their institution, there was a much 
higher compliance to the H. pylori blood serology test as well as a higher total number 
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of H. pylori diagnostic tests being requested. This might indicate a patient preference 
towards the blood serology test that might improve patient compliance to diagnosis.  
 
1.8.2. Invasive tests 
 
1.8.2.1. Gastric endoscopy 
 
Invasive diagnosis of H. pylori infection is carried out on biopsies taken from the 
stomach and confirmed through a biopsy urease test or through microscopy using the 
modified Giemsa stain (Rotimi et al., 2000; Chen, Chang and Lee, 1995). Invasive 
diagnosis by gastric endoscopy is recommended in patients over the age of 55 with 
recent, unexplained dyspepsia (Gisbert and Calvet, 2013). This is not to say that gastric 
endoscopy is never undertaken in patients under the age of 55. Patients below this age 
with persistent dyspepsia not alleviated by PPIs or lifestyle changes, sudden and 
unexplained weight-loss, persistent abdominal pain or patients with resistant H. pylori 
infection identified by a failed eradication therapy attempt are often referred for gastric 
endoscopy (Papastergiou, Georgopoulos and Karatapanis, 2014; Gisbert and Calvet, 
2013). However, as the gastric cancer rate is low in people under the age of 55 in most 
Western European countries this age threshold for gastric endoscopy referral is thought 
to be adequate (Gisbert and Calvet, 2013). Furthermore, the ‘test and treat’ strategy 
has been shown to be as efficient as the more costly prompt endoscopy for dyspeptic 
patients further validating the use of this strategy in the clinical setting (Lassen, Hallas 
and Schaffalitzky de Muckadell, 2004; Lassen et al., 2000; Talley, 2005).  
 
For these reasons, gastric endoscopy is infrequently carried out on H. pylori infected 
patients who generally follow the ‘test and treat’ strategy in the UK. However, gastric 
endoscopy is still the best method of detecting gastric cancers and gastric cancer risk 
as informed by histological examination of the pinch biopsy samples (Choi et al., 2018; 
Sakitani et al., 2018). The updated Sydney scoring system for histologically examined 
biopsies is used to score the environment for normal (0) and high (3) levels of 
inflammation, activity, intestinal metaplasia and atrophy (Dixon et al., 1996). High levels 
of intestinal metaplasia with gastric atrophy have been shown to be early markers of 
gastric cancer (Correa, 1988a; Correa, Piazuelo and Camargo, 2004). However, gastric 
cancer development is thought to be a multi-step process as a result of indirect 
inflammatory effects and/or the direct epigenetic effects of H. pylori infection as 
reviewed by Ishaq and Nunn, (2015).  
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1.9. Eradication therapy 
 
1.9.1. Eradication therapy in England 
 
1.9.1.1. First line treatment regime 
 
For geographic regions with clarithromycin susceptibility > 80-85%, a seven day triple 
therapy course consisting of amoxicillin with either clarithromycin or metronidazole 
coupled with a PPI should be prescribed (Sugano et al., 2015; Public Health England, 
2017). In case of penicillin allergy clarithromycin coupled with metronidazole and a PPI 
should be prescribed (Public Health England, 2017). 
 
1.9.1.2. Second line treatment regime 
 
If symptoms persist after first line eradication therapy a second line treatment regime 
should be prescribed consisting of a seven day course of PPI with amoxicillin and the 
antibiotic not prescribed from the first line therapy (Public Health England, 2017).  
 
In the case of allergy to penicillin, seven days of PPI coupled with bismuth subsalicylate 
or tripotassium dicitratobismuthate with tetracycline hydrochloride and metronidazole 
are prescribed (Public Health England, 2017). 
 
1.9.1.3. Third line treatment regime 
 
Persistent symptoms after first line treatment regime and previous patient exposure to 
metronidazole and clarithromycin should be prescribed third line treatment.  
 
Third line treatment consists of a PPI with amoxicillin and tetracycline hydrochloride or 
levofloxacin for a course of seven days (Public Health England, 2017).  
 
In case of amoxicillin allergy, third line therapy consists of the second line therapy plus 
levofloxacin (if patient not previously exposed to levofloxacin) and metronidazole for 
seven days (Public Health England, 2017).  
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1.9.2. Other eradication regimes 
 
1.9.2.1. Bismuth quadruple therapy 
 
Bismuth coupled with a triple therapy consisting of a PPI and two antibiotics has been 
shown to be an effective eradication regime (Tursi et al., 2017; Fiorini et al., 2017). 
 
However, bismuth quadruple therapy is recommended as a potential rescue regime or 
in areas with high antibiotic resistance to clarithromycin (Malfertheiner et al., 2017).  
 
1.9.2.2. Sequential and concomitant therapy 
 
Sequential therapy usually consists of a PPI coupled with an antibiotic for a seven day 
course immediately followed by a second seven day course of a different proton pump 
inhibitor and antibiotic (O’Morain et al., 2018). 
 
Concomitant therapy consists of a PPI and three antibiotics (O’Morain et al., 2018). 
 
Sequential therapy has been shown to be better at eradicating H. pylori infection and 
concomitant therapy has been shown to be superior to sequential therapy as reviewed 
by O’Morain et al. (2018). However, patient compliance to these regimes is low and no 
longer recommended (O’Morain et al., 2018). 
 
1.9.2.3. Hybrid therapy 
 
Hybrid therapy usually follows a course of 14 days with the first seven days consisting 
of a PPI and one – two antibiotic(s) followed by seven days with an additional two 
antibiotics (Miftahussurur et al., 2017; Ashokkumar et al., 2017).  
 
However, eradication rates were reportedly reduced due to duel antibiotic resistance 
(O’Morain et al., 2018).  
 
1.9.2.4. Culture-guided treatment 
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Culture-guided treatment has recently been recommended after a failed second line 
treatment. However, it is argued that as antibiotic resistance is ever increasing, culture-
guided treatment should be used after a failed first line treatment (O’Morain et al., 2018). 
 
Culture-guided treatment can be accomplished by antimicrobial susceptibility testing or 
resistance genotyping (O’Morain et al., 2018). However, an internationally recognised 
disk-diffusion methodology is not yet established (Ogata, Gales and Kawakami, 2014). 
 
1.9.2.5. Probiotics 
A recent meta-analysis revealed a potentially promising increase in eradication of H. 
pylori by inclusion of probiotics with existing eradication regimes (Si, Lan and Qiao, 
2017).  
 
Probiotics have been used in combination with quadruple eradication therapies with 
one study showing a 16% reduction in antimicrobial associated patient side effects such 
as dyspepsia, nausea/vomiting, diarrhoea and abdominal pain (Jung et al., 2018).  
 
Probiotics, as a potential strategy against H. pylori infection was recently reviewed by 
Qureshi, Li and Gu, (2019), who report on the efficiency of probiotics as an alternative 
to H. pylori eradication treatment, as an adjunct to H. pylori eradication treatment and 
as a potential vaccine delivery vehicle.  
 
1.10. Antibiotic resistance 
 
Antibiotic resistance is a global One Health concern that threatens effective eradication 
and prevention of virtually all clinically relevant bacterial infections. 
 
Antibiotic resistance in H. pylori is conferred by chromosomal mutations and not through 
mobile genetic elements. Therefore, spread of resistance phenotypes is thought to 
occur vertically from the resistant strain to its descendants (Mégraud, 2004). However, 
H. pylori is known to have an extremely high recombination rate suggesting that 
resistance genotypes could be passed horizontally between strains via homologous 
recombination (Falush et al., 2001a). Furthermore, H. pylori is capable of transformation 
suggesting that resistance genotypes could be integrated from the DNA of lysed cells 
(Bubendorfer et al., 2016a).  
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Resistant phenotypes might develop within a susceptible population during the course 
of infection due to the extremely high natural mutation rate of H. pylori (Falush et al., 
2001a). As H. pylori can persist as a lifelong infection, antibiotics taken by a patient for 
an unrelated bacterial infection is unlikely to eradicate the resident H. pylori population 
(see eradication therapy, section 1.9). However, antibiotics taken by the patient 
throughout life, might contribute to the clearance of susceptible strains, leaving behind 
the more resistant phenotypes, driving H. pylori antimicrobial resistance as a result.  
 
A recent study by Savoldi et al. (2018), systemically reviewed the prevalence of all 
WHO regions and found alarming levels of resistance worldwide. In particular, 
resistance to clarithromycin, metronidazole, and levofloxacin were ≥15% in almost all 
WHO regions.  
 
Due to concerning levels of resistance to clarithromycin worldwide, a first line antibiotic 
in the eradication of H. pylori (see eradication therapy, section 1.9), the WHO 
designated clarithromycin-resistant H. pylori as a high priority bacterium for antibiotic 
research and development in 2017 (World Health Organization, 2017).  
 
Heteroresistant H. pylori infections are becoming more common, but there is no 
standardised protocol for the detection and treatment in the clinical setting (Rizvanov 
et al., 2019). Furthermore, H. pylori strains taken between the antrum and corpus of 
same patients have presented with varying phenotypic resistances to antibiotics (Kim, 
Kim and Kwon, 2003; Selgrad et al., 2014). However, mixed H. pylori strain infections 
are difficult to investigate due to fastidious growth requirements hampering the selection 
of a wide range of single colony isolates to provide a representative sample. 
Furthermore, the presence of just one resistant strain has the potential to survive 





The first complete genome sequence of H. pylori was published in 1997, using a 
random sequencing approach and dye-terminator sequencing (Tomb et al., 1997). This 
strain, denoted as strain 26695, was obtained from a patient in UK suffering from 
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gastritis. This strain was also found to elicit an immune and inflammatory response in 
animal models and was known to be toxigenic and transformable. The first complete 
sequence revealed H. pylori has a relatively small genome size of 1,667,867 bp in 
length, has a low GC content of 39% and contained approximately 1590 coding 
sequences (CDSs). This first complete H. pylori genome highlighted potential important 
genes that might be involved in host-pathogen interactions such as adhesins, 
lipoproteins and other outer membrane proteins due to their high abundance.  
 
In 1999 a second research group published the second complete genome sequence of 
H. pylori denoted as strain J99 and compared it with 26695 using comparative 
genomics techniques (Alm et al., 1999). This study revealed a similar genomic 
organisation in terms of gene order and predicted proteomes, but with extensive 
genomic and allelic diversity. This study also reported that 7% of genes were unique 
between the two strained investigated suggesting a diverse accessory genome.  
 
A follow up study a year later by Alm et al. (2000b), used comparative genetics to 
analyse OMP families using H. pylori strains 26695 and J99. They further investigated 
the large number of OMP present between the genomes and identified five paralogous 
gene families. This revealed a generally high orthologous protein pair identity, but some 
OMP genes had much lower nucleotide identity. Furthermore, it was found that gene 
duplication was not uncommon for some OMP related genes.  
 
These early comparative genomics studies started to reveal the astonishing allelic 
diversity of H. pylori whilst also revealing comparatively similar genomic organisation 
and accessory genome flexibility.  
 
1.11.1. Multilocus sequence typing and phylogeographic clustering 
 
Multilocus sequence typing (MLST) is based on the nucleotide sequences of seven 
‘housekeeping’ genes that groups isolates by homology (Maiden et al., 1998).  
 
The largest MLST database is that of H. pylori, but this database is by no mean 
comprehensive with one study uploading ten genomes for which more than half of the 
alleles were not present within the database at the time of the study (Larsen et al., 
2012). This further highlights the extraordinary genetic diversity of H. pylori strains and 
suggests so called ‘housekeeping’ genes are much more diverse than those generally 
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used in the MLST scheme. Such diversity will certainly limit the power of MLST analysis 
in the short term as more sequences will need to be uploaded and potentially in the 
long term as such diversity might begin to confuse analysis.  
 
Despite this, MLST analysis was first applied to H. pylori strains from different 
geographical regions, revealing phylogeographic clustering (Achtman et al., 1999). 
Similar MLST studies have followed including the use of virulence genes in identifying 
local and global phylogeographical clustering of H. pylori strains and even identified 
past human migration events and an African origin around 58000 years ago (Falush et 
al., 2003; Linz et al., 2007; Moodley et al., 2009; Wirth et al., 2004; Yamaoka et al., 
2002b) 
 
1.11.2. Natural mutation, homologous recombination and natural transformation 
 
Studies investigating the natural mutation rate of H. pylori agree on a rate between 1.38 
´ 10-5 and 0.7 ´ 10-6 per year per site (Falush et al., 2001a; Linz et al., 2014; Morelli et 
al., 2010; Didelot et al., 2013; Furuta et al., 2015a; Kennemann et al., 2011). This 
natural mutation rate is between 10 – 100 times higher than Escherichia coli (Dorer, 
Sessler and Salama, 2011).  
 
The recombination rate of H. pylori has been shown to be around 6.9 ´ 10-5 per initiation 
site per year (Falush et al., 2001a). However, recombination has been shown to vary 
between H. pylori strains but are thought to introduce up to 100 times more substitutions 
than natural mutations (Didelot et al., 2013).  
 
Natural transformation of H. pylori can result in the uptake of DNA resulting in up to 8% 
of sequence replacement through multiple transformation cycles (Bubendorfer et al., 
2016a). High natural transformation in H. pylori introducing mosaic DNA imports is 
thought to be a driver of allelic diversity (Kulick et al., 2008). 
 
1.11.3. Genetic diversity 
 
Helicobacter pylori has colonised humans for at least 58,000 years and persists as a 
chronic lifelong infection (Linz et al., 2007). These properties have allowed H. pylori to 
co-evolve with humans with evidence of global, local and individual adaptations, 
conferring vast genetic diversity.  
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High natural mutation, homologous recombination and natural transformation rates of 
H. pylori all drive genetic diversity at a global, local and individual patient population 
level. Natural mutation drives clonal diversity over time while homologous 
recombination and natural transformation can introduce genetic diversity across 
sections of DNA by single or multiple events. Therefore, mixed H. pylori strain infections 
are thought to amplify within patient diversity more than a single strain infection. 
 
Studies have highlighted OMP genes and other cell surface-related protein genes, 
restriction-modification genes, virulence associated genes and signal transduction 
genes to be especially genetically diverse (Oleastro et al., 2010; Furuta et al., 2015; 
Pride, Meinersmann and Blaser, 2001). It is thought that some genes may be highly 
diverse due to specific host adaptation (Dubois et al., 1999). 
 
1.12. Study rationale 
 
Patients are thought to be initially infected by single or multiple strains of H. pylori during 
early childhood. This can persist as a lifelong infection of the host. Considering the 
exceptionally high natural mutation and recombination rate of H. pylori the infecting 
strain is thought to diversify by natural mutation and homologous recombination that 
ultimately leads to sub-populations or quasispecies, with a mixed infection accelerating 
and amplifying this further. This potentially leads to low abundant strains within the 
larger or dominant population that are harder to isolate which might hold higher 
virulence and resistance phenotypes. Indeed, there is a large body of evidence that 
describe this extensive H. pylori genetic diversity both within and between patients.  
 
Despite this knowledge, most studies follow a single colony isolation methodology, with 
all genomics-based studies following this protocol to date. This has potentially resulted 
in a low-resolution snapshot of the more common genetic diversity, which has had 
considerable impact on the progression of our understating of H. pylori infection. 
However, there are still questions outstanding and questions that have not been fully 
elucidated such as how H. pylori is able to persist as a lifelong chronic infection, why 
most patients remain asymptomatic while others develop more severe gastritis and 
disease progressions, what contributes to eradication therapy failure and if different 
niches within the human stomach select for different H. pylori strains.  
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In this thesis, single colony and population-based methodologies were designed and 
executed to better understand H. pylori genomic and phenotypic diversity within 
patients by investigating both within and between niche genomic diversity from paired 
antrum and corpus biopsies. This between and within niche line of study was designed 
to investigate potential niche specific adaptations due to the differences between the 
antrum and corpus niches (section 1.4.4).  
 
To investigate the within and between niche (antrum and corpus) antibiotic resistance 
differences, an inexpensive and reliable disk diffusion based method was developed 
(Chapter Three). 
 
Populations of clinically isolated H. pylori were screened for minor allelic variants using 
a deep population sequencing technique and read mapping based bioinformatics 
analysis (Chapter Four). This analysis aimed to elucidate the population level of genetic 
diversity at a single point in time.  
 
Single colony isolates of H. pylori were also isolated from a subset of patient biopsies 
to allow for further analysis not permitted by deep population sequencing such as 
phylogenetic reconstructions and recombination detection. Additionally, the single 
colony isolate analysis was compared to the deep population sequencing dataset and 
used for data validation (Chapter Five).  
 
Two patients with sequential biopsies taken from before and after failed eradication 
therapy were investigated by the deep population and single colony sequencing to 




















2.1. Sample acquisition, typing, culture, and storage 
information 
 
Clinical biopsies were taken from patients attending for upper gastrointestinal 
endoscopy with suspected H. pylori infection at the Queens Medical Centre in 
Nottingham by Professor John Atherton and team at the University of Nottingham. 
Paired biopsies of the antrum and corpus of 15 patients, along with single biopsies from 
one region of three patients were taken. The updated Sydney scoring system (Dixon et 
al., 1996) was used to determine clinical inflammation, activity, atrophy and intestinal 
metaplasia at the time of endoscopy by Professor Atherton and team. Separate 
biopsies were taken for histology and isolation of H. pylori but were taken from the same 
region of the stomach. 
 
Initial H. pylori culture from pinch biopsy samples was carried out by Professor Atherton 
and team at the University of Nottingham and not by the author. These pinch biopsies 
were plated onto blood base #2 agar plates (Oxoid, UK) containing 5% (v/v) horse blood 
(TCS Biosciences, UK) and incubated for 2-3 days at 37°C under microaerophilic 
conditions (10% CO2, 5% O2, 85% N2). Single colony isolates and/or sweeping growth 
from each biopsy was picked and pooled, avoiding bacterial contaminants that might 
also be present. Picked growth was stored within iso-sensitest medium (Oxoid, UK) 
containing 15% (v/v) glycerol (Sigma Aldrich, UK) and stored at – 80°C.  
 
The resulting H. pylori clinical sweep stocks were then provided to Nottingham Trent 
University by Professor Atherton and colleagues and sub-cultured by the author (as 
described later in section 2.2) for use in the studies described herein. Approval for use 
of clinical isolates was granted by the NHS National Research Ethics Service, 
Nottingham Research Ethics Committee (Ref: 08/H0408/195) 27th January 2009 
(Appendix, figure 10.2.1). 
 
It must be noted that virulence genotyping by PCR for vacA, cagE, cagA and CagA 
serology by ELISA was conducted and reported by Professor Atherton and colleagues 
at the University of Nottingham and not by the author. These were carried out as 
previously described by the research group (Atherton et al., 1995; Peek et al., 1995; 
Kidd et al., 2001; Reyes-Leon et al., 2007a).  
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It must be noted that the anonymised patient data presented within this thesis was 
collected by Professor Atherton and colleagues at the University of Nottingham and not 
by the author. 
 
2.2. Culture from frozen stocks 
 
Helicobacter pylori stocks were part thawed by gently warming the top section of the 
cryo-tube and a 75 µl quantity was immediately pipetted onto a pre-warmed (inoculum 
free culture plate placed in the 37°C incubator overnight) culture plate made up of blood 
base #2 agar containing 5% (v/v) horse blood. A pre-warmed culture plate was used to 
ensure there was no prior contaminant present on the culture plate before inoculation. 
A sterile inoculation loop/swab was then used to spread this droplet across the culture 
plate in cross sections (figure 2.1) to maximise the abundance of edge growth. This 
method also allowed for better determination of contaminants post incubation.  
 
Special care was taken to minimise culture passage cycle numbers of H. pylori stocks 
to avoid laboratory-adaptation as large passage numbers can lead to loss of viability, 
loss of virulence and other genetic mutations (Leiser et al., 2015; Wirth et al., 1998; 
Gaillard et al., 2011).  
 
Once inoculated, culture plates were incubated for 48-72 hours under microaerophilic 
conditions to allow for sufficient growth from frozen stocks and then subcultured onto a 
fresh culture plate using the culture pattern described below (figure 2.1) for 16-24 hours 
under microaerophilic conditions. Subsequent cultures were used for the experiments 
described herein, unless otherwise stated.  
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Typical culture pattern of H. pylori from frozen stock. Brown cross sections show how stocks 
were spread across a blood agar base #2 culture plate supplemented with 7.5% defibrinated horse 
blood to allow for better contamination detection by manual observation. This method also 
allowed the researcher to extract more viable H. pylori growth by extracting from the edge of 
these lines.  
 
2.3. Rapid urease test 
 
A rapid urease test was carried out on all stocks obtained from the University of 
Nottingham in order to determine the presence of H. pylori and to help identify stocks 
that were contaminated.  
 
A 10% weight/volume of urea powder (Sigma Aldrich, UK) was dissolved in sterile 
distilled water. A 1% phenol red solution (Sigma Aldrich, UK) was prepared in sterile 
distilled water and 2-3 drops were added to a 10 ml stock of the 10% urea solution to 
create a working stock for the rapid urease test.  
 
Approximately 100 µl of the working stock of the rapid urease solution was added to 
the wells of a sterile 96 well microtiter plate (Appleton Woods, UK). Using a 1 µl 
inoculation loop, a small amount of bacterial growth was collected and used to inoculate 
a single well containing the rapid urease solution. A sudden colour change within 15 
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seconds of inoculation from orange to pink indicated the presence of the H. pylori 
urease and thus a H. pylori positive culture. Negative samples were discarded.  
 
2.4. DNA extraction 
 
Whole genomic DNA was extracted from clinical sweep populations from all patients 
described in Chapter Three. Samples selected for whole genome sequencing were 
cultured as described previously (Chapter Two section 2.2) and gDNA was extracted 
using the QIAGEN (Netherlands) QIAmp DNA Mini Kit following the manufacturer’s 
instructions with minor alterations. These alterations were; reduction of incubation in 
lysis buffer AW to less than ten minutes, extension of incubation of proteinase K to 16-
20 hours in buffer ATL, additional five minutes incubation at 70°C with 100 mg/ml 
RNase A (QIAGEN, Netherlands) in buffer AL, use of 4°C 100% (v/v) 200 proof 
molecular grade ethanol and additional final centrifugation step at 16,000 rpm on a 
benchtop centrifuge for ten minutes at room temperature. DNA was eluted in 90 µl non-
DEPC treated nuclease free distilled water (Thermo Fisher Scientific, USA), after 
incubation of the extraction column with the nuclease free water at room temperature 
for a minimum of 30 minutes. 
 
Reducing the incubation time of H. pylori culture in buffer AW ensured that proteinase 
K was promptly added to counter the effect of endonuclease action as H. pylori is known 
to harbour an abundance of restriction-modification (R-M) systems (Bubendorfer et al., 
2016b; Xu et al., 2000). Extending proteinase K incubation improved bacterial lysis and 
protein degradation, resulting in better column flow through, more consistent 
homogeneity and reduced protein contamination in the final eluate. Pre-cooled ethanol 
allowed genomic DNA to precipitate out of solution more efficiently and an additional 
centrifugation step at maximum speed (16,000 rpm) ensured that spin columns were 
thoroughly dry and free of residual ethanol. Reducing the elution volume while 
increasing the incubation time increased the resulting DNA eluate concentrations. 
 
During all incubation steps, with the exception of the incubation of nuclease free water 
prior to elution, samples were vortexed at frequent intervals and where possible, 
incubated on a shaking dry-heat block to prevent separation and autoagglutination of 
the bacterial component. 
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Transfer of samples to the spin columns was performed using broad 1,000 µl tips to 
avoid mechanical shearing of genomic DNA. 
 
Taken together, these amendments to the standard genomic DNA extraction protocol 
improved DNA yield and quality. 
 
2.5. DNA Qualification and Quantification 
 
DNA quality was determined using the NanoDrop2000 spectrophometer (ThermoFisher 
Scientific, USA) using strict absorbance ratio cut-off values. Quality ratios considered 
acceptable were the A260/A280 and A260/A230 with a range of 1.8 - 1.9 and 1.9 - 2.2 
respectively. 
 
Samples with an irregular spectral curve or distortion were discarded and re-extracted 
due to suspected contamination. 
 
A minimum sample concentration as determined by the NanoDrop2000 of 30 ng/µl was 
required with samples found to be below this discarded and DNA extraction repeated. 
However, this quantification was not relied upon for downstream processing such as 
sequencing library preparation and was used only as an inclusion criterion. This was 
due to the inaccuracy of ds-DNA quantification of the NanoDrop2000 platform as the 
concentration is determined by absorbance at 260 nm which include all nucleic acids 
present within the sample. Therefore, this reading also includes RNA and ssDNA which 
will not be sequenced, resulting in an overestimation of the ds-DNA sequencing target 
within the sample (Nakayama et al., 2016).  
 
Samples with extracted genomic DNA passing the above criteria were frozen at -20°C 
for long term storage (up to 12 months). 
 
Immediately prior to whole genome sequencing, stock DNA was diluted 1:5 in nuclease 
free water to create a sequencing stock. This sequencing stock was then accurately 
quantified for ds-DNA using the ds-DNA high sensitivity (HS) assay kit (ThermoFisher 
Scientific, USA) on the Qubit fluorometric quantification platform (ThermoFisher 
Scientific, USA). In contrast to the NanoDrop2000, the Qubit detects the fluorescence 
of PicoGreen which is a fluorochrome that specifically binds ds-DNA, detected by a 
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significant increase in fluorescence with very little background interference (Ahn, Costa 
and Rettig Emanuel, 1996). Sequencing stocks were diluted to the desired starting 
library preparation concentration of 0.3 ng/µl. To improve the detection accuracy of the 
Qubit, the input genomic DNA was loaded at 10 µl in 190 µl of loading dye. 
 
2.6. Population whole genome sequencing considerations 
 
Herein, deep sequencing is defined as an average nucleotide coverage depth of >100.  
 
In order to obtain high sequencing coverage depth at each nucleotide base within the 
target genome, the number of samples loaded onto each run was significantly reduced 
so that the available sequencing output was dedicated to these samples. This allowed 
for greater resolution at each nucleotide base position within the genome permitting the 
detection of allelic variation observed within the sequenced bacterial population.  
 
To this end, the MiSeq V3 reagent kit (Illumina, USA) was chosen over the V2 chemistry 
as the difference in sequencing output was 6.5 Gb with a difference in read output of 
10 million reads. This permitted more samples to be loaded onto a single sequencing 
run while keeping the desired average sequencing coverage of >100 per sample. The 
expected sequencing depth per sample was calculated by utilising the Lander and 
Waterman (1988) equation as follows: 
 
 





Although this modified Lander and Waterman (1988) equation assumes a number of 
fixed parameters that are not achievable in actual sequencing operation, it acts as an 
estimation of sequencing coverage. These assumptions include; fixed fragment 
lengths, uniform fragment selection, stable target genome lengths and a fixed cartridge 
read output (Evans, Hower and Pachter, 2010). Therefore, to counter variations from 
actual sequencing operation and to more confidently obtain an average coverage of 
>100, we targeted a sequencing coverage of >200 using this equation. For these 
reasons, a maximum of 18 samples were used as input on any single deep sequencing 








  = 206.68 
 
2.7. Single colony sequencing considerations 
 
For single colony sequencing of H. pylori isolates, an average coverage of ³30x at each 
nucleotide position within the genome was desired. A coverage of this size allows for 
more accurate downstream analysis and a better genome assembly. Using the 
equation described above (section 2.6) a sequencing run sample size of 48 single 
colony isolates was chosen as this provided a theoretical average coverage of 77.5 
bases per nucleotide position on the genome. Again, this theoretical coverage was 
more than double the desired coverage to account for any variations in actual 
sequencing operation. 
 
2.8. Whole genome sequencing 
 
All whole genome sequencing runs were conducted inhouse at Nottingham Trent 
University on the Illumina MiSeq platform (Illumina, USA). Two deep sequencing and 
two single colony isolate runs were performed by the author while a third single colony 
sequencing run containing 23 single colony isolates was carried out by Pauline 
Ogrodzki (fellow postgraduate researcher) following the same methodology.  
 
Following DNA qualification and quantification (section 2.5) and taking the library type 
into consideration (sections 2.6 – 2.7) the Nextera XT DNA Library Prep Kit Reference 
Guide (Document # 15031942 v02, Illumina, USA) was consulted and followed with 
minor adjustments. Briefly, genomic DNA (gDNA) underwent tagmentation using the 
Nextera XT transposase which fragments the ds-gDNA whilst tagging adapter 
sequences to the ends of the DNA fragments. Genomic libraries were then indexed 
using the Nextera XT Index Kit (Illumina, Cambridge, UK) and cleaned using Agencourt 
AMPure XP beads (Beckman Coulter, USA). Following this, indexed and cleaned 
libraries were manually normalised to 4 nM using the Qubit method described in section 
2.5. In order to account for the molar conversion of ng/µl an average insert/fragment 
size was determined using the Agilent 2200 TapeStation (Agilent Technologies, USA) 
and input into the following equation: 
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Molarity (nM) = STUSVUWXYWZTU	[XT\	]^_ZW	(ng/µl)
``a	g/mol ´	YbVXYcV	ZUdVXW	dZeV 	× 	10
`    
 
This normalisation method was preferred over the bead-based normalisation method 
described within the Nextera XT DNA Library Prep Kit Reference Guide as it allowed 
for more control over the library normalisation step. 
 
Normalised libraries were pooled and denatured into single stranded DNA (ssDNA) 
using 0.2 N sodium hydroxide as described in the MiSeq System Denature and Dilute 
Libraries Guide (Document # 15039740 v01, Illumina, USA). Libraries were diluted to a 
loading concentration of 20 pM and spiked with 1% PhiX. PhiX was used as a control 
and to allow for better quality reporting and cluster density quantification by the MiSeq 
base calling software.  
 
The MiSeq was set up to sequence in lengths of 250 bp in paired end mode. The post 
processing options were selected for adapter trimming, FastQ generation and 
demultiplexing into sample directories. 
 
2.9. Quality control of sequencing reads 
 
On completion of each sequencing run, the Illumina BaseSpace (Illumina, USA) online 
application produced run statistics were consulted to adjudge whether sequencing runs 
were successful. Statistics considered were; Q score distribution for all reads >Q30 
above 80%, smooth intensity plots over all cycles that do not overlap, cluster density 
close to the recommended density of 1,300 k/mm2 and near to equal read index 
distribution.  
 
Although the Illumina software reporter automatically detects and removes sequencing 
adapters from the 5’ of each paired end sequence, it does not always capture all 
sequencing adapter sequences and does not filter reads based on quality. Therefore, 
further curation processing steps were conducted on sequencing reads using additional 
software. Sequencing reads were trimmed for Illumina Nextera XT adapters and read 
through using Trimmomatic version 0.38 (Bolger, Lohse and Usadel, 2014) in paired-
end mode employing both a palindrome and simple read trimming method. In paired-
end mode, Trimmomatic maintains mate pair read correspondence, and uses 
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information obtained from both sequences to better identify and remove sequencing 
adapters. A ‘simple’ trimming event occurs when a sufficiently aligned match (by a user 
defined minimum alignment score) is found between the adapter sequence and the 
output sequencing reads. A palindrome trim detects adapter read through by ligating 
adapters to the beginning of mate pairs and their biological sequences are then aligned, 
if the biological sequence aligns with adapters present within the read of the reverse-
complement mate pair a trimming event occurs, leaving only the biological sequence 
and removing the adapter read through. This is important as these sequences are not 
part of the target biological sequence. The following command was used: 
 
trimmomatic PE -threads {user specified CPU/thread/core number} 
-trimlog {user named log output} {path to forward/mate pair 1 
reads} {path to reverse/mate pair 2 reads} {user named output 
for paired-end trimmed forward/mate pair 1 reads} {user named 
output for single-end trimmed forward/mate pair 1 reads} {user 
named output for paired-end trimmed reverse/mate pair 2 reads} 
{user named output for single-end trimmed reverse/mate pair 2 
reads} ILLUMINACLIP:{path to fasta with adapters}:2:20:10 
 
This allowed for a seed mismatch of 2 nucleotides so that trimming events were specific 
for the adapter sequence while still allowing for instances of incorrect base calling. The 
palindrome trimming threshold was lowered to an alignment score of 20 for paired-end 
reads to ensure the removal of adapter read through. For single ended reads, an 
alignment score of 10 was used for the palindrome trimming. A log file was created for 
troubleshooting purposes.  
 
Further to the removal of Illumina sequencing adapters, resulting reads were trimmed 
for quality and length using Sickle version 1.33 (Joshi and Fass, 2011). Sickle uses a 
sliding window approach equal to 0.1 times the length of the read and trims the read 
when the resulting quality within the window drops below a sequence/base quality 
threshold (user specified) by identifying where in the window this drop occurs. In paired-
end mode, Sickle takes two paired end inputs and outputs two trimmed paired-end 
sequencing read files. Where reads only pass in the forward or reverse mate pair, one 
of the mates is dropped and the passed mate is outputted as a ‘single’ read. The 
following command was used: 
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sickle pe -f {path to forward/mate pair 1 reads from Trimmomatic 
output} -r {path to reverse/mate pair 2 reads from Trimmomatic 
output} -t sanger -o {user named output of trimmed forward/mate 
pair 1 reads} -p {user named output of trimmed reverse/mate pair 
2 reads} -s {user named output of single reads} -q 30 -l 50 -g  
 
A quality cut off score of Phred 30 was chosen (i.e. base call accuracy >99.9%). This 
was chosen to improve data quality and enhance the reliability of downstream data 
processing steps such as variant discovery. In consideration of the possibility of 
trimming adapter read through, and to maximise the reads processed while removing 
very short reads, reads less than 50 bases in length were removed from the dataset.  
 
Curated reads were passed to FastQC version 0.11.7 (Andrews, 2010) for confirmation 
of expected trimming behaviour. In particular, the removal of sequencing adapters, 
base quality >Phred 30 and length distribution between 50 and 250 bases. Individual 
reports were generated for each forward and reverse read set and manually inspected 
for each sample. The following command was used: 
 
fastqc {path to input curated reads} --threads {user specified 
CPU/thread/core number} --outdir {path to output directory} 
 
2.10. Contamination detection of sequenced libraries with non-
H. pylori  
 
Contamination within sequenced libraries was detected by Kraken version 1.0 (Wood 
and Salzberg, 2014) using the MiniKraken 8GB database which was constructed from 
complete bacterial, archaeal and viral genomes available within RefSeq as of 18th 
October 2017. Kraken uses a k-mer based classification method over sequence 
alignment that maintains high sensitivity while reducing run time and computing 
memory (Wood and Salzberg, 2014).  
 
The following Kraken command was used: 
 
(kraken --threads {user specified CPU/thread/core number} --
preload --db {path to MiniKraken database} --fastq-input --gzip-
compressed --paired {path to forward/mate pair 1 reads from 
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Sickle} {path to reverse/mate pair 2 reads from Sickle} > {Kraken 
output}) 2> {user named Kraken log file directed from standard 
output} ; kraken-translate --db {path to MiniKraken database} 
{path to kraken output file} > {user specified output file for 
sample taxonomic lables} ; kraken-report --db {path to MiniKraken 
database} {input taxonomic lables file} > {user named output 
report file} 
 
For a sample library to be classed as contamination free (i.e. only contain reads 
belonging to the H. pylori species) > 92% of reads must be in support of H. pylori spp. 
classification with >95% of reads supporting the Helicobacter genus. This was to allow 
for a degree of leniency in relation to the vast genetic diversity observed within the 
Helicobacter genus.  
 
Contaminated samples were retained for downstream analysis as it was important to 
observe how the methods described within this thesis behave with such datasets. 
Furthermore, due to the nature of H. pylori sampling by endoscopy, it is not always 
possible to obtain a contaminant free/pure culture of H. pylori, despite considerable 
efforts to do so. Therefore, it was decided that there was utility in retaining contaminated 
datasets in order to stress-test bioinformatics methodology and to determine if 
contaminated datasets could be analysed in the context of this project. However, all 
contaminated datasets were noted and considered at all analysis steps and where 
included are detailed as such in each section.  
 
2.11. Whole genome assembly of sequenced populations and 
single colony isolates 
 
Curated sequencing reads (section 8) were assembled using SPAdes version 3.11.1 
(Bankevich et al., 2012). SPAdes applies the de Brujjn approach to assemble genomes 
by utilising varying k-mer strings from sequenced reads. Paired-end data is handled by 
reverse complementing one of the sequencing mates and assembling both together as 
a read pair, where resulting graphs show the reverse complement at their edge. 
SPAdes was invoked as follows: 
 
spades.py –-careful -t {user specified CPU/thread/core number} –
-pe-1 {path to forward/mate pair 1 reads from Sickle} –-pe-2 
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{path to reverse/mate pair 2 reads from Sickle} -o {path to 
output directory} 
 
SPAdes was run in ‘careful’ mode which informs SPAdes to run the post processing 
tool ‘MismatchCorrector’ that better resolves short indels and assembly based 
mismatches, resulting in improved genome assemblies.  
 
2.12. Curation of assembled genomes 
 
All assembled contigs for each sample were then passed through the quality 
assessment tool (QUAST) version 5.0.2 (Gurevich et al., 2013) which provides 
assembly quality based statistics. Statistics used for assembly inclusion were: total 
number of contigs (<500), number of contigs with more than 1,000 base pairs (<200), 
N50 (>18,000), total length of all combined contigs (1.68 Mb ± 1.4 kb) and GC content 
(38.8 % ± 0.5 %). Although the expected genome size of H. pylori is ~ 1.68 Mb we 
allowed for ± 1.4 kb as only high-quality reads (reads with a Phred score ³30) were 
used to create assembled genomes, potentially resulting in a reduced genome size in 
contrast to using all available sequencing reads. This was done to ensure high quality 
assembled contigs for downstream analysis steps. Furthermore, including lower quality 
reads from deep sequenced populations of H. pylori has the potential to introduce 
further assembly error as the likelihood of erroneous bases sequenced increases. This 
coupled with the naturally high mutation and recombination rate of H. pylori makes the 
curation of sequencing reads from population deep sequenced samples essential for 
further assembly based downstream analysis.  
 
2.13. Whole genome annotation 
 
Whole genome annotation was achieved using two different methods. Where genome 
annotations were used as part of an analysis pipeline, the associated tool used will also 
be described.  
 
Whole genome annotation by the rapid prokaryotic genome annotation (PROKKA) tool 
version 1.13 (Seemann, 2014) was used by running the following command: 
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prokka --cpus {user specified CPU/thread/core number} --compliant 
--centre C --locustag {user specified} --kingdom Bacteria --genus 
Helicobacter --species pylori --outdir {user specified} --prefix 
{user specified} --proteins {path to reference strain 26695 
annotation file} --evalue 0.001 {path to assembled genome .fasta} 
 
Prokka was run in ‘compliant’ mode to ensure a Genbank standard file format was 
produced as an output file. Further taxanomic information was written to the Prokka 
produced Genbank file in the form of kingdom, genus and species flags. The 
sequencing centre flag was used to shorten the centre ID that had proven to cause 
difficulties for some downstream analysis steps. The H. pylori reference strain 26695 
(NC_000915.1) was used to guide genome annotations and to provide ‘HP’ gene 
names as accepted nomenclature in the research field. The ‘evalue’ of 0.001 was set 
to increase the similarity e-value cut-off threshold to allow for potential gene diversity. 
 
A second annotation method was also employed for selected analysis pipelines using 
the rapid annotations using subsystems technology (RAST) online server (Aziz et al., 
2008). Assembled genomes were submitted to the RAST server (http://rast.nmpdr.org) 
and the taxonomy identification number 210 was inputted, relating to the taxonomy 
string of the Helicobacter genus as assigned by the NCBI (Sayers et al., 2009; Benson 
et al., 2009). The species was manually input as pylori and the genetic code 11 
(Archaea, most Bacteria, most Virii, and some Mitochondria) was selected. RAST was 
executed with the ‘Classic RAST’ annotation scheme, ‘FIGfam’ release 70, 
automatically fix errors, build metabolic model, back fill gaps and disable replication 
parameters. These settings were selected for all whole genome sequences to ensure 
all resulting annotations were comparable and standardised.  
 
2.14. Single nucleotide polymorphism/variant annotation and 
location determination (CDS / IGR)  
 
A pipeline was created to determine whether a single nucleotide polymorphism (SNP) 
was identified within a CDS or intergenic region (IGR) by intersecting SNP(s) on the 
corresponding fully annotated reference genome of the query dataset. All SNP/variant 
annotations were called from RAST annotated genomes (Chapter Two, section 2.13) 
to enable cross sample comparisons. 
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Briefly, all sequence sets were annotated through RAST (Chapter Two, section 2.13) 
and gene locations (chromosome number, start position, end position and gene product 
name) were extracted from GTF (general transfer format) files and input into individual 
files with four respective columns; CHR, FROM, TO, ANOTATION. These files were 
compressed and then indexed. Variant call format files containing SNPs from indexed 
same sample annotated genomes were then annotated through VCFtools version 
0.1.16 (Danecek et al., 2011). The following command was used: 
 
cat {path to VCF file} | vcf-annotate -a {path to compressed 
annotation file for the corresponding query dataset} \ 
 -d key=INFO,ID=ANN,Number=1,Type=Integer,Description='My custom 
annotation' \ 
 -c CHROM,FROM,TO,INFO/ANN > {path to output directory and user 
specified output file name} 
 
Resulting output VCF files contained an additional ‘ANN;’ field when the corresponding 
SNP was located within a CDS. However, if no ‘ANN;’ field was present for a particular 






















Gastric endoscopy and histological scoring by the updated Sydney system of the 
antrum and corpus has revealed niche specific differences (Zhang et al., 2005). This 
could be an indicator of different virulence types of a mixed H. pylori infection acting 
within these environments. Indeed, a study by Carroll et al. (2004), identified virulence 
gene differences between cagA 3’-end repeats from paired antrum and corpus isolates 
taken from the same patients as well as vacA signal type differences (s1/s2) from 
phylogenetically related familial isolates. This intra-patient virulence diversity has also 
been observed by others, including virulence positive and negative genotypes for the 
cagPAI (Melo-Narváez et al., 2018; Ailloud et al., 2019; Armitano et al., 2013; Peña et 
al., 2017). 
 
The vacA gene encodes a pore-forming toxin that has direct action towards gastric 
epithelial cells causing vacuoles to form (Cover and Blaser, 1992). However, the VacA 
toxin is known to be multi-functional and has other effects such as cell apoptosis and 
T-cell proliferation as well as other effects on different cell types (recently reviewed by 
Chauhan et al., 2019). The vacA gene has been shown to be multi allelic, consisting of 
multiple genotypes of the signal (s1a-c, s2), intermediate (i1, i2, i3) and middle (m1, 
m2) region (Chauhan et al., 2019). A study by Winter et al. (2014), revealed that H. 
pylori with the more active s1/i1 genotypes of vacA induced more severe and extensive 
metaplasia as well as inflammation than the less active s2/i2 genotype. Therefore, 
differences in inflammation and intestinal metaplasia between different niches of the 
human stomach might indicate the presence of a mixed H. pylori infection. The different 
middle region genotypes have been shown to affect colonisation of H. pylori highlighting 
another potential marker of a mixed infection by virulence type (Letley et al., 2003; Ji et 
al., 2000) 
 
Whilst the vacA gene is present in virtually all H. pylori strains, the cagPAI is either 
present or absent. Furthermore, strains can harbour an incomplete cagPAI which may 
affect the virulence potential of the cagPAI (Shimoyama, 2005; Ahmadzadeh et al., 
2015). The cagPAI is made up of a compliment of ~30 genes (Olbermann et al., 2010b). 
The cagPAI encodes for a type IV secretion system that ultimately results in the 
translocation of the effector protein CagA into the gastric epithelial cells (Odenbreit et 
al., 2000). Translocated CagA is able to bind to ~25 cell signalling factors causing 
effects ranging from inflammation induction, cell proliferation and cell apoptosis (Knorr 
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et al., 2019). Due to this oncogenic property, patients harbouring a functional cagPAI 
have been shown to be at higher risk of gastric cancer (Shanks and El-Omar, 2009; 
Hatakeyama, 2014).  
 
The cagE gene has been shown to be an essential core gene of the cagPAI, suggesting 
that the absence of this gene is important in the translocation of cagA (Pham et al., 
2012; Backert, Tegtmeyer and Fischer, 2015; Olbermann et al., 2010b). Furthermore, 
it has been shown that strains lacking cagE are more likely to harbour an incomplete 
cagPAI with additional missing genes (Markovska et al., 2018). However, the cagE 
gene has been implicated as a potential virulence factor associated with duodenal 
ulceration, suggesting it might have more than one function (Day et al., 2000). 
 
Antibiotic resistance profiles of H. pylori strains isolated between the antrum and corpus 
of the human stomach have also been identified (Kim, Kim and Kwon, 2003; Selgrad et 
al., 2014). Both studies concluded that patients harboured heteroresistant infections, 
most likely from a single infecting strain that has developed more resistant phenotypes 
as a result of natural mutation during chronic infection. One exception was noted by 
Selgrad et al. (2014), who identified one patient with a suspected multi strain infection. 
However, this was based on DNA fingerprinting by random amplified polymorphic DNA 
analysis, thus the true population diversity was not fully elucidated. Nonetheless, this 
methodology was able to detect one incidence of a mixed infection suggesting this 
technique could be employed to identify mixed strain H. pylori infections from patient 
biopsies. This is further supported by an early study by Kim, Kim and Kwon (2003) who 
investigated 220 strain pairs of H. pylori taken from antrum and corpus biopsies of 220 
different patients and found that 50% of patients held antibiotic resistant strains with 
heteroresistance from paired biopsy strains found in 38% of patients harbouring 
antibiotic resistant strains.  
 
Antibiotic resistance is usually associated with specific point mutations within the H. 
pylori chromosome rather than plasmid associated resistance acquisition. It is still 
possible for H. pylori strains to spread antibiotic resistance phenotypes to other 
susceptible H. pylori strains through homologous recombination, cell to cell conjugation-
like transfer and natural transformation (Paul et al., 2001; Hua et al., 1998; Oyarzabal, 
Rad and Backert, 2007; Kao et al., 2014; Hoffman, 1999). However, for this to occur, 
the sensitive and resistant strains would need to interact within the same environment. 
Considering the extent of re-infection with a different H. pylori strain or a new infection 
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via adult-adult transmission is not fully understood and is a currently open debate, the 
opportunities for a naturally antibiotic resistant strain to interact with a sensitive strain 
of H. pylori are perhaps limited (Perry et al., 2006; Stone, 1999; Perez-Perez et al., 
1991; Schutze et al., 1995). That being said, mixed H. pylori infections are not 
uncommon and are potentially a result of a multi-strain infection acquired during early 
childhood, most likely from an adult to child transmission from familial members (Malaty 
et al., 1998; Breckan et al., 2016; Ben Mansour et al., 2016). This presents an 
opportunity for different strains presenting varying antibiotic sensitivity to interact, 
potentially resulting in the spread of antibiotic resistance as adult H. pylori eradication 
failure rates increase.  
 
This thesis focused on investigating H. pylori diversity across the stomachs of individual 
patients.  
 
Due to financial and operational constraints, selection criteria were developed in order 
to target patients primarily with paired antrum and corpus samples with indicators of a 
mixed H. pylori infection. These indicators included cagA and cagE status and patient 
CagA serology status, antibiotic resistance differences between antrum and corpus H. 
pylori populations and histological differences between the two stomach niches.  
 
3.2. Materials and methods 
 
Clinical sweeps of H. pylori were obtained from patient pinch biopsies as described in 
Chapter Two section 2.1. 
 
Helicobacter pylori clinical sweep stocks were provided to Nottingham Trent University 
by Professor Atherton and colleagues and sub-cultured by the author for use in this 
thesis as described in Chapter Two sections 2.2 – 2.3. 
 
It must be noted that the anonymised patient data presented here was collected by 
Professor Atherton and colleagues at the University of Nottingham and not by the 
author. 
 
It must be further noted that virulence genotyping by PCR for vacA, cagE, cagA and 
CagA serology by ELISA was conducted and reported by Professor Atherton and 
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colleagues at the University of Nottingham and not by the author. These were carried 
out as previously described by the research group (Atherton et al., 1995; Peek et al., 
1995; Kidd et al., 2001; Reyes-Leon et al., 2007a).  
 
3.2.1. Sample selection for use in this thesis 
 
The University of Nottingham’s H. pylori culture collection database was interrogated to 
identify patients that potentially harboured a mixed H. pylori infection. Patients with 
paired antrum and corpus samples were prioritised to enable between and within niche 
comparisons. Patients were further identified by one or more of the following criteria: 
 
3.2.1.1. Virulence differences between different niches 
 
Differences between paired antrum and corpus virulence factor genotyping for cagA 
and cagE status (presence or absence) were identified and highlighted across tables 
3.2A and 3.2B in blue (opposite niche differences). This was an indication of a between 
niche mixed H. pylori infection.  
 
Antrum and corpus H. pylori genotyping differences in vacA signal (s1/s2), intermediate 
(i1/i2) and mid (m1/m2) type were identified across tables 3.2A and 3.2B as indicators 
of between niche H. pylori strain differences.  
 
3.2.1.2. Virulence differences within niches 
 
The indicator of within niche mixed H. pylori infection was multiple vacA signal (s1/s2), 
intermediate (i1/i2) and mid (m1/m2) types within one niche. Such occurrences were 
highlighted in orange across tables 3.2A and 3.2B.  
 
CagA serology was also used as an indicator. For example, if the patient was CagA 
serology positive but their H. pylori infection was cagA negative by PCR genotyping, 
this might be an indicator of a mixed infection where the genotyping missed the H. pylori 
strain(s) responsible for CagA delivery. A second example was where the genotyping 
result revealed a cagE negative and a cagA positive result for the H. pylori infection, 
but the patient was serology positive for CagA. A cagE negative result would indicate a 
potentially compromised type-4 secretion system, preventing the delivery of the CagA 
protein (Backert, Tegtmeyer and Fischer, 2015). Therefore, the CagA positive serology 
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result could indicate H. pylori strains with an intact type-4 secretion system held within 
the wider H. pylori infection. Other ambiguities such as a serology negative but a cagA 
or cagE and cagA positive genotype were also highlighted in orange across tables 3.2A 
and 3.2B.  
 
3.2.1.3. Histologically determined Sydney score differences between antrum and 
corpus niches 
 
Histologically determined Sydney scores were used to identify between niche 
environmental differences within the same patient. Sydney scores that were different 
between paired samples were highlighted in blue across tables 3.2A and 3.2B.  
 
3.2.1.4. Sequentially isolated cultures 
 
Although most patients in the Nottingham collection had been seen only once, there 
were two patients that had undergone gastric endoscopy on at least two different 
occasions. The first endoscopies were taken prior to eradication therapy while the 
second were post failed eradication therapy.  
 
While only one patient had antrum and corpus cultures available both before and after 
eradication therapy, both patients were included in this thesis. This is described in more 
detail in Chapter Six, but these patients were included due to the unique and rare 
opportunity to investigate differences between H. pylori infection before and after failed 
eradication therapy.  
 
3.2.2. Design of disk diffusion based antimicrobial resistance assay 
 
The British Society for Antimicrobial Chemotherapy (BSAC) was once the recognised 
authority in the UK for antimicrobial susceptibility breakpoint guidance in the clinical 
setting. However, BSAC has now moved towards the European Committee on 
Antimicrobial Susceptibility Testing (EUCAST) antimicrobial breakpoint guidelines in an 
effort to standardise breakpoints across Europe (Brown, Wootton and Howe, 2016). 
Neither BSAC nor EUCAST have a disk diffusion based antimicrobial clinical breakpoint 
guidance for H. pylori as they do for many other clinically relevant bacterial species. 
Instead, they recommend determining the minimum inhibitory concentration (MIC) of H. 
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pylori, to which they advise MIC breakpoints for amoxicillin, clarithromycin, levofloxacin, 
metronidazole, rifampicin and tetracycline (EUCAST, 2019). 
 
Therefore, a comprehensive search of the literature was undertaken to identify research 
studies that had employed a disk diffusion based antimicrobial susceptibility assay for 
use in this study. A combination of the EUCAST/BSAC and studies described within the 
literature were used to develop the disk diffusion based antimicrobial susceptibility 




Firstly, the reference H. pylori strain 60190 (ATCC 49503) was taken from long term 
storage (-80°C) and plated as described in Chapter Two section 2.2 onto three culture 
plates to ensure sufficient bacterial load. 
 
Following the EUCAST/BSAC guidelines a McFarland 3 standard was determined 
using the reference H. pylori strain 60190 (ATCC 49503) (http://bsac.org.uk/wp-
content/uploads/2014/06/Helicobacter-pylori.pdf). The H. pylori 60190 culture was used 
to inoculate 6 ml of sterilised (autoclave) 0.85% saline (Thermo Fisher Scientific, USA) 
within 18 mm, round bottomed, clear Pyrex® glass test tubes (wall thickness 1.2 mm ; 
Sigma Aldrich, UK) and made to a density of 0.582 ±0.008 (600 nm) using a 
spectrophotometer (model 6300; Jenway, UK). The spectrophotometer was blanked 
prior to reading using uninoculated 0.85% saline (NaCl). The H. pylori 60190 
suspension within the test tube was then placed into a densitometer (DEN-1; Grant 
Instruments, UK). This was repeated in triplicate and a McFarland reading of 2.8 was 
reported each time. The standard deviation of this instrument was 0.1 for a McFarland 
3 standard, as described in the manufacturer’s instructions, so this was used as the 
acceptable deviation during subsequent sampling (Grant Instruments, UK).  
 
A literature search of other research studies using a disk diffusion methodology for 
antimicrobial resistance typing inferred antibiotic concentrations and breakpoints as 
displayed in table 3.5. Antibiotic containing disks containing 10 µg amoxicillin, 15 µg 
clarithromycin, 1 µg levofloxacin, 5 µg metronidazole, 5 µg rifampicin and 30 µg 
tetracycline was sourced from Oxoid (Basingstoke, UK). 
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A total of four controls were selected to standardise the antimicrobial resistance assays. 
These strains were H. pylori 60190 (ATCC 49503), Escherichia coli DH5a (laboratory 
strain), E. coli 10418 (ATCC 10536) and Staphylococcus aureus (ATCC 9144). All 
control strains of bacteria were cultured as described in Chapter Two section 2.2, with 
the exception of the non- H. pylori cultures which were initially cultured from frozen 
stocks for 16-24 hours before subculture due to excessive growth over 48-72 hours of 
incubation compared to the fastidious H. pylori culture. Each culture was plated onto 
three culture plates during sub culturing (Chapter Two section 2.2) to ensure sufficient 
bacterial load.  
 
The day prior to sub culturing the frozen stocks, Mueller-Hinton agar (MHA) (Oxoid, 
Basingstoke, UK) plates containing 7.5% defibrinated horse blood were made up and 
a precise 30 ml was added to each petri dish. Once set, these antimicrobial culture 
plates were stored at 4°C until use, for a maximum of five days. Prior to culture, these 
inoculation plates were incubated overnight at 37°C in order to dry and indicate any 
culture plates that were contaminated. 
 
Each control bacterial culture was made up to a McFarland 2.8 ±0.1 using the 
densitometer (DEN-1) in 0.85% saline, with frequent light vortexing to keep the bacteria 
in suspension. Standard inoculums were stored at room temperature under aseptic 
conditions and used within 15 minutes of creation. Using a single cotton swab (wood-
stick; Scientific Laboratory Supplies, UK) and taking care the swab did not touch the 
outer or inner rim of the test tube, each cotton swab was thoroughly inoculated with the 
standard inoculum. This swab was taken out (making sure not to touch the inner or 
outer rim of the test tube – to avoid potential contamination) and plated onto one half of 
a pre-poured MHA plate containing 7.5% defibrinated horse blood. The swabs were not 
inoculated more than once. An additional control strain was treated in the same way 
and used to inoculate the second half of the culture plate, ensuring an approximate 5 
mm gap between the inoculums and avoiding cross contamination. This was repeated 
for five additional culture plate (six total). The six antibiotic containing disks were added 
to the centre of each plate (usually between the 5 mm gap – typically intersecting each 
inoculum by ~1 mm), one antibiotic disk per culture plate. This was also repeated for 
the remaining two bacterial controls (four total control strains).  
 
Inoculated culture plates containing the antibiotic disks were immediately incubated at 
37°C under microaerophilic conditions (10% CO2, 5% O2, 85% N2) for five days (120 
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hours). Zones of inhibition were measured (mm) from the circumference edge of the 
antibiotic containing disks.  
 
This methodology was repeated independently three times to gauge the reproducibility 
of this technique and to determine the expected zones of inhibition for these bacterial 
standards (table 3.1). The controls were used to validate subsequent antimicrobial 
resistance assays involving the H. pylori clinical sweeps used within this study (tables 
3.2A-B). 
 
3.2.3. Antimicrobial disk diffusion assay  
 
Antimicrobial resistance assays were conducted on all clinical sweeps used within this 
thesis (tables 3.2A-B) following the same procedure as that described above. The 
control strains were cultured alongside each antimicrobial resistance assay performed 
to validate each particular batch.  
 
Briefly, H. pylori clinical sweeps were cultured from frozen stocks and sub-cultured onto 
three culture plates to ensure sufficient bacterial load (Chapter Two section 2.2).  
 
Post sub-cultured incubation, each clinical sweep was made up to a McFarland of 
2.8±0.1 in 0.85% saline using the densitometer (DEN-1). Within 15 minutes, the 
standard inoculum was used to inoculate half of a 30 ml MHA plate supplemented with 
7.5% defibrinated horse blood using a single cotton swab. This was repeated for a total 
of six MHA plates.  
 
This was repeated for a different clinical sweep, inoculating the opposite half of the six 
MHA plates.  
 
Six different antibiotic containing filter disks were placed in the centre of each of the six 
MHA plates inoculated with two different clinical sweeps, one antibiotic disk per plate.  
 
This was repeated in triplicate for each clinical sweep.  
 
Mueller-Hinton agar plates inoculated with the clinical sweeps and antibiotic disks were 
incubated for five days under microaerophilic conditions. 
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After incubation, zones of inhibition were recorded in mm from the edge of the antibiotic 
disks to the edge of the zone of inhibition. Other information was recorded such as the 
observation of resistant colonies within the zone of inhibition or where two zones of 
inhibition were observed. If two potential zones of inhibition were observed, the stronger 
inhibition boundary of the outer zone was recorded as the main population inhibition 
size. A full table of zones of inhibition and notations on clinical sweeps with resistant 




3.3. Results and discussion 
 
3.3.1. Sample selection  
 
The initial target H. pylori clinical sweep list was much larger than those presented 
within this thesis (tables 3.2A-B). This was due to the failure of some cultures to grow 
or cultures that were contaminated, and so were excluded from the thesis. 
 
While the selection of presumptively mixed patient H. pylori samples/cultures from the 
same patients were identified for use in this thesis, it is possible that other patient 
samples outside of this selection criteria held a mixed infection and were overlooked. 
This could highlight a potential selection bias. However, the implementation of this 
selection criteria helped to identify samples of interest for use in this thesis. 
 
Furthermore, there is a potential selection bias relating to the way in which the H. pylori 
cultures were obtained from pinch biopsy samples. For instance, not all of the H. pylori 
strains within the sample might be culturable from the biopsy sample, resulting in a 
selection bias towards the culturable strains. One particular example of this could be 
related to H. pylori strains deep within gastric glands that might be difficult to extract 
whilst being passed over the agar plate (Fung et al., 2019). A second example could 
be H. pylori strains that are within a viable but non-culturable state (Boehnke et al., 
2017; Buck and Oliver, 2010). Additionally, by avoiding bacterial contaminants on the 
culture medium, there is the potential to miss the selection of all strains cultured from 
the biopsy sample.  
 
Information for the reader on patients and patient samples used within this thesis are 
presented in tables 3.1 – 3.4. 
 
There were many gaps in the information provided surrounding patient metadata (tables 
3.2A-B). However, such information was included to provide further information on the 
patients enrolled within this thesis.  
 
There were more females (n=11) than males (n=7) enrolled in this thesis (table 3.3). 
The average age of the participants was 60.39 years (standard deviation = 11.16 years; 
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minimum age 40 to maximum age 79). The reasons for gastric endoscopy varied greatly 
but all were symptomatic of H. pylori infection (de Jong, Lantinga and Drenth, 2019).  
 
All patients that were taking acid suppressant drugs had ceased use at least two weeks 
prior to gastric endoscopy (table 3.3). None of the patients had any other relevant drug 
history, such as antibiotic use before gastric endoscopy.  
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Table 3.1 Antibiotic zones of inhibition for control strains against six antibiotics 
 
 Antibiotics and zones of inhibition (mm) 
Control strains: Amx (10 µg): Clr (15 µg): Lvx (1 µg): Mtz (5 µg): Rif (5 µg): Tet (30 µg): 










24.67 (SD 0.58) 
E. coli DH5a 9.00 (SD 0.00) 0.00 11.17 (SD 1.04) 0.00 0.00 12.67 (SD 1.16) 
E. coli 10418 (ATCC 10536) 9.00 (SD 1.00) 0.00 12.83 (SD 2.37) 0.00 0.00 12.33 (SD 1.53) 





10.17 (SD 0.29) 0.00 
14.67 (SD 
0.29) 
15.00 (SD 0.00) 
 
Antibiotic zones of inhibition of control isolates for each antibiotic used within this study. The average zone of inhibition is denoted (from triplicate data) alongside 
the standard deviation (SD). All zones of inhibition were recorded in mm and measured from the edge of the antibiotic disk. These results were attained from the 
disk diffusion assay developed for this study as described in section 3.4.2. Antibiotic abbreviations; Amx – amoxicillin, Clr – clarithromycin, Lvx – levofloxacin, 
















cagE cagA CagA serology Inflammation Activity Atrophy 
Intestinal 
metaplasia 
45A s1 i1 m1 Positive Positive N/A 2 2 1 1 
77A s1 i1 m1 Negative Positive Negative 2 2 1 0 
93A s1 i1 m2 Positive Positive Negative 2 1 1 0 
120A s1 i1 m1 Negative Positive Negative 1 0 0 0 
194A s1 i1 m2 Positive Negative Positive 2 2 1 2 
265A s1 i2 m2 Positive Positive N/A 3 2 0 0 
295A*2 s1 i2 m2 Positive Positive Negative 2 2 0 0 
308A s1 i2 m2 Negative Negative Positive 2 2 0 0 
322A s1 i1 m1 Positive Positive Positive 1 0 1 3 
326A*2 s1 i2 m2 Positive Positive Negative 2 2 0 0 
439A s1 i1 m2 Positive Negative N/A 1 2 0 3 
444A s1 i1 m1 Positive Positive N/A 2 2 1 2 
495A s1 i1 m1 Positive Negative Negative 2 0 0 0 
537A*1 s1 i2 m2 Positive Positive Positive 2 2 0 0 
565A s2 i2 m2 Negative Negative Positive 2 2 1 0 
621A s1 i1 m1 Positive Positive Negative 2 2 0 0 
732A s1 i1 m2 Positive Positive Negative 2 2 0 1 
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cagE cagA CagA serology Inflammation Activity Atrophy 
Intestinal 
metaplasia 
45C s1 i1 m1 Positive Positive N/A 1 0 0 0 
77C s1 i1 m1 Negative Positive Negative 1 0 0 0 
93C s1 i1 m2 Positive Positive Negative 1 1 0 0 
120C s1 i1 m1 Negative Positive Negative 1 0 0 0 
194C s1 i1 m2 Positive Negative Positive 3 2 1 0 
249C*1 s1 i1/i2 m2 Positive Positive Positive 1 0 0 0 
265C s1 i2 m2 Positive Positive N/A 1 0 0 0 
295C*2 s1 i2 m2 Negative Negative Negative 1 0 0 0 
308C s1 i2 m2 Positive Positive Positive 2 1 0 0 
322C s1 i1 m1 Positive Positive Positive 3 2 0 1 
326C*2 s1 i2 m2 Positive Positive Negative 1 0 0 0 
439C s1 i1 m2 Negative Negative N/A 1 0 0 0 
444C s1 i1 m1 Positive Positive N/A 1 0 0 0 
495C s1 i1 m1 Positive Positive Negative 1 0 0 0 
565C s2 i1/i2 m2 Positive Positive Positive N/A N/A N/A N/A 
732C s1 i1 m1 Positive Positive Negative N/A N/A N/A N/A 
Tables 3.2A and 3.2B display the virulence typing and histologically scored Sydney results from the antrum and corpus respectively. Table fields are colour coded 
dependant on the criteria for sample inclusion of a presumptive mixed H. pylori infection (section 3.2.1). Blue = opposite sample pair (antrum/corpus) holds a 
different result, orange = sample specific indicator of a mixed infection (often inferred by adjacent cell results). Patients denoted with *1 and *2 represent returning 
patients providing sequentially sampled biopsies, referred to as sequential set 1 and 2 respectively. This is discussed in more detail within Chapter Six. The Sydney 
scores ranged from 0-3 with 0 = normal, 1 = low, 2 = moderate and 3 = high. All typing, and data reporting was provided by Professor Atherton and colleagues at 
the University of Nottingham.
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Table 3.3 General patient information 
 
Patient 









45 63 Female Caucasian Vomiting/ weight loss N/A N/A N/A N/A 
77 57 Female Caucasian Bloating/ dysphagia No Gaviscon No No 
93 77 Male Caucasian Heartburn No No No No 
120 59 Female Caucasian Heartburn No No No No 
194 63 Female Asian H. pylori culture Perforated prepyloric ulcer 2 years ago 
Ranitidine 150mg 
bi daily stopped 2 
weeks ago 
No No 
249*1 41 Male Pakistan Dyspepsia and H. pylori positive No 
Stopped 2 weeks 
ago No No 
265 64 Female N/A Fe defi No No No No 
295*2 68 Female N/A N/A No Stopped 2 weeks ago No No 
308 50 Female N/A Eradication therapy failure No 
Unclear about 
PPIs No No 
322 64 Female N/A Epi pain No No No No 
326*2 68 Female N/A Eradication therapy failure 
Previous eradication 
attempt 
Stopped 2 weeks 
ago No No 
439 51 Female N/A N/A N/A N/A N/A N/A 
444 68 Female N/A N/A N/A N/A N/A N/A 
495 40 Male N/A N/A No No No No 
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Patient 









537*1 45 Male Pakistan Eradication therapy failure 
Previous eradication 
attempt 




565 79 Male Caucasian Dyspepsia No No No No 
621 66 Male Caucasian Dyspepsia, atypical chest pain No No No No 
732 64 Male Caucasian Epi pain No No No No 
 
General patient information for all patients used within this thesis. The age, sex, ethnicity, indication for gastric endoscopy, relevant patient medical history, recent 
acid suppressant history, recent antibiotic use and other drug history are displayed. Patients denoted with *1 and *2 represent returning patients providing sequentially 
sampled biopsies, referred to as sequential set 1 and 2 respectively. This is discussed in more detail within Chapter Six. Abbreviations used within this table include; 
Fe defi – iron deficiency anaemia and Epi pain – epigastric pain. Antibiotics were recorded if taken within 2 weeks of the endoscopy. All data recording was provided 
by the University of Nottingham from Professor Atherton and colleagues.  
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Table 3.4 Patient disease status 
 
Patient ID Oesophagus Stomach Duodenum Other Notes Disease Type CLO Result 
45 N/A N/A N/A Deformed pylorus, duodenal ulcer disease (scars/craters) Past DUD/ Normal Positive 
77 Minor erosion in HH No 
Duodenal ulcer 
and erosions 
Minor HH erosion, DU and 
erosions Acute DU Positive 
93 RO(2) No No N/A Normal Positive 
120 RO(2) No No N/A Normal Positive 
194 No No Scar in Di Scar in Di (PPyU, DU scar) Previous PPyU/ DU scar/ past DU Positive 
249*1 RO(2) No eDi and deformed pylorus N/A Acute DU Positive 
265 HH and erosions No No N/A Normal Positive 
295*2 RO(1) Antral erosions eGi 2 tiny erosions possible eDi N/A N/A Positive 
308 No No No N/A Normal Positive 
322 RO(2) GU No N/A Acute GU Positive 
326*2 RO(2) No, but previous eGi 




439 N/A N/A N/A N/A N/A Positive 
444 N/A N/A N/A N/A N/A Positive 
495 RO(1) No eDi (4 erosions) N/A N/A N/A 
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Patient ID Oesophagus Stomach Duodenum Other Notes Disease Type CLO Result 
537*1 RO(2) No eDi, previous DUscar N/A N/A N/A 
565 N/A No N/A N/A N/A N/A 
621 RO(1) Atrophic gastritis No N/A N/A N/A 
732 RO(2) 2x GU on lesser curve 
Erosive pyloric. 
No DU N/A N/A N/A 
 
Disease status of the oesophagus, stomach, duodenum is displayed for each patient as well as other general notes and disease type. Patients denoted with *1 and *2 
represent returning patients providing sequentially sampled biopsies, referred to as sequential set 1 and 2 respectively. This is discussed in more detail within Chapter 
Six. The CLO test refers to the rapid urease test used to indicate H. pylori infection. Abbreviations used within this table include; HH – hiatus hernia, RO – reflux 
oesophagitis (1= mild, 2= moderate, 3= severe), eGi – erosive gastritis, GU – gastric ulcer, Di – inflamed duodenum, eDi – erosive duodenitis, DUscar – scar from 
a previous duodenal ulcer, DU – duodenal ulcer, PPyU – pre-pyloric ulcer and DUD – duodenal ulcer disease. All data was provided by Professor Atherton and 
colleagues at the University of Nottingham.  
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Table 3.5 Antibiotic breakpoints for disk diffusion assay 
 
  Zone of inhibition (mm)  
Antibiotic class Antibiotic (µg) Resistance Susceptibility Related studies 




≤ 9 mm > 9 mm McNulty et al., 2002; Ogata, Gales and Kawakami, 2014 




≤ 10 mm > 10 mm 
McNulty et al., 2002; Lang and García, 2004; Ogata, Gales and 
Kawakami, 2014 





≤ 10.5 mm > 10.5 mm Lang and García, 2004; Ogata, Gales and Kawakami, 2014  
 
Antibiotic breakpoints for the different antibiotics used within this study. Breakpoints were inferred by the literature from multiple studies and denoted in the ‘related 




3.3.2. Antimicrobial resistance assays 
 
The recording of zones of inhibition for the antimicrobial resistance assays proved 
difficult due to the dark discolouration during incubation of the culture plates containing 
defibrinated horse blood (section 3.4.2). This combined with the fastidious growth of the 
H. pylori cultures was difficult and has been recognised by other studies (Chisholm and 
Owen, 2009). However, placing the culture plates under a bright light source and 
moving the direction of the light helped with measurements.  
 
Despite the difficulties in the recording of the zones of inhibition, the standard deviations 
for independent triplicate data for each antibiotic tested across all samples was small 
(figure 3.1). This suggests that the antimicrobial resistance assay designed for this 
study was reproducible.  
 
The disk diffusion method employed within this study allowed for other useful data to 
be collected, such as clinical sweeps that held resistant colonies within the zone of 
inhibition and those with multiple zones of inhibition (Appendix, table 10.3.1). This 
technique has been recognised by McNulty et al. (2002), who also proclaim the cost 
effectiveness of this technique and ease of potential implementation into the clinical 
setting, standing alongside current techniques.  
 
Antibiotic disk diffusion breakpoints for H. pylori are not defined by internationally 
recognised guidelines, such as EUCAST (EUCAST, 2019). However, many research 
studies have used a disk diffusion based antimicrobial resistance assay (reviewed by 
McNulty et al., 2002). These studies and others (table 3.5) vary in the reported 
breakpoints for the disk diffusion method. Furthermore, most of these studies vary in 
the assay methods including length of incubation, concentration of antibiotics and 
culture media used. Therefore, there is a need to standardise an antibiotic disk diffusion 
assay for the study of H. pylori clinical breakpoints. 
 
Nonetheless, the breakpoints used to define sensitive and resistant phenotypes within 
this study are denoted in table 3.5 and were converged upon by reviewing recent 
studies that employed the disk diffusion technique.  
 
Some patients were found to hold H. pylori populations with differing sensitivity to the 
tested antibiotics by their zones of inhibition (figure 3.1). Of particular note were patients 
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265, 308 (later found to be contaminated – Chapter Four, table 4.1), 326 (later found to 
be contaminated – Chapter Four, table 4.1), 495 and 565. This correlates with other 
studies (Ailloud et al., 2019; Selgrad et al., 2014) and was used as a further indicator 
of a mixed strain H. pylori infection. These results were an indication that the sample 
selection criteria (section 3.2.1) were useful in identifying these patients with a 
presumptive mixed strain infection and justified the sequencing of these samples 
(Chapters Four – Six).  
 
The antibiotic zones of inhibition of H. pylori populations taken from the antrum and 
corpus were compared using a paired t-test to identify if there was a general sensitivity 
difference between antrum and corpus populations (figure 3.2). No statistically 
significant differences were identified suggesting that while there are observable 
between niche differences for some antibiotic resistance profiles, the sample site might 
not be important as long as multiple biopsies were cultured for antimicrobial 
susceptibility testing. However, further investigation would be required to confirm or 
dispute this observation. In particular, multiple biopsies from each niche (antrum and 
corpus) would be beneficial in determining the best biopsy site for antimicrobial 
susceptibility testing.  
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Figure 3.1 Antibiograms of all clinical sweeps used within this study 
  
Antibiograms of each patient clinical sweep used within this thesis. Antibiotics displayed; Amx (amoxicillin), Clr (clarithromycin), Lvx (levofloxacin), Mtz 
(metronidazole), Rif (rifampicin) and Tet (tetracycline). The six different antibiotics are overlaid as stacked bars for all clinical sweeps. Standard deviation bars are 
depicted for each antibiotic (triplicate data). Patients denoted with *1 and *2 represent returning patients providing sequentially sampled biopsies, referred to as 
sequential set 1 and 2 respectively. This is discussed in more detail within Chapter Six. This figure was created in Microsoft Excel (version 16.16.6). Raw data can 
be observed in Appendix table 10.3.1including populations that harboured resistant colonies within the zone of inhibition and potential second zones of inhibition.  
 68 
Figure 3.2 Paired antrum and corpus antibiogram statistics 
 
 
Paired t-test for antrum and corpus average zones of inhibition from each patient (where antrum 
and corpus pairs were available) for each antibiotic. Green circles represent antrum zones of 
inhibition where the opposite corpus pair per patient is depicted as purple squares. This analysis 





3.4. Future work 
 
Given ethical approval and agreement between both patients and the health 
practitioner, multiple (>3) pinch biopsies could be taken from the antrum and corpus of 
individual patients. Additionally, this could be extended to include the fundus region of 
the stomach. These multiple biopsies could be used to determine whether there are 
between niche as well as within niche antimicrobial resistance differences from the 
resident H. pylori populations. This would provide a more dynamic and robust study into 
H. pylori antimicrobial resistance differences within the stomach and might shed further 
light onto why some patients are not successfully eradicated of their infection. 
Furthermore, niche specific differences might be better studied with more samples. 
Such niche specific differences could potentially be a factor for increased antimicrobial 
resistance due to different selection pressures acting on the H. pylori populations. 
 
Increasing the sample size would also help to further validate the reproducibility of the 
disk diffusion assay presented in this study and could aid in the creation of a more 
standardized disk diffusion methodology. Ideally, an internationally recognised disk 
diffusion assay and related clinical breakpoints is needed.  
 
Isolating more resistant colonies found within zones of inhibition and carrying out whole 
genome sequencing on these strains might identify novel resistance mutations.  
 
Next, population deep sequencing was carried out on presumptive mixed H. pylori strain 
populations to investigate the within and between niche genetic diversity (Chapter 
Four). Following this, single colony isolates were cultured from population sweeps to 
provide another layer of genetic analysis as well as deep sequencing data validation 
(Chapter Five). In Chapter Six, sequentially sampled patients from before and after 





















Bacterial chronic infection in humans is rare as bacterial infections are usually cleared 
by the immune system or are cleared by targeted antimicrobial therapies. Helicobacter 
pylori is unusual in the fact infection usually results in some level of gastritis but is most 
often asymptomatic in nature. Therefore, most infected individuals are unaware they 
are infected by this pathogen. H. pylori infects people in early childhood and can persist 
as a chronic, lifelong infection. Typically, eradication therapy is only sought if more 
symptomatic diseases are presenting. Due to the chronic nature of H. pylori infection 
and the high mutation and recombination rate, it is thought that a diverse population of 
quasispecies is present within infected individuals. It is also thought that some patients 
can be infected by more than one infecting strain, multiplying this within patient diversity 
further still.  
 
Some studies have investigated the genetic diversity of H. pylori and have revealed a 
global population structure and diversity (Duncan et al., 2012; Latifi-Navid et al., 2010; 
Olbermann et al., 2010b; Montano et al., 2015; Vale et al., 2015a). This also holds true 
for some virulence associated genes (Duncan et al., 2012; Olbermann et al., 2010b). 
Such studies have employed a comparative genomics approach, usually of single 
colony isolates to investigate global population diversity. Other studies have looked at 
H. pylori strains isolated from specific geographical regions (Cortes et al., 2010; Kojima 
et al., 2016). This global and geographical genetic analysis has helped in the 
understanding of global and geographic diversity of H. pylori. Additionally, this has 
allowed for the identification of certain genotypes and their relation to disease types 
and severity. For example, a recent genome wide association study carried out by 
Berthenet et al. (2018), identified SNP and gene presence markers which were used to 
generate a risk score to assess gastric cancer risk. Another study identified six genes 
that were associated with peptic ulcer disease and adenocarcinoma by comparing 
multi-ethnic populations at high to low risk of these disease types (Gunaletchumy et al., 
2015). Therefore, despite there being an astonishing level of genetic diversity, genomic 
analysis at a global and geographical level has provided important insights into 
virulence and disease progression.  
 
Helicobacter pylori genomic diversity has also been investigated at a smaller scale. For 
example, some studies have investigated single colony isolates obtained from gastric 
biopsies taken from familial groups (Argent et al., 2008; Furuta et al., 2015; Didelot et 
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al., 2013; Krebes et al., 2014; Morelli et al., 2010; Kivi et al., 2003; Raymond et al., 
2004). Although transmission routes of H. pylori are not yet fully elucidated, it is 
generally thought that infection is likely to be passed on by close family members during 
early childhood. In most cases the findings of these studies supported a familial 
transmission route, although this was not always the case. These studies provide 
insights into how H. pylori might adapt to a new host and in disease progression. 
Indeed, these studies have identified familial differences in virulence and colonisation 
associated genes. Several studies agree that H. pylori outer membrane proteins and 
other cell surface related genes are particularly variable. It has also been reported that 
recombination introduced much more variability in terms of SNPs than the general clock 
rate of mutation, but that a mixed infection likely facilitates this.  
 
Few studies have investigated genetic diversity of H. pylori within individual patients 
(Didelot et al., 2013; Raymond et al., 2004; Kivi et al., 2003; López-Vidal et al., 2008; 
Matteo et al., 2007; Israel et al., 2001; Reyes-Leon et al., 2007b). Out of these studies, 
only two (Noto et al., 2017; Didelot et al., 2013) used a whole genome sequencing 
approach while the others used a PCR amplification and sequencing methodology to 
focus on specific genes/loci. López-Vidal et al. (2008), revealed differences in cagA 
genotype between niches as well as differences in gene sizes, suggesting that there 
can be virulence differences between different niches of the same stomach. This was 
further supported by earlier findings by Reyes-Leon et al. (2007), who identified a 
sequence truncation after the EPIYA-C motif between isolates taken from different 
niches of the same stomach. Didelot et al. (2013), showed that strains isolated from the 
antrum and corpus of some patients were likely originated from separate infecting 
strains, suggesting strain-specific niche adaptation. These findings were based on a 
relatively low sample size, with the whole genome studies taking just two representative 
single colonies from both the antrum and corpus of individual patients. Despite these 
low sample sizes, it is clear that insights into within host microevolution can be attained. 
However, the low sample size of these studies is likely to be unrepresentative of the 
whole population structure and not able to capture the true extent and implications of 
within niche genetic diversity. Further investigation into within niche diversity could have 
important implications in understanding how H. pylori is able to colonise a new host or 
new within host environment, how colonisation can persist life long, why some patients 
develop different disease types and why some niches of the stomach have varying 
disease severity.  
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Within patient genetic diversity of a chronically infecting population of Burkholderia 
dolosa of individuals with cystic fibrosis has been investigated by Lieberman et al. 
(2014), using a population deep sequencing approach. In this approach, the total 
genomic DNA of the whole bacterial population was extracted and sequenced to high 
sequencing coverage depth of greater than 100x. This is in contrast to single colony 
sequencing that is usually sequencing at an average depth of 30x which is considered 
reliable to call between single colony alignment-based SNPs. In the deep sequencing 
methodology described by Lieberman et al. (2014), if there are variant strains within the 
population, the genomic sequence of these strains are sequenced alongside all other 
alternative sequences. This generates a variable sequencing read set at genetically 
diverse regions within the genome. They then mapped these reads to an inferred 
reference genome that was isolated from a different outbreak patient. By mapping these 
reads to a reference genome, they were able to call polymorphisms where sequencing 
reads did not agree to that of the reference sequence. This methodology captured a 
snapshot of within patient genetic diversity of the whole population, something that 
would be extremely difficult to capture to this resolution using a single colony 
comparative genomics approach. This study found that diversifying quasispecies did 
not fix within the population but co-existed during chronic infection with polymorphic 
diversity providing a historical record of selection. Furthermore, this study revealed 
genes that were more prone to within patient polymorphic diversity, namely outer 
membrane associated genes, antibiotic resistance associated genes and iron 
scavenging genes.  
 
Helicobacter pylori, like some bacterial infections of the cystic fibrosis lung, are chronic 
infections. Therefore, a population deep sequencing methodology might be useful in 
investigating within patient genetic diversity of the human stomach. Employing this 
method might better elucidate the within patient diversity and build on the findings of 
previous studies of this nature, as previously discussed.  
 
In this Chapter, population deep sequencing was carried out on antrum and corpus 
samples from individual patients to investigate the within and between niche genetic 
diversity of H. pylori and compare findings between patients to identify genes that are 
more prone to polymorphic variation. This is the first time population deep sequencing 
has been used to investigate within patient H. pylori genetic diversity.  
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4.2. Materials and Methods 
 
Sample selection, DNA extraction, whole genome deep sequencing, sequencing read 
curation, contamination detection, whole genome assembly, assembly curation and 
genome annotation was conducted as described in Chapter Two.  
 
Definition of antrum and corpus differences are described in Chapter One section 1.4.4.  
 
Samples used in this study are denoted in Chapter Three table 3.2A-B. 
 
4.2.1. Within niche diversity 
 
4.2.1.1. Read mapping based pipeline to detect within niche common and minor 
allelic variation 
 
A read mapping and polymorphic detection pipeline was developed similar to that 
described by Lieberman et al. (2014), which employed numerous bioinformatic tools 
and processing steps.  
 
Firstly, curated read sets from each sample were aligned to their corresponding de novo 
assembly (Chapter Two, sections 2.9 – 2.12) through Bowtie2 version 2.3.4.3 
(Langmead and Salzberg, 2012). Bowtie2 was configured in ‘very sensitive mode’ to 
increase read mapping sensitivity and accuracy at the expense of speed and computing 
memory with the addition of the ‘--no-mixed’ flag forcing bowtie2 to find alignments 
with paired-end reads sets only. A further modification was made by altering the 
maximum fragment length allowed for paired-end alignments to 2,000 bp, to account 
for H. pylori biology and in consideration of population deep sequenced data. A final 
adjustment was made using the ‘--n-ceil’ flag by setting this to ‘0,0.01’ in order to 
reduce the number of ambiguous characters allowed within an aligned read. This 
effectively reduced base ambiguity to less than 1%, further increasing read mapping 
sensitivity and accuracy. The following full command was used: 
 
bowtie2-build --threads {user specified CPU/thread/core number} 
-f {sample assembly file} {user named bowtie2 index file} ; 
(bowtie2 -p {user specified CPU/thread/core number} -X 2000 --
no-mixed --very-sensitive --n-ceil 0,0.01 --un-conc-gz {path to 
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output file of paired-end reads that fail to align} -x {path to 
bowtie2 index file} -1 {path to forward/mate pair 1 reads from 
Sickle} -2 {path to reverse/mate pair 2 reads from Sickle} -S 
120A_bt2_out.sam) 2>{path to output log file} 
 
Secondly, the resulting sequence alignment map (SAM) file produced by Bowtie2 was 
passed through the SAMtools suite version 1.9 (Li et al., 2009) to sort and remove PCR 
duplicated reads. The following command was executed: 
 
samtools view -@ {user specified CPU/thread/core number} -b -h -
o {path to output BAM conversion} {path to input SAM from bowtie2} 
; samtools sort -@ {user specified CPU/thread/core number} -n 
{path to input BAM file} -o {path to output sorted BAM file} ; 
samtools fixmate -@ {user specified CPU/thread/core number} -m 
{path to input sorted BAM file} {path to fixmate processed output 
BAM file} ; samtools sort -@ {user specified CPU/thread/core 
number} {path to input fixmate BAM file} -o {path to output 
sorted fixmate BAM file} ; samtools markdup -@ {user specified 
CPU/thread/core number} -S {path to input sorted fixmate BAM 
file} {path to output PCR duplicate removed BAM file} 
 
Following SAM processing through the SAMtools suite, the resulting binary format SAM 
(BAM) files were passed to a haplotype caller, FreeBayes version 1.3.1 (Garrison and 
Marth, 2012). FreeBayes uses a Bayesian statistical inference model to call genetic 
variants from short-read alignments. FreeBayes was carefully configured using a 
number of arguments. The ‘--pooled-continuous’ mode was selected in order to 
observe alternative nucleotide frequencies. Importantly, the ‘-F’ flag was used to lower 
the minimum alternative fraction to support a particular alternative allele call to 3%. 
Additionally, a mapping quality of ³ 34 and a base quality score of ³ 30 was required to 
elevate an alternative allele call. This command is displayed below: 
 
freebayes -f {path to sample de novo assembly) -F 0.03 --pooled-
continuous -m 34 -q 30 {path to output BAM file from SAMtools} > 
{path to FreeBayes output VCF file} 
 
FreeBayes produced VCF files were filtered using two different sets of parameters to 
call common and minor allelic variants using vcflib (Garrison, 
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https://github.com/vcflib/vcflib). To call common allelic variants the ‘-f’ option was used 
to filter for SNPs, total number of alternative allele calls on the forward strand > 15 and 
total number of alternative allele calls on the reverse strand > 15. Minor allelic variation 
was determined by filtering for SNP sties only. The following example command was 
used to filter for common allelic variant sites: 
 
vcffilter -f "TYPE = snp & SAF > 15 & SAR > 15" {path to input 
VCF file from FreeBayes} > {path to filtered output VCF file} 
 
Filtered VCF files from the vcflib tools output were further filtered manually to ensure 
the called variants were of high quality and confidence. Each VCF file was inspected 
manually and variant sites were removed if they were identified in the first or last 500 
bp of a contig. Next, the mapped reads in the BAM alignment files were loaded into 
Artemis (Carver et al., 2012) alongside the reference annotated genome. Variants 
located in a repeat region of 6 nucleotides or more were identified and inspected. These 
variant sites were removed if the reads supporting the alternative call were within the 
first or last 3 bases of the reads or if the supporting reads held other variants within a 
20 bp range of the variant site. If the beginning of the reads aligned within the repeat 
region and the variant site was more than 3 bases from the beginning of the alignment, 
these were discarded due to the limitations of the Illumina sequencing by synthesis 
base calling in repeat regions. This limitation is a result of the increase in signal intensity 
when more than one base is added, which is harder to determine especially when taking 
into consideration the background noise. The support of just one read that passed these 
criteria was deemed enough evidence to classify the alternative call as valid, even if all 
other reads failed the measure. 
 
Filtered variants were annotated as described in Chapter Two section 2.14 and 
manipulated manually to produce a list of annotated gene products that were found to 
harbour polymorphic sites. This approach allowed for the grouping of genes by 
associated gene product that harboured polymorphic sites. For example, two different 
polymorphic sites might be identified within the same hypothetical protein, but another 
SNP might also be found in a different hypothetical protein, in this case the hypothetical 
protein would be recorded three separate times as three SNPs were recorded 
associated with this gene product name, indicating a high level of diversity within this 
gene associated product. Using this data, a heatmap was created using ggplot2 and 
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the RColorBrewer through the R statistical software version 3.5.1 (R Core Team, 2018) 
where deeper colours represent gene products with higher counts of polymorphic sites.  
 
An overview of the bioinformatics deep sequencing pipeline is depicted in figure 4.1. 
 
4.2.1.2. Per-base depth of coverage determination using sequence alignment 
mapping data 
 
Sequence depth at a per nucleotide level was determined using mosdepth version 0.2.3 
(Pedersen and Quinlan, 2018). This was used in the place of the SAMtools (Li et al., 
2009) depth pipeline as the mosdepth algorithm prevents the double counting from 
ends of paired-end read sets, resulting in a more accurate determination of per-
nucleotide sequencing coverage. Furthermore, mosdepth outputs a fraction based 
coverage statistic across each contig. This data was manually plot using ggplot2 and 
the RColorBrewer through the R statistical software version 3.5.1 (R Core Team, 2018) 
to present the coverage statistics per-contig of each dataset on a single graph (figure 
4.3). 
 
A second tool, weeSAM version 1.4 (https://github.com/centre-for-virus-
research/weeSAM) was used to plot further depth statistics (figure 4.4).  
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Green boxes represent software used to analyse the data with software names in bold and underlined. Key software optimisations are listed below software names. 
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4.2.2. Between niche diversity 
 
4.2.2.1. Whole genome consensus alignment of paired antrum and corpus 
patient pairs 
 
Deep sequenced populations resulting in a consensus assembled genome for each 
paired antrum and corpus sample were aligned in a pair-wise fashion using the multiple 
genome alignment (Mauve, version 2.4.0) tool in progressive mode with default settings 
(Darling et al., 2004). Mauve can align core genome sequence mosaics resulting from 
genomic rearrangement, recombination, deletions and insertions which makes this tool 
particularly suited to align H. pylori genomes.  
 
Resulting alignments were used to extract variant positions/SNPs between aligned 
segments and input into a spreadsheet for further downstream analysis (sections 
4.2.2.2 – 4.2.2.4). 
 
4.2.2.2. Mapping patient niche specific deep sequencing read sets to the 
opposite niche consensus genome 
 
To further investigate the between niche genetic diversity a second approach was 
employed, similar to the whole genome alignment of patient sample pairs as described 
above (section 4.2.2.1). The difference with this approach is the use of all sequencing 
read data available, rather than a reliance on two consensus assembled data sets. A 
consensus assembled genome of a deep sequenced population represents a snapshot 
of the most abundant sequence string taken from the population. Furthermore, it is 
possible that a variant position or run of positions within the consensus genome might 
cause a break in the assembly due to the assembler not being able to converge on a 
correct sequence pattern, resulting in a contig break. It is also difficult to determine how 
many reads cover a certain nucleotide position within the assembled genome where it 
is possible that a single read was used to determine a particular base, making this base 
position less likely to be part of the true biological sequence or a true variant position. 
For these reasons, it is not uncommon to observe an increased number of variant 
positions between aligned genomes, particularly around contig breaks and within 
contigs of short length. Despite this, these positions cannot be fully ignored as some of 
these variant positions are potentially true sites of variation between aligned genomes.  
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To better validate the variant SNP positions identified from the Mauve approach, a read 
mapping methodology was adopted to support the identification of true biological 
sequence variants between paired sample sets from the same patients.  
 
The rapid haploid variant calling and core genome alignment (Snippy, version 4.4.0) 
tool (Seemann, https://github.com/tseemann/snippy) was selected for this purpose. 
Briefly, Snippy aligns sequencing reads to a reference sequence and then passes the 
alignment to a haplotype caller that identifies SNPs and indels which are subsequently 
reported. The following command was used where A = antrum and C= corpus: 
 
snippy --cpus {user specified CPU/thread/core number} --report -
-minfrac 0.9 --mincov 30 --mapqual 30 --basequal 30 --ref 
{consensus deep sequenced genome of patient pair A} --outdir 
{user specified output directory} --R1 {path to forward/mate pair 
1 of patient pair C} --R2 {path to reverse/mate pair 2 of patient 
pair C} 
 
The reverse of this command was also executed for each paired sample set where the 
‘--ref’ genome was that of the deep sequenced corpus assembled genome and the 
sequencing read set for ‘--R1’ and ‘--R2’ was from the antrum deep sequencing 
dataset. This was done to map the SNP locations to the corresponding base positions 
within the genomes. The VCF files for each paired analysis were filtered to only include 
SNP variants. As with the Mauve method, these VCF files were annotated to determine 
whether variant SNPs were harboured within a CDS or IGR. This SNP annotation 
method is described in Chapter Two section 2.14. 
 
For a SNP to be called by Snippy, 90% of reads had to be in support of the alternative 
allele with a minimum coverage of 30 reads overlapping the variant site. Additionally, 
only high-quality reads (Q30) and mapping qualities (Q30) were used to interrogate a 
variant site. These parameters were chosen to improve the confidence of variant calls 
between the datasets. 
 
4.2.2.3. BLAST ring image generator: visually displaying between niche sites of 




The contigs from genome assemblies of paired datasets were filtered to remove contigs 
<500 bp in length (https://github.com/tinybio/filter_contigs) and individually 
concatenated to produce a single contiguous sequence. A BLAST (pairwise nucleotide 
basic local alignment search tool) approach was used to identify regions of nucleotide 
similarity between paired within patient antral and corpus genomes using the BLAST 
ring image generator (BRIG, version 0.95) (Alikhan et al., 2011; Altschul et al., 1990; 
Camacho et al., 2009). BRIG was used to align the sequences in a pair-wise fashion, 
requiring vice versa reference and query sequence overlays in order to fully investigate 
between niche genomic differences with an upper 98% and lower 95% nucleotide 
identity. Contig breaks were plotted to show contig break boundaries within the 
contiguous sequence. Approximate coverage depth was also plotted by extracting the 
per-base coverage from SAMtools depth from BAM files produced as output from 
section 4.2.2.2 by making use of the ‘-aa’ flag and using a custom command to create 
a BRIG compatible graph file by executing the following: 
 
len=$(wc -l < {path to input per base coverage statistics in tsv 
format}) ; paste <(seq 0 $((len-1))) <(seq 1 $len) {path to input 
per base coverage statistics in tsv format} > {path to BRIG 
compatible output .graph file} 
 
This command adds an additional column to the beginning of the input tsv file containing 
0 based coordinates required to plot the BRIG coverage graph.  
 
The output SNPs from both Mauve and Snippy methodologies were imported into a 
spreadsheet and a manual mapping file was constructed to identify alignment SNPs 
that were detected by one or both methods. This was done in order to improve the high 
throughput capability of this analysis by reducing the reliance on manual filtering of the 
Snippy output SNPs with the aim of viewing high quality alignment SNP calls.  
 
Briefly, the contig number(s) and SNP position(s) for both methodologies (Snippy and 
Mauve) were recorded into separate spreadsheets. Here, a unique mapping tag was 
appended to each SNP field by merging the contig identifier with the SNP position within 
the contig, separated by a colon (:). An additional column was added alongside the 
mapping locations with the number one (1) running consecutively. This was used as 
the presence absence identifier for the methodology detection step. Next, the data was 
then pooled into one spreadsheet, and duplicate mapping tags were removed. 
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Spreadsheet functions were used to determine whether each non-duplicated SNP was 
detected by one or both methods by comparisons to the mapping tags of the two 
methodologies, outputting the presence (1) or absence (0) for both Snippy and Mauve. 
This was done by using the ‘=IFERROR(VLOOKUP())’ Microsoft Excel (version 
16.16.6) function where errors/absences were reported as zero (0) and the matching 
mapping tags for each methodology was recorded as a one (1). The ‘IF’ function was 
used to record the colour of the SNP to be displayed in the BRIG figure depending on 
whether the SNP was identified by both methodologies (red), Mauve only (black) or 
Snippy only (teal).  
 
All unique variants (SNPs) identified by the Mauve and Snippy methodologies (‘verified’ 
red SNPs) were used to construct a custom VCF file for each antrum and corpus 
dataset. The VCF file was annotated as described in Chapter Two section 2.14 and 
annotations were imported into a spreadsheet. 
 
Finally, a list of the between niche SNPs start and stop positions was constructed, in 
the order they appeared in the genome. The colour of each SNP depending on the 
methodology detection (as previously described) was added to an adjoining column. A 
run of numbers from one (1) to the end of the SNP list increasing by one each time was 
added to the next adjoining column to provide a numerical SNP identifier. These were 
used to create a tab-delimited file for custom BRIG annotations as described in the 
BRIG manual. The numbered SNPs allowed for identification of specific SNPs in the 
resulting figure that can be used to obtain the SNP annotations, providing the gene in 
which the SNP(s) occur or non-coding region if there was no gene associated.  
 
This was repeated for each antrum and corpus dataset for each patient.  
 
An example spreadsheet and associated functions can be interrogated by downloading 








High-quality called variants identified by both Mauve and Snippy methodologies (red 
SNPs; Chapter Four section 4.2.2.3) for each paired antrum and corpus (same patient) 
data sets were pooled and recorded in a separate spreadsheet. Here, the Mauve 
alignment SNP file containing the locations of each SNP for both the antrum and corpus 
was imported into a spreadsheet and the unique mapping tags for the antrum and 
corpus alignment SNPs were added as previously described. Special care was taken 
to ensure the order of the antrum and corpus mapping locations were kept in the same 
order as the original alignment SNP output file (Mauve). The first alignment SNP pair 
from the antrum and corpus was given the value of one (1) in an adjoining empty cell 
and was ascended to the end of the SNP mapping list where the following cell was 
given the value of plus one (+ 1) from the cell before it. This provided a secondary 
mapping tag unique to each corresponding antrum and corpus alignment SNP location. 
This allowed for the cross comparison of the different contigs and SNP locations 
between the antrum and corpus alignments.  
 
Next, the ‘VLOOKUP’ function was used to report the secondary mapping numbers for 
both the antrum and corpus high-quality verified (red) SNPs. These numbers were 
pooled, and duplicates were removed. A ‘VLOOKUP’ function was used to create an 
antrum reference list of high-quality (red) SNPs of the pooled antrum and corpus data.  
 
A manually constructed custom VCF file containing the variant alignment positions 
(alignment SNPs) was created with the pooled antrum and corpus data. The VCF file 
was annotated as described in Chapter Two section 2.14. 
 
An example spreadsheet and associated functions can be interrogated by downloading 




This approach was taken as one dataset might call a hypothetical SNP by both methods 
(antrum), but this SNP might not be called on the reverse analysis by both methods in 
the other pair (corpus). One reason for this could be a fluctuation of sequencing 
coverage of sufficient quality on one dataset but not on the other, resulting in a variant 
detection by both methods on the first dataset, but not in the reverse pair for that variant 
position. In this example, the effect of coverage variation would have the highest impact 
on the Snippy method where an alternative nucleotide would not be called if the 
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coverage was below 30 or the alternative fraction was less than 90%. However, in this 
scenario, the called variant position by at least one antrum/corpus dataset is evidence 
that this position is a true site of variation between the niches. Furthermore, there are 
often more alignment SNPs identified around contig boundaries from aligned genomes 
(Mauve). This is mainly down to the de novo assembly of the contigs where a contig 
boundary is often a region that could not be joined/scaffolded to another contig. 
Therefore, these regions are often more variable and less reliable than further along 
the contig. Combining and comparing the Mauve and Snippy methodologies allows for 
a more accurate identification of higher quality alignment variants as the alignment 
variant by the Mauve method should be supported by the mapping of the opposite niche 
reads by the Snippy method and vice versa.  
 
To determine whether the sites of variation were synonymous or nonsynonymous a tool 
named SnpEff version 4.3 (Cingolani et al., 2012) was used after resulting VCF files 
were annotated as described in Chapter Two section 2.14. SnpEff takes VCF files and 
predicts the effect of SNPs (such as SNP resulting in an amino acid change) within 
CDS. 
 
The prebuilt database of H. pylori reference genomes could not be consulted by this 
method due to the choice of reference genomes used throughout this study. 
Furthermore, H. pylori genomes have an extremely high level of genetic diversity, 
aforementioned. Therefore, it was necessary to build custom databases within SnpEff 
for each reference genome (deep sequenced and consensus assembled genomes) in 
order to accurately determine the effect of SNPs within CDS.  
 
Custom databases were created by modifying the SnpEff configuration file 
(snpEff.config) and manually adding each new reference entry to the list with the 
selection of the bacterial and plat plastid codon table. The genome assembly sequence 
files and annotated GTF files from RAST were compressed into sample/reference 
directories within the SnpEff data directory. Following this, the custom reference 
database was created by navigating to the SnpEff directory and executing the following 
command: 
 
snpEff build -gtf22 -v {name of the database to build, as 
described in the edited config entry}  
 
 85 
After all reference databases were built, the VCF files containing the variant sites 
identified by both the Mauve and Snippy methodologies were passed through the 
SnpEff tool by the following command: 
 
snpEff -v {name of the reference to use within the SnpEff 
database} {path to VCF file corresponding to the associated 
reference} > {path to user specified output SnpEff annotated VCF 
file} 
 
On completion, the summary file was inspected to determine the overall effect of 
variants between the aligned genomes in terms of synonymous and nonsynonymous 
mutations. 
 
4.2.2.5. Pan-genome analysis 
 
A pan-genome analysis involving all deep sequenced patient paired samples was 
performed using the rapid large-scale prokaryote pan-genome analysis (Roary, version 
3.8.2) pipeline (Page et al., 2015). Roary takes multiple annotated genomes from 
PROKKA (Chapter Two, section 2.13) and identifies the shared core and soft core (99% 
- 100% and 95% - 99% respectively) genes as well as the accessory shell and cloud 
(15% - 95% and 0% - 15% respectively) genes shared between the samples. From 
here, a gene presence absence list was generated and manually inspected to identify 
gene patterns between antrum and corpus sample groups. The following Roary 
command was executed: 
 
cd {path to directory containing list of PROKKA output .gff files 
to pass to Roary} ; roary -p {user specified CPU/thread/core 
number} -e -n -v -f {path to output directory} *.gff 
 
A core genome alignment of all consensus genomes was conducted and a phylogenetic 
tree by approximately-maximum-likelihood was constructed through Parsnp (version 
1.2) which is part of the Harvest suite (Treangen et al., 2014). The clinical reference H. 
pylori genome J99 (NC_000921.1) was used as the phylogenetic root. The following 
command was executed: 
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parsnp -p {user specified CPU/thread/core number} -r {H. pylori 
J99} -d {path to directory containing genomes to analyse} -a 13 
-c -x 
 
The resulting phylogeny was visualised in FigTree version 1.4.4 
(https://github.com/rambaut/figtree) and re-rooted to the midpoint and ordered in 
decreasing order to improve visualisation. This was then uploaded into phandango 
version 1.3.0 (Hadfield et al., 2018) alongside the gene presence and absence matrix 
produced by Roary where the reference was manually appended to create a pan-
genome gene presence and absence visualisation.  
 
4.3. Results and discussion 
 
All of the analysis presented in this Chapter was carried out on all patients and samples 
used within this study (table 4.1). Where appropriate and convenient, in some results 
figures and/or tables the representative patient 265 sample data were presented. All 
other patient results can be found in the Appendix (Chapter Ten) or the Appendix 
directory (https://myntuac-
my.sharepoint.com/:f:/r/personal/n0667645_my_ntu_ac_uk/Documents/OneDrive_link
?csf=1&e=UuIp26) as stated below. However, full patient and sample results are 
displayed where convenient. 
 
4.3.1. Contamination detection of non-Helicobacter pylori biological sequences 
 
Although the human stomach was once thought to be a sterile environment, this has 
proven to be untrue. The human stomach hosts a diverse abundance of bacterial taxa 
and microbiota studies have started to characterise these bacterial taxa and their 
relative abundance. Recent studies have indicated that there are no consistent 
microbiome signatures within the human stomach but Helicobacter, Prevotella, 
Neisseria, Streptococcus, Bacteroidetes and Firmicutes are notably abundant (Wurm 
et al., 2018; Chen et al., 2018; Kupcinskas and Hold, 2018). The human stomach has 
been shown to harbour a diverse abundance of bacterial species with one recent study 
identifying 110 different species within the stomach and 106 species within the 
duodenum (Mailhe et al., 2018). It has also been shown that H. pylori infection, different 
disease status of the stomach and use of proton pump inhibitors can change the 
microbiome of the human stomach (Wang et al., 2018; Parsons et al., 2017; Lopetuso 
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et al., 2018). As isolation of H. pylori population cultures are taken from biopsies within 
the human stomach, contamination is highly likely and takes the skill of the laboratory 
team to avoid and detect. This is further complicated by the endoscopy procedure which 
removes the biopsy sample from the patient through the oral cavity which hosts its own 
unique, diverse and highly abundant microbiome (Marsh, 2018; Wade, 2013), further 
increasing the risk of culture contamination when trying to isolate H. pylori from clinical 
biopsies.  
 
For the reasons previously mentioned, it was imperative to detect potential 
contamination of population sweeps of H. pylori at the earliest opportunity. A k-mer raw 
sequence classification method was used for this purpose as described in Chapter Two 
section 2.10. The results of this analysis showed that all but two (308A and 326A) 
samples were contamination free (table 4.1). The two samples that were identified as 
contaminated did not match to any known bacterial, archaeal or viral genome within the 
RefSeq database (https://www.ncbi.nlm.nih.gov/refseq/). This suggests that this 
unknown contaminant is an as yet unsequenced or unknown bacterial, archaeal or viral 
contaminant or is eukaryotic. Despite 308A and 326A being flagged as contaminated, 
these samples were passed forward to all analysis steps in order to stress test analysis 
pipelines and to determine the utility of using contaminated datasets as contamination 
is a real risk in this type of H. pylori population research.  
 
Table 4.1 lists the bacteriophage detected within each sample, as determined by the 
sequence classifier. This analysis shows that some patient paired samples from 
different niches harbour the same bacteriophage composition (patients; 77, 322, 444, 
565 and 732), but often with varying abundance. Conversely, the majority of paired 
patient samples (67%) showed differences in phage composition between antrum and 
corpus (patients; 45, 93, 120, 194, 265, 295, 308, 326, 439 and 495). This suggests 
that there were different circulating bacteriophage between different niches of the 
human stomach. This is a novel observation and could potentially be a source of genetic 
diversity between the populations. However, while bacteriophage can be beneficial to 
the host bacterium as seen amongst a range of bacterial species (Vale and Lehours, 
2018; Harper et al., 2014; Torres-Barceló, 2018; Brussow, Canchaya and Hardt, 2004), 
no such benefit in terms of virulence or disease association has yet been reported in 
the literature for H. pylori phage (Vale et al., 2015b; Lehours et al., 2011). One study 
has correlated the cagA and vacA genotypes with orthologous phage genes (Kyrillos et 
al., 2016). Other studies have shown geographical clustering of H. pylori prophage 
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(Vale et al., 2017, 2015b). The varying phage composition observed in this study from 
between niche populations, could suggest that bacteria phage were circulating within 
but not between niches.  
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H. pylori (%) 
Second highest match (%) Phage detected (%) Unclassified reads (%) 
45A 98.55 H. acinonychis (0.3) Helicobacter phage (<0.00) 0.84 
45C 97.83 H. acinonychis (0.4) Helicobacter phage KHP40 (<0.00) 1.38 
77A 98.91 H. acinonychis (0.01) Helicobacter phage (0.15) 0.52 
77C 99.04 H. acinonychis (0.01) Helicobacter phage (0.12) 0.48 
93A 99.7 N/A Enterobacteria phage phiX174 sensu lato (<0.00) 0.09 
93C 99.71 N/A Helicobacter phage (<0.00) 0.08 
120A 98.41 H. acinonychis (0.3) N/A 0.95 
120C 99.55 H. acinonychis (0.01) Dickeya phage + Helicobacter phage (<0.00) 0.19 
194A 99.7 N/A N/A 0.11 
194C 99.68 N/A Stx2-converting phage (<0.00) 0.11 
249C 98.63 H. acinonychis (0.01) N/A 0.76 
265A 98.71 H. acinonychis (0.01) N/A 0.76 
265C 98.67 H. acinonychis (0.02) Dickeya phage RC-2014 (<0.00) + Enterobacteria phage phiX174 sensu lato (<0.00) 0.78 
295A 97.87 H. acinonychis (0.02) Helicobacter phage 1961P (0.07) + KHP30 (0.03) + KH40 (<0.00) 1.3 
295C 97.82 H. acinonychis (0.02) Helicobacter phage 1961P (0.07) + KHP30 (0.03) 1.34 
308A 56.17 H. acinonychis (0.01) Dickeya phage RC-2014 (<0.00) 42.11 
308C 98.55 H. acinonychis (0.01) N/A 0.84 
322A 96.02 H. cetorum (0.42) + acinonychis (0.19) 







H. pylori (%) 
Second highest match (%) Phage detected (%) Unclassified reads (%) 
322C 95.33 H. cetorum (0.5) + acinonychis (0.25) 
Helicobacter phage 1961P (0.03) + KHP30 (0.04) + KH40 
(0.01) 4.47 
326A 59.62 Actinobacteria (1.42) Helicobacter phage (0.07) + Dickeya phage (<0.00) + Enterobacteria phage phiX174 sensu lato (<0.00) 38.33 
326C 98.8 H. acinonychis (0.01) Helicobacter phage (0.11) 0.65 
439A 96.99 H. cetorum (0.17) Unclassified Siphoviridae (<0.00) + Myoviridae (<0.00) + Helicobacter phage 1961P (<0.00) 1.95 
439C 97.27 H. cetorum (0.15) Helicobacter phage 1961P (<0.00) 1.76 
444A 98.02 H. cetorum (0.28) Helicobacter phage 1961P (<0.00) + KHP30 (<0.00) 0.86 
444C 98.42 H. cetorum (0.16) + acinonychis (0.02) Helicobacter phage 1961P + KHP30 (<0.00) 0.68 
495A 99.37 E. coli (0.01) N/A 0.36 
495C 99.51 N/A Helicobacter phage (<0.00) 0.23 
537A 98.61 H. acinonychis (0.01) N/A 0.77 
565A 99.45 E. coli (0.01) N/A 0.26 
565C 99.61 N/A N/A 0.14 
621A 98.45 H. acinonychis (0.86) Enterobacteria phage (<0.00) 0.22 
732A 99.56 H. acinonychis (0.02) Helicobacter phage (<0.00) 0.17 
732C 99.57 H. acinonychis (0.02) Helicobacter phage (<0.00) 0.16 
 
Contamination detection was detected as described in Chapter Two, section 2.10. Table denotes the percentage of reads mapping to complete bacterial, archaeal and 
viral genomes reference genomes in the RefSeq database as of 18th October 2017. Reads that did not map to any reference genomes were displayed in the last 
column. Samples with suspected contamination are highlighted in orange.
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4.3.2. Quality statistics for deep sequenced de novo assembled consensus 
genomes 
 
All deep sequenced populations were assembled into a consensus assembled genome 
meaning that all curated sequencing reads from the population were used as input 
(Chapter Two, section 2.9). Before any bioinformatics post-processing was conducted, 
assembly statistics were calculated (Chapter Two, section 2.12) and are presented in 
figure 4.2. Importantly, this figure shows that there are no assembly quality differences 
between both sequencing run sets (denoted by colour) and between antral and corpus 
samples (denoted by shape).  
 
With the exclusion of the contaminated samples (n=31), the mean number of contigs 
was 89.48 (95% CL: 59.10 – 119.9) while the N50 mean was 94,245 (95% CL: 81,016– 
107,474) and total assembly mean length of 1,630,573 (95% CL: 1,615,608 – 
1,645,539). The lower than expected mean genome size of approximately 1.63 Mbp 
compared to the reference genome (H. pylori J99) size of approximately 1.67 Mbp was 
considered acceptable due to the de novo assembly approach (i.e. a non-reference 
based assembly) and the use of high quality curated read sets (Chapter Two, section 
2.9). Furthermore, other recent H. pylori whole genome studies report similar and often 
lower de novo assembled genome lengths of H. pylori (Kumar et al., 2012; Ali et al., 
2015; Montano et al., 2015) than achieved within this study. Pilot testing on this dataset 
showed that in most cases, using raw sequencing reads resulted in only a small 
increase in total assembly length, but in rare cases also reduced the total genome 
length (data not shown). It is thought that the deep sequencing methodology utilised 
within this study allowed for removal of low-quality reads with very little effect on the 
final genome assemblies, probably due to the high depth of coverage. Therefore, high 
quality curated deep sequencing read sets were used to reconstruct consensus whole 
genome assemblies and this was thought to produce a more accurate consensus 
assembly, especially for downstream analysis steps such as paired whole genome 









This figure depicts the quality metrics of deep sequenced consensus assembled genomes. Figure A – total number of contigs; figure B – N50 of assembled consensus 
genomes; figure C – total assembly length. This dataset includes the contaminated samples (n=33) 308A and 326A for reference purposes. Red = sequencing run 1, 
blue = sequencing run 2, circle = antrum, triangle = corpus. The mean and 95% CL are displayed as horizontal bars.  
A) B) C) 
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4.3.3. Whole genome depth of coverage 
 
For the deep sequencing dataset, an average coverage depth of 231X was achieved. 
Each sample average coverage is denoted in table 4.2 along with details on the 
proportion of the genome covered by ³100X coverage. The fraction of specific sample 
genomes covered by X coverage is depicted in figure 4.3 where a characteristic 
‘waterfall’ shape is observed, suggesting little variation around the mean of each 
sample and small proportions of the genome at coverage extremes. 
 
The representative sample for the deep sequencing dataset 265 (A and C) followed in 
this Chapter had a relatively even coverage distribution across the length of the 
genome, except for coverage spikes towards the close (figure 4.4). This was seen 
across all samples (Appendix, figures 11.4.1 – 11.4.18) and was due to short, high 
coverage contigs that were assumed to be assembly artefacts. 
 
Table 4.2 Deep sequencing samples with average coverage and percentage of 
genome covered at greater than or equal to 100X 
 
Sweep Average coverage: Bases with coverage ³ 100 
45A 198 98% 
45C 219 98% 
77A 284 99% 
77C 216 98% 
93A 290 99% 
93C 396 99% 
120A 348 99% 
120C 423 99% 
194A 277 99% 
194C 259 98% 
249C 342 99% 
265A 188 97% 
265C 163 94% 
295A 324 99% 
295C 356 99% 
308A 188 98% 
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Sweep Average coverage: Bases with coverage ³ 100 
308C 334 99% 
322A 139 90% 
322C 113 69% 
326A 50 11% 
326C 64 2% 
439A 220 95% 
439C 153 91% 
444A 100 51% 
444C 128 82% 
495A 68 6% 
495C 217 87% 
537A 309 99% 
565A 101 52% 
565C 342 89% 
621A 277 98% 
732A 241 96% 
732C 291 98% 
 
Coverage statistics were calculated as described in section 4.2.1.2. All samples are displayed 
with corresponding average and proportion of the genome covered by ³ 100X coverage.  
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Figure 4.3 Coverage distribution across all deep sequenced samples 
 
Coverage distribution displayed at each fraction of the genome for all samples. This figure was plotted in R from the statistics produced from mosdepth (Chapter 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4.4 Coverage distribution across the genome length of sample 265A and 265C 
 
 
This graph was drawn through WeeSam as previously described (Chapter Four, section 4.2.1.2) and depicts the coverage distribution across the length of the genome 
sequences of samples 265A (figure A) and 265C (figure B). Average coverage is plotted as a dashed horizontal green line and the multiple of 0.2 and 1.8 of the 




4.3.4. Within niche polymorphic diversity 
 
Within niche diversity was detected using two separate but similar pipelines to detect 
common and minor allelic diversity (Chapter Four, section 4.2.1.1). This approach was 
taken in order to highlight a strong evidence-based detection of common allelic variation 
while relaxing some parameters to detect more diversity within the datasets (minor 
allelic variation). Due to the higher thresholds of the common allelic detection pipeline, 
called positions by this method are assumed to be moving towards fixation within the 
sample due to the higher proportion of this variant within the population. Conversely, 
the allelic detection pipeline calls polymorphic positions at much lower frequencies, 
mainly attributed to the relaxation of the SAF (number of alternative reads mapping in 
the forward direction) and SAR (number of alternative reads mapping in the reverse 
direction) filters. This allowed for the detection of low frequency polymorphic sites that 
were potentially more recent polymorphisms or were variants that were persisting within 
the population but not moving towards fixation. One reason for this could be the lack of 
a selection pressure acting on the population resulting in a mixture of both fit and unfit 
populations persisting within the environment. Furthermore, the common and minor 
allelic pipelines were designed in order to detect against false positives at the expense 
of losing some true positives (common allelic variation) and the increase of true 
positives at the expense of potentially more false positives (minor allelic variation). 
However, in Chapter Five, it is further discussed how the minor allelic variants were 
matched with SNPs identified from single colony isolates and how well these different 
methods compared. As will be described later, a good crossover of detection was 
observed suggesting that the minor allelic detection was determined to be a reliable 
detection method. Furthermore, this methodology was adapted from work by Lieberman 
et al. (2014), where they tested both real and simulated datasets and show that 
identification of true positive polymorphic positions was high while the carefully tuned 
parameters reduced false positive calls. 
 
All samples were found to harbour both common and minor allelic diversity (table 4.3). 
Not surprisingly, common allelic variants were detected more rarely than minor allelic 
variants, with a median increase of 12.4 ´ from the common to the minor allelic 
detection method. This was most likely down to parameters used for the common allelic 
variation calling pipeline where alternative base calls in relation to the reference had to 
observe ³ 15 reads mapping in both the forward and reverse direction. Although this 
might appear very strict, it allowed for the calling and identification of highly polymorphic 
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sites that were proliferating within the populations, potentially moving to fixation within 
the populations or evidence of a mixed infection of two or more H. pylori strains where 
the total number of these variants are high. 
 




Number of sites with common 
allelic variation 
Number of sites with minor 
allelic variation 
45A 2 24 
45C 2 38 
77A 7 39 
77C 3 43 
93A 201 262 
93C 2 12 
120A 4 31 
120C 2 25 
194A 3 18 
194C 9 40 
249C 7 51 
265A 4 85 
265C 6 124 
295A 8 55 
295C 7 51 
308A 7 67 
308C 2 46 
322A 2 73 
322C 50 384 
326A 1 612 
326C 1 483 
439A 64 152 
439C 2 98 
444A 11 261 
444C 14 147 
495A 7 248 
495C 80 225 




Number of sites with common 
allelic variation 
Number of sites with minor 
allelic variation 
565A 6 498 
565C 7765 12885 
621A 8 123 
732A 115 1034 
732C 17 104 
 
Colour code: light green: 1 –10 dark green: 11 – 20; light orange: 21 – 60; dark orange: 61 – 
100; light red: 101 – 200; medium hue red: 201 – 400; dark red: > 401. Common allelic variation 
filtering of polymorphic positions where ³ 15 alternative base calls have to be identified in both 
the forward and reverse direction and the alternative fraction must be above 3% of total reads 
mapping to support a call. Minor allelic detection filters on the minor allelic fraction of > 3% 
only. Both methods require a mapping quality of Q34 and a base quality of Q30 as described in 
section 4.2.1.1. 
 
It is possible to comment on each gene expressing polymorphic diversity, however this 
is impractical and so only key genes and genes with the highest levels of diversity as 
well as genes with observable diversity across multiple samples will be discussed here. 
Nevertheless, this study offers a very rich dataset and further inspection of this dataset 
is welcomed by other researchers.  
 
Excluding hypothetical proteins, the highest common allelic variation was observed 
within outer membrane associated genes (bab, hop, hof, hom, hef, hor, frp and lpt), with 
polymorphisms found among 73% (n=24 samples) (figure 4.5; Appendix figure 
10.4.19). There are a wide range of outer membrane associated genes and protein 
families, where OMPs are thought to make up approximately 4% of the H. pylori coding 
genome (Alm et al., 2000a). Numerous studies have shown that OMPs are highly 
diverse and polymorphic with some strains harbouring different numbers of OMP genes 
as well as consisting of a mix of protein families (Kim et al., 2016; Solnick et al., 2004; 
Bauwens et al., 2018; Alm et al., 2000a; Oleastro et al., 2010; Pride, Meinersmann and 
Blaser, 2001). However, most studies have looked at polymorphic variation between 
single strains of H. pylori from between; patients, geographical regions, sequential 
isolates from animal models and familial isolated strains to reach these conclusions 
(Kim et al., 2016; Solnick et al., 2004; Yamaoka et al., 2002a; Akeel et al., 2019; Hansen 
et al., 2017; Furuta et al., 2015; Liu et al., 2015). The comparative genetics approaches 
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of such studies have contributed to the identification and understanding of OMP 
polymorphic diversity, but polymorphic diversity has yet to be shown within populations 
taken from the same time point, despite the identification of OMP phase variation and 
gene conversion (Solnick et al., 2004; Hansen et al., 2017; Liu et al., 2015; Yamaoka 
et al., 2006; Braga et al., 2019). This is perhaps hampered by the difficulty and 
increased workload in isolating single colonies from population sweeps, the availability 
of paired biopsy samples from the same patient and the increased sequencing costs 
such investigations incur.  
 
The deep sequencing and analysis methodology adopted within this study reveals a 
snapshot of vast polymorphic diversity within OMP associated genes at a single time 
point within populations taken from single biopsies (figure 4.5). This study also 
demonstrates the resolution and power of this analysis method. Such high polymorphic 
diversity within OMP related genes has many potential biological implications, namely; 
adaptation to new hosts/environments, persistence of chronic infection and disease 
progression (Yamaoka et al., 2006; Oleastro and Ménard, 2013; Akeel et al., 2019; 
Braga et al., 2019; Furuta et al., 2015). Therefore, a continually diverse population with 
polymorphic diversity within OMPs could add to the picture of how chronic infection of 
H. pylori is established lifelong.  
 
Some of the most frequently identified common allelic variant sites were within virulence 
related genes including vacA paralogue (HP0289, n=5 samples), babA (n=5 smaples), 
and cagA (n=4 samples). The vacA gene is present in almost all H. pylori strains but is 
known to have a number of polymorphic types defined within the signal (s1a-c/s2), 
intermediate (i1/i2/i3) and middle (m1/m2) regions (Van Doorn et al., 1998; Rhead et 
al., 2007; Chauhan et al., 2019). However, different allelic variants of vacA have 
different effects on colonisation, virulence and disease pathologies (Winter et al., 2014; 
Sheikh et al., 2018). Han et al. (1998), used restriction fragment length polymorphism 
and PCR techniques to investigate between and within patient diversity of the vacA 
genotype. These studies showed that each patient harboured a unique strain of H. 
pylori but revealed that there was no observable within patient vacA diversity between 
the antrum and corpus. The results presented in this study show that vacA presence 
can vary between antrum and corpus H. pylori populations from the same stomach 
(Chapter Three, tables 3.2A-B). Within niche genetic diversity of vacA was also 
observed but was not a common observation (4/33 deep sequenced populations; 
Appendix, figure 10.4.20).  
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This study revealed extensive within niche polymorphic diversity of vacA paralogues 
(figures 4.5 and 4.6). Paralogues of vacA have been described by other studies and 
have been shown to play a role in collagen degradation allowing access to essential 
amino acids and have also been shown to exacerbate the development of gastric 
ulceration (Castillo et al., 2008; Beswick, Suarez and Reyes, 2006; Kavermann et al., 
2003). Again, such within niche diversity could help explain how H. pylori is able to 
colonise and persist as a lifelong infection and why some patients go onto develop 
disease while others do not. Furthermore, varying levels of variation, potentially 
attributed to various vacA allele paralogues could potentially aid in virulence by a 
balance of other interacting virulence genes. However, such intra population vacA 
paralogue diversity would need to be investigated further to better understand the 
biological significance of these extensive polymorphic profiles. It must also be noted 
that analysis of the within niche minor allelic diversity does reveal some patients with 
vacA genetic variability (Appendix, figure 10.4.20). 
 
The cagA gene has been shown to be genetically diverse between individual patients 
and geographical regions (Peters et al., 2001; Olbermann et al., 2010b). Patients 
infected with cagPAI positive H. pylori strains are more likely to develop a range of 
diseases such as gastric ulcers and adenocarcinoma (Park et al., 2018; Backert and 
Tegtmeyer, 2017). However, what is not well documented prior to this study is evidence 
of within patient genetic diversity of the cagA gene. In addition to within host genetic 
diversity of the cagA gene, this study also reveals between niche cagA diversity (figure 
4.5; patients 93 and 732). As this observation is not limited to one patient, this does not 
appear to be a special case or an outlier, especially considering this detection is based 
on stringent calling parameters of the common allelic variant detection methodology. 
The biological significance of this is yet to be determined. However, as cagA is a known 
virulence associated gene, within and between niche population diversity could result 
in variations in virulence across the stomach, potentially playing an important role in 
disease development. 
 
Another notable common allelic gene product was the DNA-directed RNA polymerase 
beta subunit (HP1198; rpoB). Certain mutations within the rpoB gene of H. pylori have 
been shown to increase resistance to rifamycins (Heep et al., 2000b; a; Hays et al., 
2018; Nishizawa et al., 2011). Therefore, polymorphic diversity within rpoB is a 
concerning observation and could indicate intra population variation in rifampicin 
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resistance within populations. In some cases, this observation might help to explain 
eradication therapy failure within patients whereby underlying resistant strains persist 
within the population. The samples with polymorphisms within the rpoB gene were 
samples 93A, 194C, 439A and 732A. In relation to the antibiogram results for these H. 
pylori populations, all except for sample 439A were shown to have two zones of 
inhibition, resistant colonies within the zones of inhibition, and or resistance to rifampicin 
(Appendix table 10.3.1). Therefore, polymorphisms within the rpoB gene from deep 
sequencing of these H. pylori populations is potentially related to phenotypic variation 
in rifampicin resistance. Despite the H. pylori population form sample 439A not 
exhibiting an obvious second zone of inhibition, resistant single colonies were observed 
outside the recorded inhibition zone (Appendix table 10.3.1). Other H. pylori populations 
from patient samples recorded as observing resistant colonies or second zones of 
inhibition for rifampicin were not displayed as polymorphic in the common allelic 
detection pipeline (Chapter Three, figure 3.1; figure 4.5; Appendix, table 10.3.1). 
However, additional samples were detected as showing polymorphic variation within 
the rpoB gene in the minor allelic pipeline for samples 77C, 265C, 322C, 326A, and 
439C (figure 4.6). Sample 322C also showed an additional zone of inhibition for 
rifampicin where all other samples except for 439C presented with resistant single 
colonies within the recorded zone of inhibition. Therefore, there is a good match 
between rpoB polymorphic diversity and diversity in phenotypic rifampicin resistance. 
However, some patient samples showed the presence of resistant colonies within the 
zone of inhibition for rifampicin but were not shown as genetically variable for the rpoB 
gene. This suggests that other genes maybe further involved in rifampicin resistance. 
In relation to sample 326A which was shown to have no rpoB polymorphisms, the zone 
of inhibition was comparable to other samples harbouring polymorphic diversity 
suggesting that the resistance genotype was present within this sample and had fixed 
in the population resulting in no observable rpoB polymorphisms. Sample 439A showed 
polymorphisms within the rpoB gene but no resistant colonies or second zone of 
inhibition were seen. Furthermore, this sample had a comparably more sensitive zone 
of inhibition for rifampicin suggesting that not all polymorphic diversity or mutations 
within the rpoB gene results in higher rifampicin resistance.  
 
What is abundantly clear between the common and minor allelic detection pipeline is 
that much more genetic diversity is detected from the latter pipeline (figures 4.5 – 4.6; 
Appendix figures 10.4.19 – 10.4.20). The minor allelic detection pipeline is able to 
detect minor sub-populations of genetic variation. From the minor allelic variation 
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pipeline (figure 4.6), the most polymorphic variation across samples was identified 
within the following genes/gene products; OMP associated (hopQ, hopL, frpB, hopI, 
hefA, hopC and horD) (23/33), Methyl-accepting chemotaxis protein TlpB (16/33), type 
I and III restriction modification associated (HP0464, HP0846, HP1371 and HP1521) 
(15/33), vacA paralogs imaA and vlpC (13/33), cagY of the cagPAI (12/33), Sialic acid-
binding adhesin SabA (11/33), lipopolysaccharide biosynthesis protein (11/33) and 
glutathione-regulated potassium-efflux system protein (11/33). Again, high genetic 
diversity was observed within and between samples for OMP related and vacA 
paralogue genes (figure 4.6). However, additional genes were also identified with a 
genetically diverse signature across multiple samples as previously described. 
 
Methyl-accepting chemotaxis associated genes were identified as the second most 
allelic gene showing within niche genetic diversity between multiple patients (figure 4.6). 
Chemotaxis is the process in which bacteria sense the external environment and are 
able to move towards or away from certain chemoattractants or chemorepellents 
respectively. To understand the significance of the genetic diversity observed within this 
study of methyl-accepting chemotaxis genes, further investigations into the nature of 
the chemotaxis attractant/repellent would need to be determined or further 
characterisation of the specific gene would need to be investigated. This would allow a 
more conclusive determination of the importance of this observed diversity. However, 
it could be speculated that genetic diversity of chemotaxis associated gees could aid in 
the survival of H. pylori strains. For example, it has been shown that the chemotaxis 
receptor tplB gene is essential for the pH taxis where acidic pH is a chemorepellent, 
allowing H. pylori strains to move towards more favourable, less acidic conditions 
(Croxen et al., 2006). Furthermore, the chemotaxis receptor tplA gene has been shown 
to sense arginine, bicarbonate, and acid (Cerda et al., 2011; Huang et al., 2017). 
Genetic diversity could result in more sensitive or insensitive chemotaxis, allowing for 
colonisation of different niches. 
 
Another notable highly polymorphic group of genes identified by the minor allelic 
analysis pipeline were restriction-modification system associated. Furuta et al. (2015a), 
observed similar genetic diversity among restriction-modification associated genes by 
a comparative genetics approach of single colony isolates obtained from five different 
families. However, this project reveals the within patient population diversity rather than 
a between strain diversity from different members of a family. Furthermore, this study 
reveals a much higher extent of restriction-modification gene diversity, likely due to the 
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sampling technique of capturing diversity at a population level. Nonetheless, this 
observation is supported by that of Furuta et al. (2015a), suggesting an important role 
for restriction-modification system genetic diversity. Other studies have also observed 
restriction-modification system diversity between strains taken from different patients 
(Kojima et al., 2016; Nobusato, Uchiyama and Kobayashi, 2000; Aras et al., 2002; 
Yahara et al., 2016). Restriction-modification systems within bacteria have been 
described as a potential innate immune system that confer protection against invading 
foreign DNA such as that delivered from bacteriophages (Tock and Dryden, 2005; 
Vasu, Nagamalleswari and Nagaraja, 2012). Despite the ability to differentiate between 
self and non-self DNA, it has been shown that restriction-modification systems do not 
pose a barrier to homologous recombination (Bubendorfer et al., 2016a). Therefore, the 
observed within patient genetic diversity should not impact on the ability of 
subpopulations to recombine with one another suggesting another potential importance 
to this observed diversity. It has been shown that restriction-modification systems can 
play a role in global and specific gene expression (Vitoriano et al., 2013; Srikhanta et 
al., 2011; Furuta et al., 2014) while other studies have shown a role in adhesion and 
virulence (Lehours et al., 2007; Takeuchi et al., 2002; Ando et al., 2010; Gorrell and 
Kwok, 2017; Kumar et al., 2018; Gauntlett et al., 2014). Taken together, the observed 
within/between niche and between patient diversity of restriction-modification system 
associated genes could play a role in niche and host adaptation and may also play a 
role in chronic infection in addition to virulence.  
 
Paralogs of the vacA gene have been shown to play a role in host colonisation and 
modulation of the host immune system (Ssuse, Castillo and Ottemann, 2012). 
Therefore, these highly variable genes could help in persistence of infection.  
 
The cagY gene has been shown to be genetically diverse and is thought that cagY 
recombination can make this less or more immunogenic (Barrozo et al., 2016). 
 
Lipopolysaccharide biosynthesis associated genes were also found to be a highly 
polymorphic within H. pylori populations across many different patients. The 
lipopolysaccharide is considered highly immunogenic and is often considered a target 
for vaccine development (Santos et al., 2010; Conde-Álvarez et al., 2013; Zhao et al., 
2018). However, human sera antibodies have been shown to target specific H. pylori 
lipopolysaccharides but are generally less immunogenic due to host cell mimicry by 
blood group O-chains (Monteiro et al., 2011). Additionally, the lipopolysaccharide has 
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been associated with biofilm formation, adhesion, virulence, immune system evasion, 
increased antibiotic resistance and is essential to cell structure and integrity (Wong et 
al., 2016; Chang et al., 2011; Yu et al., 2016; Moran, 2008; Li et al., 2016; Stein et al., 
2017; Khamri et al., 2005). Due to these wide-ranging functions, the extent of 
polymorphic diversity observed within this study is perhaps not surprising. However, the 
findings have many implications such as on the developing picture of how H. pylori is 
able to persist as a lifelong infection. Such genetic diversity of lipopolysaccharide 
biosynthesis associated genes might help enable this chronic infection. Another 
implication is in vaccine development, as lipopolysaccharide biosynthesis associated 
genes might not be an ideal vaccine target due to the intra- and inter-niche and 
interpatient genetic diversity observed here.  
 
Glutathione-regulated potassium-efflux system protein KefB is involved in cellular 
homeostasis by regulating toxic electrophilic compounds and in doing so, modulating 
cytoplasmic pH (Roosild et al., 2010). This suggests a putative role in pH environmental 
adaptation which could be facilitated or modulated by genetic diversity. Furthermore, 
kefB mutations have been flagged as a gene candidate for H. pylori clarithromycin 




Figure 4.5 Common allelic variant gene products 
 
Heatmap of most common allelic genes (polymorphic genes shared by two or more different samples). Heatmap was created using ggplot2 and the RColorBrewer 
through the R statistical software version 3.5.1 (R Core Team, 2018).  Patient antral and corpus polymorphic diversity can be compared by looking between samples. 
Number of different polymorphic genes/associated gene products can be identified per sample. Colour intensity indicates a higher number of polymorphic positions 
within these gens/associated genes by product. This approach tries to keep together observed polymorphic diversity within genes by gene name and where no gene 
name is provided (by PROKKA) a unique gene number for each patient sample is provided. Sample 565C was excluded due to the extreme variation observed. An 
undocketed heatmap including sample 565C can be observed in the Appendix (figure 10.4.19) with full resolution images within the appendix directory 
(https://myntuac-my.sharepoint.com/:f:/r/personal/n0667645_my_ntu_ac_uk/Documents/OneDrive_link?csf=1&e=UuIp26).
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Figure 4.6 Minor allelic gene products identified between six or more samples 
 
Heatmap of minor allelic variant genes/gene products shared between six or more different samples. Heatmap was created using ggplot2 and the RColorBrewer 
through the R statistical software version 3.5.1 (R Core Team, 2018). This figure can be interpreted as previously described in figure 4.5. Sample 565C was excluded 
due to the extreme variation observed. A heatmap displaying all minor allelic genes and the inclusion of all samples can be observed in the Appendix (figure 
10.4.20). A full resolution image can be found in the Appendix directory (https://myntuac-
my.sharepoint.com/:f:/r/personal/n0667645_my_ntu_ac_uk/Documents/OneDrive_link?csf=1&e=UuIp26).
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After endoscopy the physician scores histological sections from stomach biopsies for 
indicators of disease severity, namely activity, atrophy, inflammation and intestinal 
metaplasia. This study hypothesised that adverse conditions (such as high levels of 
inflammation) would select for increased H. pylori population diversity or increase the 
selection of environment specific genes. In order to test these hypotheses, the total 
number of nonsynonymous mutations at polymorphic sites were recorded for each 
specific environment and corresponding disease severity (figure 4.7). No significant 
associations were found between the total number of nonsynonymous mutations at 
polymorphic positions and disease severities. 
 
Additionally, total numbers of nonsynonymous mutations identified from within niche 
polymorphic diversity from the antrum and corpus of individual patients were compared 
via a paired t-test (figure 4.8). This analysis was performed to investigate whether there 
were differences in the number of nonsynonymous polymorphic mutations between the 
antrum and corpus. No significant differences in the number of nonsynonymous 
mutations were seen between the antrum and corpus populations of the same stomach 
at a single time point. This suggests a comparable level of selection and diversity within 
the separate niches taken from a single time point. However, patients 93, 322, 565 and 
732 show big variation of total numbers of nonsynonymous mutations between the 
antrum and corpus populations which suggests that antrum and corpus differences 





Figure 4.7 Total number of nonsynonymous within niche mutations 
 
 
Total counts of nonsynonymous mutations across different niche environments of activity 
(figure A), atrophy (figure B), inflammation (figure C) and intestinal metaplasia (figure D) with 
varying severity as described by the updated Sydney scoring method (Dixon et al., 1996; Stolte 
and Meining, 2001). This figure was created using a one-way ANOVA statistical test (GraphPad 
Prism version 8.1.2). No statistically significant associations (P value <0.05) were observed for 
any condition or severity of disease. Green circles represent antrum population samples while 






Figure 4.8 Total number of nonsynonymous within niche polymorphic variants 
between the antrum and corpus of paired patient samples 
 
Paired t-test of within niche nonsynonymous polymorphic variants found within the antrum 
(green circles) and corpus (purple triangles) populations taken from the same stomachs. Only 
patients with paired antrum and corpus populations were used. 
 
4.3.5. Between niche genetic diversity 
 
Between niche genetic diversity of individual patients was investigated using a multitude 
of techniques that taken together, resulted in an informative and reliable dataset. Firstly, 
a whole genome alignment of antral and corpus consensus genomes was conducted 
to identify alignment SNPs. A second approach was used to validate these alignment 
SNPs by mapping niche specific reads to the consensus genome of the opposite niche. 
The advantage of this duel methodology was to retain the consensus or majority base 
calls as determined by the consensus genome alignment method while removing 
alignment SNPs that were potentially artefacts of assembly reconstruction and thus not 
true SNPs or biological sequence. This phenomenon is usually confined to the start and 
end of assembled contigs and is due to the assembler being unable to resolve bases 
or find a continuous string of bases/reads resulting in a contig break, usually in regions 
of lower or higher sequence coverage. These methods were combined with a 
nucleotide basic local alignment search tool (BLASTN) identity score to further identify 
genetic differences between paired antral and corpus consensus genomes as this 
method takes into consideration sequence insertion and deletions as well as regions 
with multiple nucleotide polymorphisms (figure 4.9; Appendix, table 10.4.1; Appendix, 
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figures 11.4.21 – 11.4.35). This combined analysis approach shows that there are few 
regions of 100% nucleotide identity between paired antrum and corpus consensus 
genomes. Furthermore, there was good agreement between the alignment and 
alternative niche mapping methodologies (red SNPs) and where there was 
disagreement with the alignment only identification (black SNPs) these were located 
mainly around contig breaks, as predicted. Mapping only SNP locations (teal SNPs) 
were also identified, but often in lower fractions. These were thought to be identified 
due to minor allelic diversity at these positions that were not filtered out due to the 
mapping thresholds and thus were not the consensus base call at these positions. 
Therefore, this combined analysis methodology was successful and resulted in a subset 
of alignment SNPs that were of higher confidence of being true SNPs between the 
aligned genomes. All SNPs tagged by these methodologies were colour coded and 
mapped to their exact locations between the aligned genomes (figure 4.9) and 
numbered in ascending order from the start of the largest to the smallest contig 
sequence blocks. These SNPs were numbered so that individual SNPs or groups of 
SNPs could be identified and cross-referenced to determine whether each SNP was 
from a coding or non-coding section of the genome. If a SNP related to a coding region, 
the gene annotation was determined.  
 
Noticeable gaps or regions with <95% BLASTN identity were identified between all 
aligned genomes except for samples 93A (population consensus reference) – 93C 
(Appendix, figure 10.4.23A), 194A - 194C (population consensus reference; Appendix 
figure 10.4.25B), 295A - 295C (population consensus reference; Appendix figure 
10.4.27B), 308A - 308C (population consensus reference; Appendix figure 10.4.28B) 
and 439A - 439C (population consensus reference; Appendix figure 10.4.31B) where 
gaps were only confined to the smaller contigs towards the end of each genome. These 
gaps only found towards the end of the genome are potentially attributed to sequence 
artefacts as a result of sequence assembly as previously discussed. Sequence gaps 
between aligned genomes suggests variability of gene content and could be an 
additional determinant of between niche variability.  
 
In addition to sequence presence and absence, hotspots of genetic diversity between 
aligned genomes can be identified by high density SNP regions such as SNPs 29 – 49 
(figure 4.9A) which were located outside of a coding sequence. Outside of these 
hotspots of genetic diversity, alignment SNPs were uniformly distributed across the 
genome. In terms of bioinformatics analysis, this is an important observation as an 
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uneven distribution located on a single contig, could be an indicator of assembly bias, 
a SNP calling artefact or a region of homologous recombination. This is because 
spontaneous genetic mutations occur randomly across the genome thus distribution of 
such mutations should not be confined only to a single stretch of the genome (Rosche 
and Foster, 2000). However, selection pressures might act on a strain that drive the 
selection for, or loss of, certain genetic mutations within the population, resulting in 
genes with increased genetic diversity (Didelot et al., 2016). But, considering the high 
natural mutation rate of H. pylori strains from a population level, it would be alarming to 
observe diversity confined to a single, small stretch of DNA (Falush et al., 2001a).  
 
Random mutation can have a significant effect on strain fitness and a mutant can rise 
to dominance if advantageous (positive selection) or drift out of the population if 
disadvantageous (negative selection). Therefore, in relation to within niche genetic 
variation, the most dominant polymorphic variant is likely to be the most successful at 
the sampling time point. For this reason, determination of these alignment SNPs can 
help aid in the identification of highly variable genes with potential niche specific 
adaptations. Furthermore, genes observing high levels of genetic diversity between 
populations could have wide ranging implications, such as niche specific adaptation, 
virulence and persistence of chronic infection. 
 
Despite the known presence of sequencing read contaminants of samples 308A and 
326A the same methodologies were applied to these samples to determine the utility of 
using contaminated H. pylori datasets and to stress test the analysis pipelines. 
Unexpectedly, the combined analysis pipeline revealed that the alternative niche 
aligned fully to select complete contigs, while other contigs remained alignment free or 
showed very small segments of genome alignment. It is hypothesised that the 
contaminant was assembled almost completely independent of the target H. pylori by 
the SPAdes assembler, presumably due to the contrasting GC percentage differences 
of the contaminant reads. This is evidenced by the GC content ring depicted in figures 
11.4.28A and 11.4.30A (Appendix). This analysis shows that there is a potential 
application to remove these unaligned contigs from the dataset to better resolve the 
target H. pylori consensus sequence. However, this additional processing step fell 
outside the scope of this project and the presence of short length alignments to the 
unaligned contigs has unforeseeable downstream analysis consequences. 
Nevertheless, such a methodology could be applied in situations where re-sequencing 
is not possible.  
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Figure 4.9 Between niche diversity using BLASTN and alignment-based SNPs – patient 265 
 
 
BLAST Ring Image Generator (BRIG) plots of paired antrum and corpus consensus genome assemblies constructed as described in section 3.2.2.3. Figure A depicts 
the antrum consensus genome as the reference with the corpus consensus genome as the query where figure B depicts the reverse of this. The rings represent the 
following from the centre most ring outwards; GC percentage, GC skew of the mean, sequencing coverage, contig breaks, reference consensus genome, query 
consensus genome, SNP locations. The green concentric ring represents the antral consensus genome where the purple represents the corpus consensus genome. 
SNPs are a numbered for reference purposes so that they can be linked to a specific SNP within the VCF files. Additionally, SNPs were colour coded as follows; 
black = identified by whole genome alignment only, teal = identified only by the alternative niche read mapping approach, red = identified by both methodologies. 
An upper BLASTN identity threshold of 98% and lower identity of 95% were used. BRIG diagrams for all other patients with paired antrum and corpus data are 
presented in the Appendix (figures 11.4.21 – 11.4.35). 
A) B)
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Validated (red) alignment SNPs were pooled from both antrum and corpus references 
and duplicate validated SNPs removed to create a final list of between niche validated 
alignment SNPs. These were then annotated to a single reference genome of the 
antrum or corpus from each patient and determined to be synonymous or 
nonsynonymous in nature to the alternative call on the opposite paired genome and 
statistically tested through a paired t-test to determine if there was a mutational 
significance to these between niche alignment SNPs (figure 4.10). These results show 
that there are statistically more nonsynonymous mutations between paired antrum and 
corpus populations. This suggests that there are selection pressures acting 
independently of these niches, resulting in more nonsynonymous fixed mutations 
between the populations. This finding is in contrast to the within niche genetic diversity 
when compared between the antrum and corpus (figure 4.8). An alternative 
interpretation of this result is one where there is no selection acting between the 
populations, proceeding to the accumulation of more nonsynonymous mutations that 
are not being positively or negatively selected against, resulting in intra population 
persistence of higher numbers of nonsynonymous mutations. Despite this alternative 
argument, the stark difference of nonsynonymous to nonsynonymous mutational 
differences of the within niche (figure 4.8) and between niche (figure 4.10) suggests 
differences in selection by the two analysis methodologies. Regardless of the favoured 
theory, these results further add to the picture of within and between niche genetic 
variability and differences between synonymous and nonsynonymous mutational 
profiles within the same patient.
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Figure 4.10 Synonymous to nonsynonymous SNPs between aligned paired 
patient antrum and corpus consensus genomes 
 
 
The validated (red) SNPs identified by the combined whole genome alignment and alternative 
niche mapping methodologies (figure 4.9; Appendix, figures 11.4.21 – 11.4.35) were annotated 
and the CDS SNPs were determined to be synonymous or nonsynonymous in nature between 
the populations. A paired t-test was performed using GraphPad (version 8.1.2) with the total 
numbers of synonymous and nonsynonymous mutations between the paired populations. The 
resulting p-value is displayed above the graph. 
 
The annotated and validated (red) SNPs were further grouped by gene/gene product 
to identify the number of alignment SNPs found harboured between the aligned 
genomes. This was used to create a heatmap of genes showing SNPs between aligned 
genomes and their corresponding densities (figure 4.11). This figure shows that all 
patients have different levels of between niche alignment variability across genes with 
low (93, 194, 295, 308, 326, 349 and 495), moderate (77, 120, 256, 444 and 77) and 
high (45, 322, 565 and 732) levels of gene diversity between paired antrum-corpus 
isolates. In relation to the low, medium and high determination of within niche 
polymorphic variability (table 4.3), there appeared to be a disconnect between the total 
number of between niche alignment SNPs (figure 4.12) and the total number of within 
niche polymorphic variants (table 4.3) suggesting that high within niche polymorphic 
diversity does not correlate with high between niche alignment SNPs. Therefore, if only 
one of these analysis methodologies was followed, such as alignments of paired 
genomes from the same patient isolated from different niches (in the absence of deep 
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sequencing data) any underlying intrapopulation diversity might be missed. The 
opposite is also true, where a population is analysed following the allelic calling pipeline 
and there is an observed high polymorphic diversity, this does not necessarily mean 
there will be high levels of between niche alignment associated genetic diversity. This 
is an important distinction as future studies of within patient genetic diversity would 
require similar or improved sampling methodology (i.e. sampling more areas of the 
stomach such as the fundus or multiple samples from the same niche) to capture and 
better interoperate this type of analysis. In short, to better capture and understand within 
and between niche variability this duel methodology (within niche allelic variant calling 
and between niche consensus whole genome alignment) should be followed. However, 
there were some similarities to the within and between niche comparisons from the 
minor allele calling results (figure 4.6). For example, OMPs showed the most between 
niche diversity across all samples (figure 4.11). Other genes were equally common 
including vacA paralogue and restriction modification associated genes. This analysis 
confirms and characterises the highly diverse genetic variation of H. pylori populations 
observed within the stomachs of individual patients.  
 
Bringing the within niche polymorphic diversity and between niche whole genome 
alignment results together (figure 4.12), the differences and similarities between the 
whole genome alignment and within niche allelic calling pipelines are clearer to 
observe. It is important to note that some genes identified with between niche diversity 
by alignment also had polymorphic diversity within one or both niches. One such 
example is the iron-regulated OMP within sample 265C that is polymorphic within this 
population but has also been identified as an alignment variable gene between the 
consensus genome sequences of the paired antrum and corpus derived patient 
samples (figure 4.12). This observation is not uncommon across the dataset and has 
more than one possible explanation. First, this gene is variable at multiple sites within 
this gene group and one of these positions is polymorphic within one population and 
not the other (within niche variation) where at a separate position there is a SNP 
between the two populations (consensus genome alignment SNP) that is no longer 
detected as polymorphic within the population due to fixation. Second, the polymorphic 
position within a specific niche (265C) has a consensus base call that is different to that 
of the opposite niche, resulting in a between niche consensus genome alignment SNP. 
However, in this scenario the base called as a between niche alignment SNP also 
observes within niche polymorphic diversity at this same base position resulting in one 
niche observing polymorphic diversity in comparison to the opposite niche population. 
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Such an observation may help in the understanding of which direction a SNP is 
occurring as the population observing polymorphic diversity at this site is potentially 
more likely driving the change than the population that shows no polymorphic diversity 
at this position. Further manual inspection of the VCF files from the within niche 265C 
and between niche whole genome alignment methodologies revealed that the latter 
was true where the between niche alignment SNP was identified as polymorphic at the 
same position within the minor allele calling pipeline. 
 
Some genes show both within niche polymorphic diversity from the antrum and the 
corpus, and between niche diversity from the alignment of consensus genomes (figure 
4.12). One such example was the cagY gene for patient 265 (figure 4.12). The same 
explanations could still apply here as described for when only one niche is observing 
polymorphic diversity. However, if both niches observe polymorphic diversity at the 
same aligned position then this might indicate a position that is under similar selection 
across both niches and is starting to reach fixation within one population sooner than 
the other. Alternatively, this could indicate a position that is under no selection and is 
persisting within the population at different abundances due to the lack of clearance of 
unfit strains. Manual inspection of this particular gene revealed that the between niche 
alignment SNP position was polymorphic at the same alignment base position within 
both niches.  
 
Finally, some genes were identified with genetic diversity by between niche consensus 
alignments but showed no within niche genetic diversity for the same gene. One such 
example was the oppA gene from patient 120 (figure 4.12). This is perhaps the 
strongest case of positive selection between the different niches as there is no evidence 
of the potentially less fit strain persisting within one niche. However, it is not possible to 
know in which direction this mutation occurred due to unknown sequence of the 
ancestral/originally infection isolate. Taken together, not only are these significant 
observations in terms of between genome alignment methodologies/comparative 
genomics of non-clonal samples due to the potential bias of the consensus call, but 
also these observations validate the reliability of the analysis pipelines developed within 
this study to capture the within patient genetic diversity dynamics. Additionally, studies 
that employ comparative genomics methodologies of non-clonal samples might not 
capture the full extent of sample diversity or allow for a consensus base call that would 
otherwise result in a between sample SNP which in fact is a position that is not variable 
among a subset of strains within the population and vice versa.  
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Figure 4.11 Heatmap of between niche genetic diversity by whole genome alignment verified SNPs 
 
Heatmap of patient antrum and corpus consensus genome alignments using the validated (red) SNPs as described in the materials and methods section 4.2.2.3. 
Heatmap was created using ggplot2 and the RColorBrewer through the R statistical software version 3.5.1 (R Core Team, 2018). This figure represents variable 
genes found between three or more different patients. Only patients with paired antrum and corpus data were included. A full undocketed heatmap can be visualised 
in the Appendix (figure 10.4.36).  
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Figure 4.12 Heatmap of genetically diverse genes identified from whole genome alignment and within niche allelic variability 
 
Heatmap created using ggplot2 and the RColorBrewer through the R statistical software version 3.5.1 (R Core Team, 2018). The data used to create figures 4.6 and 
4.11 were pooled due to the use of the same allelic variant and alignment SNP annotation methodology (Chapter Two, section 2.14) and used to create this hybrid 
heatmap depicting genetic diversity both within each patient niche (antrum or corpus) by the within population minor allele calling pipeline (section 4.2.1.1) and 
between niche (antrum and corpus) by comparing the population minor allelic genes or through the verified niche consensus alignment (red) SNPs (section 4.2.2.3). 
Gene products/genes that were shown to be diverse six or more times by any methodology across the patient datasets were included in this figure. Hypothetical 
proteins and intergenic nucleotide diversity was removed from this dataset to improve visualisation. Only patients with paired antrum and corpus data were included. 
Patient 565 was excluded due to the extensive, outlier minor allelic diversity dataset to improve visualisation of the most genetically diverse genes/gene products. 
A undocketed figure including patient 565 can be found in the Appendix (figure 10.4.37).  
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To further investigate the between niche alignment gaps and regions of <95% BLASTN 
identified from the BRIG analysis (figure 4.9) a gene presence and absence analysis 
was conducted to distinguish differences in gene content. Roary (Page et al., 2015) 
was used to identify a total of 4,755 unique genes across 31 H. pylori populations 
(Appendix, figure 10.4.38). These were made up of; 935 core genes (99% - 100% 
strains), 55 soft-core genes (95% - 99% strains), 788 shell genes (15% - 95% strains) 
and 2,977 cloud genes (0% - 15% strains). This analysis revealed that there was a 
relatively small core genome shared between all populations and a genetically diverse 
accessory genome (appendix, figure 10.4.38). 
 
To investigate how diverse these patient populations were to one another, a core 
genome phylogeny was constructed by approximately-maximum likelihood (Treangen 
et al., 2014) and the gene presence and absence was overlaid as a heatmap in order 
to better depict these differences (figure 4.13). As expected, each patient sample 
clustered independently on the phylogenetic tree. There were substantial genetic 
content differences between all patients outside the core genome. However, the paired 
antrum and corpus consensus genomes from each patient have remarkably similar 
accessory gene content, creating a unique gene barcode for each patient, with very 
little variability observed. The only exception to this was patient 565 which showed 
much more genetic content variability between the antrum and corpus. This result is 
similar to that observed in figures 11.4.34A-B (Appendix) and shows consistency across 
the different types of analysis. It is possible that this patient was infected with more than 
one strain of H. pylori that have co-existed and independently diversified over time, 
resulting in the analysis observations seen here. It also appears that the antral dominant 
population is present within the corpus but that the corpus harbours an additional 
genetically diverse H pylori population that is genetically distinct. This theory is backed 
up by the unusual gene content differences observed between the antrum and corpus 
of patient 565 whereby the antral gene presence absence is comparable to the corpus, 
but the corpus has many more additional genes. Furthermore, by de novo whole 
genome assembly, the consensus length of the corpus genome was significantly larger 
than that of the antrum (203,239 bp), suggesting that the corpus population was much 
more complex and held additional genetic content than that of the antrum. Considering 
the average whole genome length of H. pylori is approximately 1.67 Mbp in length, the 
antral population was comparable to this suggesting the presence of a single strain 
infection that has diversified over time. However, the genome size of the corpus 
consensus genome was 1.75 Mbp suggesting the presence of more than one infecting 
 121 
isolate. In comparison to other paired patient samples, patient 565 showed one of the 
highest between niche alignment variability (788 verified CDS SNPs) and by far the 
highest number of within niche CDS polymorphic diversity (antrum = 463 polymorphic 
positions; corpus = 12,754). Again, the vast within niche polymorphic diversity of the 
corpus further highlights the possibility of this niche being populated by more than one 
distinct infecting strain, resulting in the inflation of observed polymorphic diversity.  
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Figure 4.13 Pan-genome gene presence/absence of all deep sequenced samples and core genome phylogeny 
 
Pan-genome analysis of deep sequenced samples from this study, excluding the contaminated samples 326A and 308A. This figure was constructed as described in 
the materials and methods (section 4.2.2.5) and visualised by Phandango version 1.3.0 (Hadfield et al., 2018). The left-hand side of the figure displays the core 
genome phylogeny. The bottom graph represents the percentage of the strains harbouring each specific gene. The top graph represents the accumulating total length 
of all genes combined. At the centre is the gene presence/absence indicated by blue (presence) and white (absence). Other pangenome output statistics are presented 
in the Appendix (figure 10.4.38). 
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4.4. Future work 
 
The findings described in this Chapter are novel both in terms of the application of H. 
pylori population deep sequencing and the pipelines used to analyse the datasets. 
Novel insights have been obtained by combining analysis pipelines in the 
understanding of intra- and inter-population genetic diversity. However, this Chapter 
focused on between niche diversity of the antrum versus corpus using single biopsies 
taken from these locations. It might be beneficial to take additional samples from the 
same stomach region to understand if there is further within niche diversity and/or to 
determine if the results observed here were down to sampling distance rather than 
niche specific diversity. Secondly, there are other regions within the stomach that were 
not studied, such as the fundus. Finally, the samples used within this study were taken 
from patients attending a single hospital within the UK and expanding the scope of 
sample collection to additional countries could prove informative, especially considering 
that H. pylori is known to be a globally diverse pathogen, with geographical genetic 
clustering. These additional samples might further elucidate the within patient genetic 
diversity of H. pylori and allow for further insights into niche specific adaptation. 
Obtaining further samples from a single patient could prove difficult due to the distress 
the patient endures during the endoscopy sampling procedure and may not be ethically 
viable.  
 
The analysis presented in this study has presented a snapshot of genetic diversity 
within H. pylori sample populations. Chapter Five will go on to investigate single colony 
isolates extracted from the same populations described here, from a subset of patients. 
Thus, providing further data resolution in the form of additional analysis and allowing 
for the cross comparison of results that can be used to help validate the methodologies 



























The advantage of using a duel deep population and single colony isolate sequencing 
approach from the same environments is that it allows for the analysis of the populations 
in a more comprehensive way. For example, there is no advantage to looking at the 
phylogeny of the two deep sequenced consensus antrum and corpus assembled 
genomes from an individual patient because population structure would be difficult to 
investigate. However, multiple single colony isolates taken from each of the antrum and 
corpus allow for the investigation of population structure between the different niches. 
Furthermore, paired deep sequenced populations do not allow for the investigation of 
recombination occurring within or between them as strain level comparison is 
impossible.  
 
Previous studies on H. pylori population structure have revealed large scale 
phylogeographic clustering as well as more local geographical clustering. This is 
expertly reviewed by Suerbaum and Josenhans (2007). The advent of MLST and its 
use on H. pylori strains isolated globally revealed phylogeographic clustering of isolates 
(Achtman et al., 1999; Montano et al., 2015; Bullock et al., 2017). Phylogeographic 
clustering has also been observed by comparing coding sequences from single genes 
such as the antigen binding babA (Thorell et al., 2016) and virulence associated genes 
from the cagPAI in particular the cagA gene (Olbermann et al., 2010a). A study by Vale 
et al. (2015), identified H. pylori subpopulations within Europe that generally clustered 
according to wider geographical regions inferred from phylogenetic analysis of 
prophages. Such studies confer the idea of population specific adaptations, colonisation 
and virulence. Indeed, some studies have gone as far as associating phylogeographic 
clustering with differences in disease risk (Sheh et al., 2013; de Sablet et al., 2011; 
McClain et al., 2009). 
 
Two important studies by Falush et al. (2003) and Linz et al. (2007), took advantage of 
the phylogeographical clustering approach and identified significant human migration 
events in human prehistory. This further highlighted the intimate relationship of H. pylori 
infection and co-evolution with humans since anatomically modern humans migrated 
out of Africa approximately 58,000 years ago (Linz et al., 2007). These studies 
prompted further research into the history of H. pylori and human infection with more 
recent studies identifying further insights into human migrations with one study 
identifying a second African migration in the last 52,000 years (Moodley et al., 2012). 
 126 
Other studies have investigated evidence of human migrations in geographical areas 
that were otherwise hard to trace by human genetics or more traditional linguistic and 
archaeological approaches, through the analysis of H. pylori genomes taken from 
infected individuals from various countries (Breurec et al., 2011). 
 
It is clear then, that human infection with H. pylori predates human migration out of 
Africa around 58,000 years ago and has resulted in the global scale phylogeographical 
clustering we observe today. However, few studies have looked at the H. pylori 
population structure within patients, especially from the different niches of the human 
stomach. A recent study by Fung et al. (2019), investigated the colonisation of isogenic 
H. pylori strains by fluorescent strain tagging in a mouse infection model. By increasing 
the transparency of the gastric tissue through CLARITY staining (Tomer et al., 2014), 
they were able to observe the colonisation of fluorescently tagged H. pylori using 
confocal microscopy. They proposed a model of infection whereby founder strains 
colonise deep within gastric glands where they spread to colonise adjacent glands, 
forming islands comprised of predominantly clonal strains. This study also suggests 
that the clonal colonisation islands persist preventing free-swimming strains in the 
mucosa from colonising pre-infected glands, potentially reducing their interactions. 
However, founder strains compete for space with adjacently colonised glands. 
Ultimately, the colonisation of the gastric niche is potentially dominated by sub-
populations of H. pylori due to these founders. Although this study provides novel 
insights into how H. pylori colonise the gastric epithelium and persist in the face of 
constant turnover of epithelium cells as well as mucus, it is important to note that this 
study used genetically similar strains. Therefore, it is not fully representative of a 
potential multi strain infection or of a genetically diverse H. pylori infection that has 
evolved during a long-term chronic infection. A multi strain infection or a diverse H. 
pylori infection has the potential to hold fitness differences between strains, which might 
change the dynamics of the infection. Furthermore, very little colonisation of the corpus 
was observed, suggesting that niche specific differences between the antrum and 
corpus could be preventing colonisation. Therefore, H. pylori populations and isolates 
between the antrum and corpus could hold niche specialised strains and it is not clear 
how these different populations might differ or interact.  
 
A recent study by Ailloud et al. (2019), isolated ten single colony isolates from the 
antrum, corpus and fundus of 16 patients. This study highlighted a patient specific 
degree of isolates clustering into niche specific clades. The isolates from some patients 
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generally clustered into niche specific clades, while other patients didn’t show a defined 
niche specific phylogenetic clustering. The authors suggest the disparity between 
results could in part be explained by migration events between the different stomach 
niches of the antrum, corpus and fundus. Using a marginal state reconstruction 
migration model, it was shown that migration between the corpus and fundus was more 
common than migration between the corpus and the antrum. Migration events between 
the antrum and fundus was rare. These results suggested that the antrum population 
was generally segregated from the corpus and fundus, potentially attributed to the 
differences between the oxyntic epithelium of the corpus and fundus and the antrum 
that lacks parietal cells. While this study explores the local spatial phylogenetic 
clustering (or lack thereof) of isolates taken from the antrum and corpus it is important 
to note that this is a low resolution snapshot of genetic diversity taken from a relatively 
small sample size. Therefore, the populations of the antrum, corpus and fundus and the 
genetic differences observed between them could potentially be over simplified.  
 
Homologous recombination plays an important role in H. pylori genetic diversity. 
Recombination can lead to faster diversification of the genome than spontaneous SNPs 
alone. This is especially true in a mixed strain H. pylori infection (Falush et al., 2001b; 
Kennemann et al., 2011; Krebes et al., 2014). As all H. pylori infections are different 
due to each individual harbouring their own unique H. pylori strains, the recombination 
rate of H. pylori is most likely to be variable. One main factor for this variation could 
potentially be the lack of opportunities for homologous recombination to occur, perhaps 
due to an absence of a mixed strain infection. This is noted by Didelot et al. (2013), who 
investigated the recombination of familial strains. However, in some patients an 
astonishing level of recombination was detected that introduced up to 100 times more 
substitutions then spontaneous mutations.  
 
Other studies have investigated the number of recombination clusters within H. pylori 
genomes from familial and sequentially isolated samples, identifying between 16 and 
441 import clusters (Kennemann et al., 2011; Krebes et al., 2014). The core genome, 
and more specifically the house keeping genes, are thought to be less prone to 
homologous recombination. However, this has been shown to be untrue in the case of 
H. pylori where recombination has been shown in housekeeping genes, core and 
accessory genes with little or no differences in recombination frequencies (Yahara, 
Lehours and Vale, 2019; Achtman et al., 1999). Such genetic diversity driven by 
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recombination is thought to help in colonisation and adaptation of H. pylori to new 
patients and niches as well as persistence of chronic infection.  
 
It is difficult to investigate both the population structure and recombination of deep 
sequenced H. pylori populations. This is mainly because of the limited number of 
comparable genomes, in this case the consensus genomes, and the genetic diversity 
attributed to specific strains. While the deep sequenced populations allow a snapshot/ 
insight of the genetic diversity at a population level, this Chapter aims to investigate 
single colony isolates obtained from these populations. This allows for a comprehensive 
investigation of the patient samples from the antrum and corpus adding analysis that 
could not be attempted by the population deep sequencing methodology. Combining 
the data generated from both methodologies will provide a high-resolution analysis of 
the structure and diversity of each sampled population. Furthermore, this dual approach 
will allow for the cross comparison of results, providing a unique opportunity to 
scrutinise the results of both analysis pipelines.  
 
5.2. Materials and Methods 
 
Sample selection, DNA extraction, whole genome deep sequencing, sequencing read 
curation, contamination detection, whole genome assembly, assembly curation and 
genome annotation was conducted as described in Chapter Two.  
 
5.2.1. Isolation of single colonies and whole genome sequencing 
 
Population sweeps from frozen stocks were cultured in two different ways in an attempt 
to maximise the chance of isolating non-clonal single colony isolates and to better 
observe single colony diversity. Method 1 – frozen stocks were cultured as described 
in Chapter Two section 2.2. After incubation for 48-72 hours, edge growth was taken 
from multiple random areas of the agar plate using the same inoculation loop. A 
quadrant streak was performed on a fresh blood base #2 agar plate supplemented with 
7.5% defibrinated horse blood and incubated for 48 – 120 hours at 37°C under 
microaerophilic conditions (10% CO2, 5% O2, 85% N2). These were checked daily for 
the identification of single colony isolates. Once single colony isolates were visible 
approximately six well-spaced and isolated single colony isolates were carefully 
extracted using a 1 µl plastic inoculation loop and spread in a small quadrant onto a 
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fresh agar plate as described previously. Where appropriate, a range of different colony 
morphologies were extracted. For example, colonies of different size and gloss were 
taken. The significance of the small quadrant streak was to increase visualisation and 
density of bacterial growth from the initial single colony transfer after incubation. The 
remaining surface area of the agar plate was spread randomly whilst rotating the same 
inoculation loop to maximise the chance of bacterial transfer. After 72 – 120 hours of 
incubation under conditions previously described, the agar plates with patched up 
single colony growth were investigated for any signs of contamination and plates were 
discarded if contamination was suspected. To aid with this process a rapid urease test 
was carried out on each agar plate containing bacterial growth as described in Chapter 
Two section 2.3. Urease negative samples were discarded. A cotton swab was used to 
extract all bacterial growth that was urease positive and spread it onto two fresh agar 
plates which were incubated for 24 – 48 hours as previously described. Resulting 
growth over the two agar plates were harvested into Iso-Sensitest broth supplemented 
with 10% glycerol and stored at -80°C for long term storage. 
 
Method two – the same process as method one was followed with the exception of the 
first step whereby 50 µl of the frozen stock was taken after gently thawing the top 
section of the cryogenic-tube and inoculated onto the outer section of the agar plate. 
From here a quadrant streak was performed in order to isolate single colony isolates. 
Therefore, this method required one fewer inoculation/patching of growth and 
incubation step than method one but, single colony isolates usually took longer to form 
by this method making the total incubation time comparable to that of method one.  
 
Further to increasing the potential diversity of single colony isolates, method two was 
followed to mitigate against the potential effect of ‘fitter’ colony growth outcompeting the 
growth of slower growing H. pylori isolates from the initial culturing of the frozen stock 
in method one. 
 
Once all single colonies were isolated they were numbered with the original patient 
number and biopsy location (A – antrum; C – corpus) followed by a unique single colony 
isolate number.  
 
From the collection/database of single colony isolates, five – six single colony isolates 
were randomly selected from each patient biopsy location with equal number of strains 
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from each isolation methodology and brought forward for DNA extraction and single 
colony sequencing as described in Chapter Two sections 2.4 – 2.5 and 2.7 – 2.8. 
 
A list of single colony isolates used within this study can be referred to in table 5.1.  
 
Table 5.1 Single colony isolates used within this study 
Patient number and biopsy 
location 
List of single colony isolate numbers used within 
this study 
194A 194A1, 194A2, 194A4, 194A6, 194A9, 194A12 
194C 194C1, 194C2, 194C3. 194C4, 194C5, 194C6 
249C 249C1, 249C3, 249C6, 249C8, 249C10, 249C16 
295A 295A1, 295A2, 295A3, 295A4, 295A5, 295A6 
295C 295C1, 295C2, 295C4, 295C6, 295C7, 295C8 
322A 322A1, 322A2, 322A3, 322A4, 322A6, 322A7 
322C 322C3, 322C4, 322C5, 322C6, 322C7, 322C8 
326A 326A22, 326A23, 326A24, 326A25, 326A26, 326A27 
326C 326C1, 326C2, 326C3, 326C4, 326C5, 326C6 
439A 439A1, 439A4, 439A5, 439A6, 439A7, 439A8 
439C 439C2, 439C3, 439C5, 439C6, 439C7, 439C8 
444A 444A1, 444A2, 444A3, 444A4, 444A6, 444A8 
444C 444C1, 444C2, 444C6, 444C8, 444C9, 444C10 
495A 495A2, 495A3, 495A5, 495A6, 495A8 
495C 495C1, 495C2, 495C3, 495C4, 495C5, 495C6 
537A 537A1, 537A3, 537A4, 537A5, 537A7, 537A8 
565A 565A1, 565A3, 565A4, 565A5, 565A6, 565A13 
565C 565C1, 565C3, 565C6, 565C8, 565C12, 565C14 
732A 732A2, 732A3, 732A4, 732A5, 732A7, 732A8 
732C 732C1, 732C2, 732C3, 732C4, 732C5, 732C6 
All H. pylori single colony isolates used within this study. A = antrum-derived isolate, C = 
corpus-derived isolate. 
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5.2.2. Sequencing read curation, contamination detection, whole genome 
assembly, assembly curation and genome annotation 
 
Sequencing read curation, contamination detection, whole genome assembly, 
assembly curation and genome annotation was conducted as described in Chapter Two 
sections 2.9 – 2.13.  
 
5.2.3. Creation of the patient reference consensus genome 
 
A patient reference genome was created by merging all curated deep sequenced 
antrum and corpus sequencing reads from each patient and assembled as described 
in Chapter Two section 2.11. This was done to allow the comparison of all antrum and 
corpus single colony isolates to a single reference. This was in place of the selection of 
either the antrum or corpus deep sequencing reference. In essence, this was a hybrid 
assembly of the deep sequencing antrum and corpus reads resulting in a patient 
reference sequence. 
 
It must be noted that there is still a potential assembly bias at play in this hybrid 
assembly. Of particular note are differences in sequencing coverage between the 
antrum and corpus read sets. For example, if the corpus reads were in support of a 
particular genetic sequence but there were more antrum reads in support of an 
alternative sequence then the patient reference consensus would be selected based 
upon the highest read depth, which in this case would be that of the antrum. This would 
cause an antrum biased reference. However, this hybrid approach was used because 
of the problems inherent in the alternative of selecting the reference as either the antrum 
or corpus deep sequenced consensus genome. Furthermore, due to the extremely high 
mutation and recombination rate as well as the differences between the accessory 
genomes of different H. pylori strains, a ‘traditional’ reference H. pylori genome such as 
H. pylori 26955 (NC_000915.1) would have been unsuitable for this research project. 
 
The most suitable reference would have been the whole genome sequence(s) of the 
initial infecting isolate(s). However, obtaining these from naturally infected individuals 
presenting for gastric endoscopy many years after the suspected initial infection was 
not possible.  
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5.2.4. Phylogenetic analysis 
 
A read mapping approach was used to create a core genome phylogeny for patients 
with single colony isolates from both the antrum and corpus (patients; 194, 295, 322, 
326, 439, 444, 495, 565 and 732). Areas of recombination within the core genome were 
detected and removed from the phylogenies to create a more accurate phylogenetic 
tree construction.  
 
The following pipeline was used: 
 
snippy --cpus {user specified CPU/thread/core number} --report -
-minfrac 0.9 --mincov 6 --mapqual 30 --basequal 30 --ref {patient 
reference consensus genome GenBank annotation file} --outdir 
{user specified output directory} --R1 {path to forward/mate pair 
1 of a single colony isolate} --R2 {path to reverse/mate pair 2 
of a single colony isolate} 
 
snippy-clean_full_aln {input file generated from previous 
command: core.full.aln} > {user specified output: clean.full.aln} 
 
run_gubbins.py -p gubbins {input file generated from previous 
command: clean.full.aln}  
 
snp-sites -c {input file generated from previous command: 
gubbins.filtered_polymorphic_sites.fasta > {user specified 
output: clean.core.aln} 
 
FastTree -gtr -nt {input file generated from previous command: 
clean.core.aln > clean.core.tree 
 
Snippy version 4.4.0 (Seemann, https://github.com/tseemann/snippy) was executed 
using the snippy-multi script which is part of the Snippy package. This was done in 
order to group all single colony isolates from each patient sample together but is 
essentially the same Snippy command (above) but run consecutively for each individual 
isolate. The snippy-multi script enacts the snippy-core script on completion which 
generates a core genome alignment of all single colony isolates used as input against 
the user defined reference.  
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The Snippy core genome alignment output file was cleaned using the snippy-
clean_full_aln script from the Snippy package to remove ambiguous characters 
with ‘N’ bases. Recombination within the core genome alignment was detected and 
removed by Gubbins version 2.3.1 (Croucher et al., 2015). Polymorphic sites between 
the aligned genomes were extracted to create a SNP alignment file using the SNP-sites 
tool version 2.4.1 (Keane et al., 2016). Finally, SNP alignment-based phylogeny of the 
isolates core genome was constructed using FastTree version 2.1.1 (Price, Dehal and 
Arkin, 2010) which infers approximately-maximum-likelihood.  
 
A SNP based core genome phylogeny was used as the single colony isolates from the 
same patient were potentially very similar and this methodology allows for fine scale 
resolution of the differences between the isolates.  
 
5.2.5. Whole genome alignment of patient specific single colony isolates 
 
The assemblies for all single colony isolates and patient reference consensus were 
filtered to remove contigs <500 bp in length (Payne, 
https://github.com/tinybio/filter_contigs). 
 
Patient specific single colony isolates from both the antrum and corpus were aligned in 
a pair-wise fashion using the multiple genome alignment (Mauve, version 2.4.0) tool 
(Darling et al., 2004) in progressive mode with default settings as previously described. 
However, the patient consensus genome for each patient (Chapter Five, section 5.2.3) 
was used as the reference.  
 
Mauve was used to reorder the contigs of each single colony isolate to the patient 
reference consensus genome. 
 
5.2.6. BLAST ring image generator: single colony alignments and variant calling 
to the patent reference genome 
 
A similar approach was taken to that described in Chapter Four section 4.2.2.3, but with 
some key differences.  
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Firstly, the patient reference consensus genome was used as the reference sequence. 
This allowed for clearer visualisation of between niche single colony variation by 
aligning all patient specific single colony isolates from the antrum and corpus.  
 
Secondly, variant genes that were identified between single colony isolates were 
compared to the allelic genes identified by the population minor allele calling pipeline 
(Chapter Four, section 4.2.1.1). Unlike the deep population sequencing BRIG 
alignments, the exact variant positions could not be mapped due to the use of the 
patient (antrum plus corpus) reference genome. Instead, the single colony reads were 
mapped to the patient reference genome and the positions of the variants were 
annotated (Chapter Two, section 1.14). The annotated variant genes were harvested 
manually and compared to the allelic genes from the minor allele calling pipeline 
(Chapter Four, section 4.2.1.1). Concordant variant/allelic genes were then identified 
between the deep population sequencing and single colony analysis, as were the genes 
that were uniquely identified as variable for each analysis. These genes were identified 
in the annotation file (Chapter Two, section 2.13; PROKKA gbk/gff output files) of the 
patient consensus reference where each gene start and stop position was extracted for 
the gene names that matched the variable genes. A custom annotation file was 
constructed with these genes start and stop positions along with an abbreviated gene 
name (where appropriate) and colour coded. The variant genes were colour coded in 
relation to how they were detected. Red gene labels represented those that were 
detected as variable by the single colony sequencing and the minor allele population 
deep sequencing methodologies while the single colony only and minor allele only 
variable genes were coded black and teal respectively. This custom annotation file was 
loaded into BRIG (Alikhan et al., 2011) to better depict the variable genes along the 
genome and by which methodology they were detected by. 
 
While this helps in the visualisation of variable genes across the genome there are three 
caveats to this display. One being that where there are more than one gene copy, both 
copies are displayed on the BRIG diagram even if only one of those genes was detected 
as variable. The next being that both methodologies might not identify the same base 
within a gene as being variable, showing a distorted picture of gene variability not site-
specific concordance of gene variability like the deep population sequencing BRIG 
figures provide (Chapter Four, figures 4.9A-B). Leading on from this, there is no SNP 
density information within variable genes.  
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The single colony isolate reads were mapped through Snippy (Seemann, 
https://github.com/tseemann/snippy) using the following command:  
 
 snippy --cpus {user specified CPU/thread/core number} --report 
--minfrac 0.9 --mincov 6 --mapqual 34 --basequal 30 --ref 
{patient antrum/corpus consensus genome GenBank annotation file} 
--outdir {user specified output directory} --R1 {path to 
forward/mate pair 1 of a single colony isolate} --R2 {path to 
reverse/mate pair 2 of a single colony isolate} 
 
Finally, a higher BLASTN identity threshold was used for the BRIG plots as the single 
colony isolates are potentially less diverse at an individual strain level than the deep 
population dataset. Upper and lower identity thresholds of 99% and 96%, respectively, 
were used.  
 
5.2.7. Pan-genome analysis 
 
As described in Chapter Four section 4.2.2.5, a pan-genome assembly was performed 
using Roary (version 3.8.2) to investigate whole genome differences between the single 
colony isolates within and between the antrum and corpus of the same stomach.  
 
To enable this, Roary (Page et al., 2015) was run in the same way as the deep 
sequencing dataset but instead included all single colony isolates used within this study. 
Once complete, the Roary script roary-query_pan_genome was executed for each 
patient with antrum and corpus isolate sets (patients; 194, 295, 322, 326, 439, 444, 
495, 565 and 732) with the antrum isolates set as input 1 and the corpus isolates as 
input 2, using the difference flag. This output the differences between the two groups 
of isolates revealing antrum and corpus unique genes. The following pipeline was used: 
 
cd {path to directory containing list of PROKKA output .gff files 
to pass to Roary} ; roary -p {user specified CPU/thread/core 
number} -e -n -v -f {path to output directory} *.gff  
 
roary-query_pan_genome -a difference --input_set_one {Patient 
specific antrum isolate list of PROKKA output .gff files) --
input_set_two {patient specific corpus isolate list of PROKKA 
output .gff files) 
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The resulting unique set statistics (set_difference_unique_set_one_statistics.csv and 
set_difference_unique_set_two_statistics.csv files) for each patient isolate set was 
manually inspected and brought together into an antrum unique and corpus unique 
spreadsheet. Duplicate gene names were removed and a COUNTIF (Microsoft Excel 
version 16.16.6) function was used to count the number of instances each sample set 
harboured that unique gene. This resulted in a table containing information on how 
many single colony isolates harboured that specific antrum/corpus unique gene for 
each patient biopsy location and allowed comparisons across patients. 
 
A core genome alignment of all single colony isolates was conducted and a 
phylogenetic tree by approximately-maximum-likelihood was constructed through 
Parsnp (version 1.2) which is part of the Harvest suite (Treangen et al., 2014). The 
clinical reference H. pylori genome J99 (NC_000921.1) was used as the phylogenetic 
root. The following command was executed: 
 
parsnp -p {user specified CPU/thread/core number} -r {H. pylori 
J99} -d {path to directory containing genomes to analyse} -a 13 
-c -x 
 
The resulting phylogeny was visualised in FigTree version 1.4.4 
(https://github.com/rambaut/figtree) and re-rooted to the midpoint and ordered in 
decreasing order to improve visualisation. This was then uploaded into phandango 
(Hadfield et al., 2018) alongside the gene presence and absence matrix produced by 
Roary where the reference was manually appended to create a pan-genome gene 
presence and absence visualisation. 
 
5.2.8. Pan-genome wide association study 
 
The gene presence and absence output from Roary (section 5.2.7) was interpreted by 
Scoary (Brynildsrud et al., 2016). Scoary calculates gene associations between all 
genes in the pan-genome to user specified traits of interest.  
 
The single colony isolates from the antrum were compared against the isolates obtained 
from the corpus for each patient to investigate patient specific between niche 
differences. Additionally, all antrum isolates from the dataset were compared to all 
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corpus isolates from the dataset to investigate population specific antrum or corpus 
differences. This was extended to the isolates corresponding to histology Sydney 
scores (where available) for absent/low (Sydney scores 0-1) versus moderate/high 
(Sydney scores 2-3) for activity, atrophy, inflammation and intestinal metaplasia (Dixon 
et al., 1996).  
 
The following command was executed:  
 
scoary.py –-genes {path to input gene presence/absence table 
output from Roary} –-traits {path to table of traits to compare} 
--threads {user specified CPU/thread/core number} --outdir {path 
to output directory} 
 
5.2.9. Recombination detection  
 
Homologous recombination was inferred between all single colony isolates taken from 
each patient with isolates from both the antrum and corpus regions of the stomach 
(patients; 194, 295, 322, 326, 439, 444, 495, 565 and 732).  
 
Sites of homologous recombination were inferred using two different methods 
employing different recombination detection algorithms. Genealogies unbiased by 
recombinations in nucleotide sequences (Gubbins; Croucher et al., 2015) relies on a 
phylogenetic reconstruction that defines a base substitution rate on each branch of the 
phylogenetic tree and calls substitutions while measuring the distance between them. 
Each branch is then scanned to identify clusters of substitutions and recombination is 
inferred across branches or marked as an outside recombination site.  
 
The second method fastGEAR (Mostowy et al., 2017), has four main steps which 
ultimately infer both recent and ancestral recombination events. Step one identifies 
sample lineages, step two identifies recent recombination events, step three identifies 
ancestral recombination and step four removes false positive recombinations by testing 
statistical significances. Steps one – three make use of the hidden Markov model 
(Husmeier, 2005) and is based on the recombination detection software STRUCTURE 
(Falush, Stephens and Pritchard, 2003).  
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The two different tools were used as they analyse the data and infer recombination by 
taking opposite approaches. Gubbins ultimately identifies substitution clusters within 
similar datasets that are flagged as outliers whereas fastGEAR locates similar genetic 
segments from diverse clusters and uses them to infer recombination. Combining both 
analyses allowed for a more comprehensive investigation of recombination between 
the input datasets.  
 
Gubbins recombination detection pipeline:  
 
mugsy -p {user defined output alignment prefix} --directory {path 
to directory containing assembled genomes from SPAdes to align} 
*.fasta 
 
trimal -in {path to mugsy alignment} -out {user defined output 
file name} -gt .5 
 
run_gubbins.py {path to trimmed alignment file from trimal 
output} --threads {user defined} --outgroup {name of reference 
to root the phylogeny} -i 20 
 
Firstly, Mugsy (Angiuoli and Salzberg, 2011) was used to align the whole genome 
sequences of all single colony isolates isolated from each patient. Mugsy was chosen 
due to the balance between high throughput and alignment accuracy in terms of 
comparable alignment tools (Angiuoli and Salzberg, 2011). Furthermore, Mugsy does 
not depend on a reference sequence to inform an alignment of multiple genomes which 
was preferable in this study due to the potential increase in perceived intra-species 
diversity by the use of a diverse reference (Deloger, El Karoui and Petit, 2009). Mugsy 
also allows for genomic rearrangements, inclusion of gene loss and gain as well as 
duplications, all of which could be part of strain diversity.  
 
A tool named trimAI (version 1.2) (Capella-Gutiérrez, Silla-Martínez and Gabaldón, 
2009) was then used to lower the fraction of genomes with gaps allowed in their 
alignments to 50%. This was ultimately done to reduce the number of ‘gaps’ observed 
in the figures produced by Gubbins and fastGEAR and lowered the total genome sizes 
closer to the expected size of 1.67 Mbp. Furthermore, if only one sample was to hold 
an additional gene then it would be impossible to determine recombination within this 
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region as there would be no comparable genetic sequence to infer recombination. 
Depending on the sample size, this threshold can be lowered but 50% was deemed 
appropriate for this study.  
 
Gubbins was enacted with default parameters with the exception of the number of 
iterations performed which was increased to 20, bringing it in line with the number 
performed by fastGEAR.  
 
FastGEAR recombination detection pipeline:  
 
mugsy -p {user defined output alignment prefix} --directory {path 
to directory containing assembled genomes from SPAdes to align} 
*.fasta  
 
trimal -in {path to mugsy alignment} -out {user defined output 
file name} -gt .5 
 
run_fastGEAR.sh {path to MATLAB version 901 runtime component} 
{path to input alignment file from Mugsy output} {output file 
and path} {path to input specifications file} ; 
 
run_plotRecombinations.sh {path to MATLAB version 901 runtime 
component} {path to run_fastGEAR.sh output file} 1 1 ; 
 
run_plotColors.sh {path to MATLAB version 901 runtime component} 
- {path to run_fastGEAR.sh output file} ; 
 
run_plotMarginalsForStrain.sh {path to MATLAB version 901 runtime 
component} {path to run_fastGEAR.sh output file} 1 0 
 
The pre-processing of recombination detection by fastGEAR was identical to the 
Gubbins pipeline (see above) for the whole genome alignments and alignment gap 
processing.  
 
The fastGEAR script was then used to process the alignment file using a modified 
specification file as script arguments. The following specifications was used: 
 
 140 
20 # Number of iterations 
15 15 20 30 # Upper bound for the number of clusters (possibly 
multiple values) 
0 # Run clustering for all upper bounds (0=no / 1=yes) 
- # File containing a partition for strains 
0 # 1=produce reduced output, 0=produce complete output 
 
The recombinations were then visually plotted, labelled and the marginal probabilities 
were plot using the run_plotRecombinations, run_plotColors, 
run_plotMarginalsForStrain scripts respectively.  
 
Ancestral recombination was detected following the same pipeline but with a modified 
run_plotRecombinations command. This was: 
 
run_plotRecombinations.sh {path to MATLAB version 901 runtime 
component} {path to run_fastGEAR.sh output file} 2 1 ; 
 
It is important to note that ancestral recombination does not necessarily mean a 
recombination event that occurred distantly in the past, rather it is a recombination 
event that has occurred on all samples in the data. Conversely, recent recombination 
detected by fastGEAR does not necessarily mean it was a very recent recombination 
event, rather it is a recombination event that has not occurred in all lineages.  
 
5.2.10. Comparing and validating the deep sequencing minor allele detection with 
the single colony isolate variants 
 
The curated reads obtained from the single colony isolates for each patient sample 
location (antrum and corpus) were mapped to the population deep sequenced 
consensus genomes of the corresponding patient sample locations. This was done to 
investigate and validate the results of the population deep sequenced minor allelic 
calling pipeline (Chapter Four, section 4.2.1.1).  
 
The corresponding curated single colony sequencing reads (Chapter Two, section 2.9) 
were mapped to the antrum or corpus deep sequenced de novo consensus genomes 
(Chapter Two, section 2.11) using Snippy (Seemann, 
https://github.com/tseemann/snippy). The following parameters were used: 
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snippy --cpus {user specified CPU/thread/core number} --report -
-minfrac 0.9 --mincov 6 --mapqual 34 --basequal 30 --ref {patient 
antrum/corpus consensus genome GenBank annotation file} --outdir 
{user specified output directory} --R1 {path to forward/mate pair 
1 of a single colony isolate} --R2 {path to reverse/mate pair 2 
of a single colony isolate} 
 
The minimum proportion of reads mapping to reference base calling an alternative base 
had to be greater than 90% to be called as a variant position with a coverage of 6 or 
more reads. A mapping quality of 34 was selected so that the parameters matched with 
the minor allele calling pipeline (Chapter Four, section 4.2.1.1) including a base quality 
of phred 30.  
 
The resulting variant call format files were processed with vcflib (version 1.0.0) 
(Garrison, https://github.com/vcflib/vcflib) to select only fields containing SNP variant 
sites. The following command was executed:  
 
vcffilter -f "TYPE = SNP” {path to VCF file from Snippy output} 
> {path to filtered VCF output} 
 
Each filtered VCF file was further filtered by manual inspection as described in Chapter 
Four section 4.2.1.1. Briefly, variant sites were removed if they were identified in the 
first or last 500 bp of a contig. Next, the mapped reads in the BAM alignment files were 
loaded into Artemis (Carver et al., 2012) alongside the reference annotated genome. 
Variants located in a repeat region of 6 nucleotides or more were identified and 
inspected. These variant sites were removed if the reads supporting the alternative call 
were within the first or last 3 bases of the reads or if the supporting reads held other 
variants within a 20 bp range of the variant site. The support of just one read that passed 
these criteria was deemed sufficient evidence to classify the alternative call as valid, 
even if all other reads failed the measure. 
 
This additional filtering was carried out to ensure the resulting variant files were 
standardised and comparable to those output from the minor allele pipeline (Chapter 
Four, section 4.2.1.1). The total number of variants were recorded for each single 
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colony isolate mapped to the corresponding patient sample deep sequenced 
consensus genome. 
 
All single colony and antrum/corpus minor allele called VCF files were compressed with 
samtools (Li et al., 2009) bgzip and indexed with tabix. Each single colony variant 
file was used to intersect the minor allele called variant file of the associated patient 
sample location using bcftools which is part of the samtools package. The -f and -c 
flags were used to ignore column discrepancies plus variant call format version 
differences and to output unique records found in the second input file respectively. The 
following command was used: 
 
vcf-isec -f -c {single colony filtered VCF file} {minor allele 
called VCF file for corresponding patient sample location} > 
{path to output file of single colony unique SNPs} 
 
The resulting output files contained the single colony specific SNPs not identified by the 
minor allele called deep sequencing pipeline. The number of SNPs identified by each 
single colony and not by the deep sequencing pipeline were recorded.  
 
The number of uniquely identified sites of variation by the single colony isolates was 
calculated to determine the number of sites potentially missed by the minor allele calling 
pipeline. This was done by concatenating all single colony output variant call format 
files from the previous command for each patient location and removing the duplicate 
positions. The resulting unique SNPs were recorded. The following command was 
used: 
 
bcftools concat -a -D {path to all single colony isolate output 
files from the previous command} > {path to variant call format 
file containing unique sites of variation not identified in the 
deep sequenced minor allele detection pipeline} 
 
The -a flag was used to allow for correct processing of the concatenation of the files 
so that overlaps could occur whereby the first coordinate of the next file to be processed 




As some single colonies could hold duplicate SNPs between those isolated from the 
same niche, they were further investigated to calculate the total number of uniquely 
identified sites of variation so that they could be compared to the variant sites detected 
by the minor allele pipeline. This was achieved by combining all single colony variant 
files (VCF files) and removing all duplicate SNPs, leaving only unique variants. The total 
number of single colony detected sites of variation were recorded. The following 
command was executed through the samtools package, following the same format as 
the previous command: 
 
bcftools concat -a -D {path to all single colony variant call 
format files from one patient sample location} > {path to output 
variant call format file containing unique list of variants 
detected by all single colony isolates} 
 
The detection potential from the minor allele deep sequencing pipeline and the single 
colony isolates were compared by recording the total number of the deep sequencing 
unique, single colony unique and unique concordantly detected sites of variation. These 
were drawn as a venn diagram using the R statistical software version 3.5.1 (R Core 
Team, 2018) by the VennDiagram package version 1.6.20 
(https://www.rdocumentation.org/packages/VennDiagram). 
 
5.3. Results and discussion 
 
All of the analysis presented in this Chapter was done on all patients and samples used 
within this study (table 5.1). Where appropriate and convenient, in some results figures 
and/or tables the representative patient 439 sample data were presented. All other 
patient results can be found in the appendix as stated below. However, full patient and 
sample results are displayed where convenient. 
 
5.3.1. Detection of contaminating non-Helicobacter pylori sequences 
 
Contamination detection is much easier using a single colony isolation methodology. 
This is because an experienced microbiologist can usually identify single colonies on a 
culture plate and distinguish between target and contaminant colonies based on a 
number of different criteria. From a population sweep this is much harder to do as the 
culture plate is usually heavy with bacterial growth, potentially disguising contaminant 
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bacteria. Visually, colony morphology that encompasses shape, depth, colour and gloss 
is often the first indicator of the target organism. Secondly, the biochemical 
characteristics of certain bacterial species can be exploited to indicate the target 
organism. Such is the basis of indicator and selection culture media.  
 
Despite the care taken to minimise the contamination risk of isolating single colony 
isolates and the aid of the rapid urease test, contamination can still be present in the 
samples. This could be due to a number of reasons. For example, the presumptive 
bacterial colony could have the same morphology as another bacterial species. 
Furthermore, a rapid urease positive result could occur if there was a mixed population 
of the contaminant and the target H. pylori or if other urease positive bacteria are 
colonising the stomach and/or the oral cavity (due to oral microbiota contamination of 
the gastric biopsy) (Osaki et al., 2008; Mora and Arioli, 2014; Brandi et al., 2006).  
 
Therefore, contamination detection was conducted in silico by mapping all curated 
single colony sequencing reads to all bacterial, archaeal or viral genomes within the 
RefSeq database (https://www.ncbi.nlm.nih.gov/refseq/). This method is described in 
Chapter 2 section 2.10. This output statistics from Kraken (Wood and Salzberg, 2014) 
which revealed that >95% of single colony isolate reads mapped to H. pylori reference 
genomes in all isolates with the exception of samples 322A1, 322A2, 322A3, 322A4, 
322C5, 322A7 and 322C7, in which between 92.53% and 94.77% of reads mapped to 
H. pylori reference genomes. However, at least 95% of reads mapped to references 
from the Helicobacter genus in all cases. Therefore, these isolates were retained in this 
dataset as H. pylori has a very diverse genome and accessory genes which could all 
contribute to a drop in the proportion of reads mapping to the reference genomes. 
Furthermore, the percentage of unclassified reads were not close to comparable with 
the contaminated deep sequenced 308A and 326A samples where 42.11 and 38.33 
percent of reads did not map to any bacterial, archaeal or viral reference genomes. In 
comparison, the datasets generated from isolates 322A1, 322A2, 322A3, 322A4, 
322C5, 322A7 and 322C7 held between 3.57% to 4.88% of reads that failed to map to 
a reference genome. As isolates from both the antrum and corpus of patient 322 all 
showed a similar percentage of reads mapping to the reference H. pylori genomes it 
was shown as further evidence of inclusion of these samples as it would be unlikely for 
all 12 single colony isolates to be contaminants. Finally, in comparison to Kraken results 
from the deep sequenced antrum and corpus populations from patient 322 (Chapter 
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Four, table 4.1) a comparable percentage of mapped reads was shown. This is perhaps 
evidence at a low resolution of the diversity observed in the H. pylori species.  
 
The assembly statistics were calculated for all single colony isolates, excluding 565C1 
and 565C6 due to the unusually large genome sizes (n=117). The mean number of 
contigs was 39.37 (95% CL: 37.96 – 40.78) while the N50 mean was 93,899 (95% CL: 
89,316 – 98,481) and total assembly mean length of 1,609,285 (95% CL: 1,602,833 – 
1,615,738). These statistics were plot in figure 5.1.  
 
The assembly statistics were generally comparable to the deep sequencing patient 
population consensus genome assemblies, but with some important differences 
(Chapter Four, figure 4.2). The mean number of contigs was 50.11 lower which might 
reflect the clonal nature of the single colony sequencing dataset. As each single colony 
isolate dataset derived from one single strain the SPAdes assembler was likely able to 
resolve more contig boundaries due to less read variation. The N50 was very similar 
(346 bp difference) indicating that the deep sequenced consensus assemblies were 
comparable to single colony assemblies. The N50 statistic refers to the minimum contig 
length that is able to cover 50% of the genome. Therefore, despite the inclusion of more 
read complexity by the addition of all population reads in the deep sequenced dataset, 
the genomes were comparable to those generated by single colony sequencing. These 
comparisons start to validate both methodologies.  
 
The difference between the genome length means of the deep sequenced populations 
and single colony isolates was 21.288 kb. This was unsurprising as the deep 
sequenced population dataset might be expected to have much higher genome lengths 
because accessory genes within the populations should be better captured with the 
population deep sequencing method. However, the reads covering these accessory 
genes might be in low abundance within the population read dataset, causing assembly 
issues. Nonetheless, the difference between the average genome lengths between the 
sequencing methods might be reflecting a low number of possible accessory genes 
within the deep sequenced populations.  
 
Despite the outlier single colony isolates 565C1 and 565C6 with an unexpected 
genome length approximately 1 Mb higher than expected, there was no evidence of 
contaminated reads within the read sets. The Kraken contamination detection pipeline 
(Chapter Two, section 2.10) showed that 98.84% and 99.11% of reads mapped to the 
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H. pylori reference genomes respectively. These two isolates also had an unusually 
high number of contigs (565C1 – 1,501; 565C6 – 1,295) and low N50 (565C1 – 3,665; 
565C6 – 3,977) which can be identified in figure 5.1A-B. One explanation to this could 
be the percentage of reads identified within these samples that might result in low 
coverage of the target genome. However, samples 565C1 and 565C6 had a share of 
2.575% and 2.9246% respectively of the Illumina pass filtered sequencing reads 
generated by the MiSeq with the average share of sequencing reads per sample of 
2.0239%. The most likely explanation of these outlier genomes is the possibility of 
inaccurate isolation of a single colony isolate, resulting in a non-clonal stock of two or 
more strains that are genetically distinct. This could result in the SPAdes assembler 
being unable to converge on a more contiguous assembly, causing an increase in the 
number of contigs observed in these sample.  
 
Due to the helical shape of H. pylori it might be possible for individual bacterial cells to 
intertwine with one another. This might not be limited to two intertwined bacterial cells 
but numerous cells. If this was to occur, a single colony observed on a solid-state culture 
medium might look like any other true single colony isolate as the entwined cells will 
essentially have the same centre point of growth. To investigate this in more detail, the 
stocks for 565C1 and 565C6 would need to be streaked out to purity and new single 
colonies picked and sequenced. However, the deep sequenced corpus population of 
patient 565 also resulted in a higher than expected genome size, which supports the 








This figure depicts the quality metrics of the single colony assembled genomes. Figure A – total number of contigs; figure B – N50 of assembled genomes; figure 
C total assembly length. This dataset includes all single colony isolates (n=119). Circle = antrum, triangle = corpus. The mean and 95% CL are displayed as 
horizontal red bars. This figure was plot using GraphPad Prism (version 8.2.0). 
A) B) C) 
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5.3.2. Within patient phylogenetic analysis of single colony isolates 
 
The single colony isolates from patients 326 and 732 show a good phylogenetic 
clustering of antrum and corpus clades. Patients 194, 322, 439 and 565 show a general 
clustering pattern between the antrum and corpus but usually with one additional 
cluster. For example, the antrum isolates from patient 322 have all clustered together, 
but the corpus isolates have separated into two separate clusters. In this case, it would 
suggest that the isolates isolated from the corpus are much more genetically diverse 
than the short-branched antrum cluster. However, the opposite is true for patient 439. 
The phylogeny of antral and corpus isolates isolated from patients 295 and 444 do not 
indicate an obvious clustering topology. This could suggest that the strains taken from 
these patients are highly diverse or that there is little genetic difference between the 
isolates taken from the antrum and the corpus. Study by Cao et al. (2015), found that 
strains taken from a single patient biopsy separated into two phylogenetic clades were 
of a mixed strain infection, which might suggest that the different clades are potentially 
an indicator of a mixed strain infection.  
 
The phylogenetic structures of isolates obtained from the antrum and corpus closely 
match those observed by Ailloud et al. (2019), whereby some patients have a good 
antrum/corpus clustering while others are not as obviously split. Ailloud et al. (2019), 
also highlighted that migration of H. pylori strains from the antrum to the corpus are 
relatively infrequent whereas migration between the corpus and fundus is a more 
common event. They argued that the differences between the antrum and corpus 
niches hamper the migration of strains between the colonised environments. The 
phylogenetic tress displayed in figure 5.2A-H potentially highlight that where an antrum 
cluster is present, corpus strains are more frequently observed within antrum clades 
than the reverse to this. Particular examples of this can be seen in figures 5.2D (patient 
326), figure 5.2G (patient 495) and more loosely associated in figure 5.2B (patent 295). 
The only exception to this is the 439A isolate clustering amongst the corpus isolates in 
patient 439 (figure 5.2E). This might suggest that while migrations between the antrum 
and corpus are less frequent, the corpus isolates are more likely to migrate to the 
antrum than the other way around. Again, this could be due to the differences between 
the antrum and corpus environments where antrum isolates are less fit or poorly 
adapted to colonise the harsher oxyntic epithelium whereas the corpus strains are able 
to colonise the more neutral antrum glands. Additionally, the antral niches of these 
patients held higher Sydney scores by histological examination compared to the corpus 
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niche, which might suggest higher histological scored niches allows for the colonisation 
of strains from other stomach niches. However, more patients and patient strains should 
be included to investigate this observation further and the biological significance 
investigated.  
 
An alternative explanation to the non-clustering of antrum and corpus strains in patients 
295 and 444 could be due to the biopsy sampling location and method. Fung et al. 
(2019), showed how founder strains initially colonise glands and then spread to 
adjacent glands in the immediate vicinity. This creates islands of closely related H. 
pylori strains, and where island boundaries occur the inhabitants may then compete for 
space. At these boundaries there are mixed strain glands or adjacent glands containing 
the different strains side by side. Furthermore, the transaction zone between the antrum 
and corpus is usually more of a mixture of H. pylori strains. Taken together, this may 
mean that if a biopsy is taken closer to a transition zone between the antrum or corpus 
or if a large biopsy is taken (that spans multiple strain islands) then the observed 
diversity might be greater. This could potentially disrupt the genetic clustering and 
phylogenetic topology of the antrum and corpus. Therefore, a standardised sampling 
location within the antrum and corpus might be beneficial to this type of analysis. 
However, this may not be implementable in practice as biopsies are usually taken from 
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Phylogenetic trees constructed as described in section 5.2.4 by approximately-maximum-likelihood. For improved visualisation, antrum-derived strains are shown 
in green and corpus-derived strains in pink/purple. The patient reference consensus genome is shown in black. Phylogenies were visualised in FigTree version 1.4.3 
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5.3.3. Whole genome alignments of within patient single colonies taken from the 
antrum and corpus 
 
The phylogenetic analysis of the H. pylori populations within individual patients 
highlighted a potential clustering of isolates within each niche (figures 5.3A, C – E, H – 
I). But this method was based on a core genome analysis and thus ignored all genes 
that were within the soft core and accessory genome. Therefore, this analysis alone 
could miss out important differences between the antrum versus corpus isolates. To 
address this, the single colony sequences from the antrum and corpus of patients with 
paired samples were aligned and visualised using a high BLASTN identity between 
96% and 100%. This was done to identify small scales differences between the aligned 
genomes. 
 
The representative patient example followed in this Chapter (patient 439) revealed that 
there were defined regions of 100% BLASTN identity in relation to the patient reference 
genome (figure 5.3). This generates a visual fingerprint that can differentiate the 
isolates taken from the antrum and corpus. However, there is also evidence of diversity 
within each niche. This analysis supports observations from the core genome 
phylogeny (figure 5.2E).  
 
The deep population consensus genome alignments visualised using BRIG often 
highlighted regions of similarity and difference between the paired populations (Chapter 
Four, figure 4.9; Appendix, figures 11.4.21 – 11.4.35). This is supported by the single 
colony isolates where they are often grouped by their 100% BLASTN fingerprint. 
However, the perceived advantage of capturing the whole population diversity had a 
negative effect on the identification of potential pan-genome differences of the prevalent 
population and/or between strain differences. For example, if a single isolate within the 
antrum that was in low abundance harboured a gene that was not common within the 
population, this gene would still have been sequenced and potentially assembled into 
the consensus genome of the antrum population. This is further complicated when an 
accidental strain is taken from the corpus population due to human error such as during 
sample collection or biologically through migration or samples taken from strain island 
boundaries aforementioned (Fung et al., 2019). Furthermore, due to the more complex 
nature of whole genome assembly from a potentially mixed strain population, it is 
possible that not all genes within the population were assembled into the consensus 
 153 
genome. In these examples, key strain differences within the population could be 
missed or overlooked.  
 
The advantages of using a combination of deep sequencing and single colony 
methodology start to show in these analyses. In figure 5.3, there is a section of the 
genome that is either missing or has a BLASTN identity <96% approximately between 
positions 1.29 – 1.325 MBp in relation to the reference genome. This accounts for a 
missing genomic length of around 35 kb. This region appears to be missing or of low 
BLASTN identity in all corpus-derived strains and one antrum-derived strain from 
patient 439 but is present in the majority of the antrum-derived isolates (n=5). However, 
there is no evidence of a segment of this size missing from 439C in the comparison of 
the deep sequenced 439A and 439C consensus populations (Appendix, figures 
11.4.31A-B). This shows that although sequencing of single colony isolates has utility 
in identifying this type of antrum-corpus difference, deep sequencing of the whole 
population completes the picture. Clearly, some isolates within the corpus must harbour 
this missing or higher identity genomic segment that is prevalent in the antrum-derived 
colonies. But, by sequencing a low number of single colony isolates it was possible that 
isolates harbouring this genetic segment were simply missed due to the 
unrepresentative sample size. This is better captured from a deep population 
sequencing approach as the entire genomic content of the population is captured. 
 
On further examination of this region (1.29 – 1.325 Mbp to the reference genome), most 
of the genes were hypothetical (n=25). However, genes xerH, virC1, traG, virB11, 
virB10, topA and ptlC were annotated by PROKKA (Seemann, 2014). As these genes 
are not present within some strains they are likely to be mobile genetic elements. It is 
not possible from this analysis to determine whether these mobile genetic elements are 
associated with, a plasmid, bacteriophage or transposable element.  
 
However, xerH is a recombinase gene shown to aid in chromosome segregation and 
colonisation. Knockout xerH mutants have been shown to affect colonisation and to 
have a higher sensitivity to ciprofloxacin, potentially attributed to the function of DNA 
joining and repair (Debowski et al., 2012). The strains harbouring this genomic segment 
harboured an additional xerH gene which could potentially cause differences in 
resistance and colonisation. Despite this, there were no obvious differences in 
levofloxacin sensitivity, at least at the population level, between the antrum- and corpus-
derived H. pylori isolates from patient 439 (Chapter Three, figure 3.1). However, 
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another DNA damaging, and fragmentation associated antibiotic (Sisson et al., 2000; 
Jenks and Edwards, 2002), the antrum-derived H. pylori population was more resistant 
to metronidazole than the corpus-derived population (Chapter Three, figure 3.1). The 
additional xerH gene could potentially be contributing to the higher metronidazole 
resistance within this population, but experimental investigations would be needed to 
prove this.  
 
The virC1 gene is well defined in Agrobacterium tumefaciens and is associated with 
DNA transfer contributing in genome plasticity (Atmakuri et al., 2007). Mutation of virC1 
have been shown to reduce pathogenicity of A. tumefaciens in plants. The role of this 
gene in H. pylori is not fully understood but it is possible that it contributes to virulence, 
as part of the alternative type IV secretion system tfs4 (Alandiyjany et al., 2017). 
 
TraG like proteins in H. pylori have been shown to bind DNA non-specifically and are 
essential in DNA transfer by conjugation (Schröder et al., 2002). Therefore, the 
presence of this gene could suggest that these genes are part of a H. pylori acquired 
plasmid and would explain why some strains harbour this while other do not. 
Furthermore, the predominant absence of this presumptive plasmid in the corpus 
strains could be further evidence of antrum and corpus specific populations/divisions, 
albeit with acquired differences. The presence and absence of plasmids or even 
plasticity zones could potentially be used to track migration of H. pylori between niches 
of the human stomach and might explain why some, very closely related strains, can 
infect one niche but are not found in as high abundance in others, due to the acquisition 
of beneficial genes.  
 
The virB11 gene is usually associated with the cagPAI and codes for an ATPase that 
provides energy for T4SS apparatus assembly and/or CagA transport (da Costa, 
Pereira and Rabenhorst, 2015). The virB11 and cagE genes are genetically linked and 
are thought to be associated with increased gastritis, particularly through increase of 
IL-1B and IL-8 (de Negreiros Bessa et al., 2014). The presence of the virB11 gene could 
suggest that the antrum strains have a more complete cagPAI. This might have 
implications in virulence differences between the strains, and more widely between the 
antrum and corpus.  
 
The virB10 gene is essential for T4SS function, encoding a protein integral to the 
structure of the system and interacting with other T4SS encoded proteins both 
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functionally and structurally (Terradot et al., 2005). This is further evidence that the 
cagPAI is potentially more complete in the antrum isolates then in the corpus and again, 
could provide differences in virulence between them.  
 
The virulence associated topA gene works by inducing negative DNA supercoiling in 
replication (Nitharwal et al., 2011; McNairn, Bhriain and Dorman, 1995). It has also 
been found to be highly conserved and positionally linked with the flaB gene and thus 
the expression of one gene effects the other (Suerbaum et al., 1998). Again, this might 
suggest that there are differences between the two antrum and corpus niches, in this 
case colonisation and motility differences. The topA gene was found to have only one 
promotor, low in comparison to the three promotors of the topA gene in E. coli 
(Suerbaum et al., 1998; Qi, Menzel and Tse-Dinh, 1997). Therefore, an additional copy 
of the topA gene within the strains isolated from the antrum could be conferring further 
gene expression relationships, potentially attributing to differences in virulence, 
colonisation or resistance.  
 
The ptlC gene has close homology to the cagE gene and this might explain why it was 
clustered with the virB11 and virB10 genes, perhaps providing further evidence of these 
genes being associated with a complete cagPAI (Censini et al., 1996). However, a 
Helicobacter ptlC gene has previously been identified in a H. pylori strain and has close 
homology to the Bordetella pertussis toxin. This toxin was shown to increase 
inflammation by induction of IL-8 (Tummuru, Sharma and Blaser, 1995).  
 
Taken together, it is clear that there are gene content differences between strains and 
potentially between closely related strains taken from different environments within the 
same patient’s stomach. These differences are potentially overlooked in the deep 
sequence population datasets because the presence of a single strain harbouring a 
gene could incorporate this gene into the consensus genome assembly of the 
population.  
 
Although the discussion above has focused on strains isolated from patient 439 as a 
representative, this is not an uncommon observation across the wider dataset from all 
patients. Gaps and/or genes with <96% identity to the reference were observed in 
patients 194, 322, 326, 439, 495, 565 and 732. The highest density of and number of 
gaps were observed in patients 565 and 732. All of the analyses so far indicate that 
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these two patients potentially harboured multi strain infections that diversified over the 




Figure 5.3 Single colony isolate comparisons from paired antrum and corpus 
niches of patient 439 
 
 
BLAST Ring Image Generator (BRIG) plots of paired antrum and corpus consensus genome 
assemblies constructed as described in section 5.2.6. The rings represent the following from the 
centre most ring outwards; GC percentage, GC skew, 439A1, 439A4, 439A5, 439A7, 439A8, 
439C2, 439C3, 439C5, 439C6, 439C7 439C8, gene direction and gene names. The green 
concentric rings represent the strains isolated from the antrum and the purple rings represent the 
corpus-derived strains. Genes were colour coded as follows; black = identified as variable 
gene(s) by mapping single colony reads to the within niche deep sequenced consensus genome 
only, teal = identified allelic genes by the deep sequencing minor allele pipeline only, red = 
identified by both methodologies. An upper BLASTN identity threshold of 99% and lower 
identity of 96% were used. BRIG plots for all other patient single colony datasets presented in 
this study can be found in the Appendix figures 11.5.1 – 11.5.8. 
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5.3.4. Pan-genome analysis of within patient strains isolated from the antrum 
and corpus 
 
Following on from the phylogenetic analysis (section 5.3.2) and the whole genome 
alignments of single colony isolates taken from each patient (section 5.3.3) questions 
arose around potential accessory gene differences between antrum and corpus 
populations. Therefore, an analysis of the pan-genome was carried out.  
 
All single colony isolates were analysed together by Roary (Page et al., 2015) which 
clustered all genes and a core genome assembly was constructed by approximately-
maximum likelihood (Treangen et al., 2014). This was done to see how the core 
genome phylogeny linked with the clustering of the genome wide gene clusters. This 
analysis is depicted in figure 5.4.  
 
The pan genome analysis (figure 5.4) supported the analysis observed in the deep 
sequencing dataset (Chapter Four, figure 4.13), whereby a unique fingerprint of gene 
presence and absences was observed for strains derived from each patient. However, 
there were no obvious gene presence/absence differences between antrum and corpus 
isolates, at least on visual inspection. This may be due to the density of the pan-genome 
across all samples, making visual identification of small differences more difficult. 
Furthermore, the phylogeny, which orders the gene presence/absence heat map, did 
not always infer an obvious antrum-corpus phylogenetic split within individual patients. 
This is likely due to the smaller gene content that makes up the core genome of all the 
combined isolates across multiple patients, making small scale differences harder to 
observe. This is further compounded by the diversity of H. pylori isolates between the 
different patients. Additionally, the core genes shared across one patient’s samples that 
ultimately contributed to antrum-corpus differences, could have been excluded from the 
analysis if these genes were not shared by all other isolates in the dataset.  
 
Despite these limitations, this visual analysis (figure 5.4) does highlight some interesting 
observations. For example, the suspected mixed H. pylori samples 565C1 and 565C6 
showed a close gene presence/absence pattern, but also harboured different genes. 
These strains still clustered on the patient 565 branch suggesting that they are more 
closely related to these patient samples. But, samples 565C3 and 565C14 were also 
branched off from the majority of strains along with 565C1 and 565C6. This might 
suggest that generally, the corpus isolates from this patient are much more diverse than 
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the antrum isolates, not just allelically (Chapter Four, table 4.3) but also in their gene 
content.  
 
The strains taken from patients 295 and 526 clustered together as did strains from 249C 
and 537A. This was an expected result because these strains are part of sequential 
datasets and will be further examined in Chapter Six. 
 
To investigate the gene presence and absences between the antrum and corpus strains 
taken within individual patients, a genome-wide association study was conducted as 
described in section 5.2.8. All strains belonging to separate niches within patients 
harboured niche specific genes, except for patents 295 and 444 (table 5.2; Appendix 
table 10.5.1 – 11.5.6). This was based on the sensitivity (niche specific gene presence 
to determine niche-positivity) and specificity (using gene absence to determine niche-
negativity) greater 80% with a naïve p-value of < 0.05 (the presence/absence of a gene 
is unrelated to the niche status). Due to the relatively low sample size, p-values were 
not adjusted for multiple comparisons.  
 
The genes identified as potentially missing between antrum and corpus isolates in 
figure 5.3 were confirmed to be missing by the GWAS (table 5.2). Genes HP1001, 
HP1005, HP0894, HP1006, pfdA, HP1421 and HP1002 were all found to have a 
sensitivity score of 83.33% and specificity of 100% for the antrum isolates of patient 
439. This equates to each gene being found in 5/6 antrum strains and not present in 
any of the corpus strains. A further 26 genes were identified as potentially niche specific 
and should be investigated further to determine any potential role in niche adaptation 
and/or survival.  
 
All of the hypothetical genes with high sensitivity to the antrum should be investigated 
further to determine their importance (tables 5.2 and 5.3). 
 
There were only two corpus associated genes in patient 439 (table 5.2). One was a 
hypothetical protein (HP1283) while the other was a second copy of a pldA like gene 
(phospholipase A). The pldA gene is a phospholipase and has been shown to play an 
important part in colonisation of the gastric mucosa with a potential role in epithelium 
tissue damage (Dorrell et al., 1999). The pldA gene has also been shown to be phase 
variable, resulting in strains that are low or high in lysophospholipids content with further 
associations in urease and VacA secretions (Tannaes et al., 2001). This phase variation 
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was shown to be selected for under lower pH conditions and might explain why a 
second copy of this gene was identified in the corpus strains of patient 439, due to the 
oxyntic corpus environment (table 5.2). Alternatively, the second copy identified in these 
strains could be due to active phase variation of the strains during culture, that have 
then been picked up during the subsequent sequencing of these strains, resulting in the 
observation of two genes. Nevertheless, this was not observed in the antrum strains 
and thus highlights a potential difference between these strains isolated from the 
different stomach niches. 
 
All of the antrum strains were compared against all of the corpus strains from each 
patient to determine if there were any universal antrum or corpus specific genes (table 
5.3). No genes reached > 80% specificity and sensitivity in the antrum dataset 
suggesting that there are no clear antrum-associated genes. Furthermore, neither the 
Bonferroni correction nor the Benjamini-Hochberg correction for multiple comparisons 
which account for false positive and false negative adjusted p-values reached statistical 
significance, which likely reflects the low sample size used. However, genes dxr and a 
hypothetical protein (group 763) had relativity high sensitivity scores of 71.2% and 61% 
with low specificity scores of 6.7% and 13.3%, respectively. This suggests that while 
these genes are present in both niches, their presence or clustering is more variable in 
the corpus-derived isolates. While the hypothetical gene would need to be studied in 
more detail, the dxr gene is an essential gene in isoprenoid synthesis. Knockout 
mutants of dxr gene in E. coli have been shown to be lethal (Takahashi et al., 1998; 
Rodrı ́guez-Concepción et al., 2000). Therefore, the potential higher variation of dxr in 
the majority of corpus strains is surprising. However, the group 136 gene in table 5.3 
has a dxr non-unique gene name meaning that the same gene was identified by Roary 
but clustered separately (Page et al., 2015). Therefore, this gene is present in the 
corpus strains but clusters very differently to the antrum dxr. This might suggest that 
there are antrum and corpus low abundance strain specific dxr variants or that their 
position within the genome is different to that of presiding antrum associated strains. 
This is further supported by the high specificity of 95 and low sensitivity of the group 
136/dxr variant gene cluster highlighting corpus isolate diversity of this gene. Further 
investigation into this finding is warranted. Especially as the dxr gene has been 
suggested as an antimicrobial target (Singh et al., 2007; Rodrı ́guez-Concepción et al., 
2000; Pérez-Gil et al., 2010).  
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The antrum strain dataset (table 5.3) also highlighted instances of 100% specificity but 
low sensitivity (8.4-10.2%). This suggests that there are low abundance strains with 
antrum specific genes. Most of these genes were hypothetical (n=11), but annotated 
genes included; tlyA, selA, prmC, dxr, oppD and gsiA. However, with only 5-6 strains 
harbouring these genes they could be associated with just one set of more clonal strains 
from one patient. This might suggest that these are most likely to be additional 
accessory genes within one patient population. However, as the gene names are non-
unique, it would indicate that these genes have clustered independently and are 
potentially homologous but ultimately more genetically diverse, resulting in the 
observed sub-clustering (table 5.3). 
 
Like the antrum strain GWAS, the corpus strain dataset had a number of genes with 
100% specificity but low sensitivity (10%). This suggests that a low abundance of 
strains harbour corpus only genes. Again, the majority of these genes were hypothetical 
(n=8) but HP1417m (metal-dependent hydrolase), HP1472 (type IIS restriction enzyme 
M protein Mod), HP1513 (selenocysteine synthase SelA) and HP0066 (ATP-binding 
protein) genes were annotated. Since the gene names are non-unique (i.e. gene names 
followed by ‘_’), it would suggest that these genes have clustered independently and 
are potentially not additional corpus associated genes but gene homologues. 
 
While there were antrum and corpus specific genes identified from individual patients, 
no antrum or corpus specific genes could be identified from the dataset as a whole 
across all patients (table 5.3). Therefore, this suggests that where antrum/corpus gene 
differences are observed, these are patient-specific. In some patients, there was no 
evidence of antrum and corpus specific genes (samples 295 and 444)). 
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Figure 5.4 Pan-genome analysis of all single colony isolates used within this study 
 
This figure was constructed as described in the materials and methods (section 5.2.7) and visualised by phandango (Hadfield et al., 2018). The left-hand side of the 
figure displays the core genome phylogeny. The bottom graph represents the percentage of the strains harbouring each specific gene. The top graph represents the 
accumulating total length of all genes combined. At the centre is the gene presence/absence indicated by blue (presence) and white (absence).  
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Table 5.2 Genome-wide association study of genes associated with the antrum-derived H. pylori strains from patient 439 
 
  Antrum Corpus 
Gene Annotation Sensitivity (%) Specificity (%) Sensitivity (%) Specificity (%) 
HP1283_2 Hypothetical protein 0.00 0.00 100.00 100.00 
HP1001 hypothetical protein 83.33 100.00 0.00 16.67 
virC1 PARA protein 83.33 100.00 0.00 16.67 
group_1484 hypothetical protein 83.33 100.00 0.00 16.67 
HP1005 PZ11b 83.33 100.00 0.00 16.67 
HP0894 Addiction module toxin 83.33 100.00 0.00 16.67 
HP1006 hypothetical protein 83.33 100.00 0.00 16.67 
group_1766 hypothetical protein 83.33 100.00 0.00 16.67 
group_2380 hypothetical protein 83.33 100.00 0.00 16.67 
pfdA hypothetical protein 83.33 100.00 0.00 16.67 
group_2410 hypothetical protein 83.33 100.00 0.00 16.67 
xerH Tyrosine recombinase XerH 83.33 100.00 0.00 16.67 
ptlC VirB4-like protein 83.33 100.00 0.00 16.67 
topA_2 DNA topoisomerase 1 83.33 100.00 0.00 16.67 
group_2705 hypothetical protein 83.33 100.00 0.00 16.67 
group_2745 hypothetical protein 83.33 100.00 0.00 16.67 
group_2746 hypothetical protein 83.33 100.00 0.00 16.67 
hisZ hypothetical protein 83.33 100.00 0.00 16.67 
group_2748 hypothetical protein 83.33 100.00 0.00 16.67 
HP0446 hypothetical protein 83.33 100.00 0.00 16.67 
group_3054 hypothetical protein 83.33 100.00 0.00 16.67 
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  Antrum Corpus 
Gene Annotation Sensitivity (%) Specificity (%) Sensitivity (%) Specificity (%) 
group_3105 hypothetical protein 83.33 100.00 0.00 16.67 
HP1421_1 Type IV secretion system protein VirB11 83.33 100.00 0.00 16.67 
group_3107 hypothetical protein 83.33 100.00 0.00 16.67 
group_3108 hypothetical protein 83.33 100.00 0.00 16.67 
HP0443 hypothetical protein 83.33 100.00 0.00 16.67 
HP0442 hypothetical protein 83.33 100.00 0.00 16.67 
group_1715 hypothetical protein 83.33 100.00 0.00 16.67 
HP0499_2 Phospholipase A 0.00 16.67 83.33 100.00 
group_3218 hypothetical protein 83.33 100.00 0.00 16.67 
group_3828 hypothetical protein 83.33 100.00 0.00 16.67 
group_4306 hypothetical protein 83.33 100.00 0.00 16.67 
HP1002 hypothetical protein 83.33 100.00 0.00 16.67 
 
Sensitivity and specificity of genes associated with either the antrum or corpus. Only genes with a naïve p-value (null hypothesis = the presence/absence of a specific 
gene is unrelated to the antrum/corpus status) < 0.05 are shown. Hypothetical genes were denoted by ‘group’ followed by a unique clustering number. Sensitivity; 
the sensitivity if using the presence of this gene as a diagnostic test to determine trait-positivity. Specificity; the specificity if using the non-presence of this gene as 
a diagnostic test to determine trait-negativity. Statistics and identification of antrum/corpus associated genes were calculated as described in the materials and 
methods (section 5.2.8). GWAS results for patient samples 194 (table 10.5.1), 322 (table 10.5.2), 326 (table 10.5.3), 495 (table 10.5.4), 565 (table 10.5.5) and 732 
(table 10.5.6) can be found in the Appendix. Samples 295 and 444 did not identify any niche specific genes through the GWAS analysis.  
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Table 5.3 Identification of antrum- and corpus- associated genes from all patient isolates used in this study by genome-wide association 
study 
  Antrum Corpus 







dxr 1-deoxy-D-xylulose 5-phosphate reductoisomerase 71.19 6.67 93.33 28.81 
group_763 hypothetical protein 61.02 13.33 86.67 38.98 
HP0505 hypothetical protein 28.81 91.67 8.33 71.19 
HP1471 Type IIS restriction enzyme R protein (BCGIB) 30.51 43.33 56.67 69.49 
HP0980 RIP metalloprotease RseP 0.00 88.33 11.67 100.00 
group_2834 hypothetical protein 10.17 100.00 0.00 89.83 
HP1517_2 hypothetical protein 10.17 100.00 0.00 89.83 
HP1471_1 hypothetical protein 10.17 100.00 0.00 89.83 
selA L-seryl-tRNA(Sec) selenium transferase 10.17 100.00 0.00 89.83 
group_5051 hypothetical protein 10.17 100.00 0.00 89.83 
HP0066_2 hypothetical protein 10.17 100.00 0.00 89.83 
tlyA 16S/23S rRNA (cytidine-2'-O)-methyltransferase TlyA 10.17 100.00 0.00 89.83 
group_5138 hypothetical protein 10.17 100.00 0.00 89.83 
HP0629_2 hypothetical protein 10.17 100.00 0.00 89.83 
prmC_3 Release factor glutamine methyltransferase 10.17 100.00 0.00 89.83 
group_5171 hypothetical protein 10.17 100.00 0.00 89.83 
HP0250_1 Oligopeptide permease ATPase protein OppD 1.69 85.00 15.00 98.31 
dxr 1-deoxy-D-xylulose 5-phosphate reductoisomerase 18.64 95.00 5.00 81.36 
HP1243 hypothetical protein 8.47 100.00 0.00 91.53 
gsiA Dipeptide ABC transporter- ATP-binding protein DppD 8.47 100.00 0.00 91.53 
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  Antrum Corpus 







group_2496 hypothetical protein 8.47 100.00 0.00 91.53 
group_4306 hypothetical protein 8.47 100.00 0.00 91.53 
HP1002 hypothetical protein 8.47 100.00 0.00 91.53 
group_4775 hypothetical protein 8.47 100.00 0.00 91.53 
group_209 hypothetical protein 0.00 90.00 10.00 100.00 
HP1417m_2 metal-dependent hydrolase 0.00 90.00 10.00 100.00 
group_2831 hypothetical protein 0.00 90.00 10.00 100.00 
HP1283_2 Hypothetical protein 0.00 90.00 10.00 100.00 
group_5181 hypothetical protein 0.00 90.00 10.00 100.00 
HP1472 Type IIS restriction enzyme M protein Mod 0.00 90.00 10.00 100.00 
HP1511 Hypothetical protein 0.00 90.00 10.00 100.00 
HP1513 Selenocysteine synthase SelA 0.00 90.00 10.00 100.00 
group_5186 hypothetical protein 0.00 90.00 10.00 100.00 
HP0647 Hypothetical protein 0.00 90.00 10.00 100.00 
HP0629_2 Hypothetical protein 0.00 90.00 10.00 100.00 
HP0066_1 ATP-binding protein 0.00 90.00 10.00 100.00 
acxA_2 Acetone carboxylase beta subunit 20.34 93.33 6.67 79.66 
Sensitivity and specificity of genes associated with either the antrum or corpus. Only genes with a naïve p-value (null hypothesis = the presence/absence of a specific 
gene is unrelated to the antrum/corpus status) < 0.05 are shown. Hypothetical genes were denoted by ‘group’ followed by a unique clustering number. Sensitivity; 
the sensitivity if using the presence of this gene as a diagnostic test to determine trait-positivity. Specificity; the specificity if using the non-presence of this gene as 
a diagnostic test to determine trait-negativity. Statistics and identification of antrum/corpus associated genes were calculated as described in the materials and 
methods (section 5.2.8).
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5.3.5. Within patient recombination 
 
The isolation of multiple strains from the antrum and corpus of individual patients 
allowed for the investigation of homologous recombination and to determine if the 
populations recombine with one another.  
 
A dual analysis approach was taken with differing algorithms as described in the 
materials and methods, section 5.2.9. This approach was taken to fully investigate the 
recombination of within patient isolates, because different methodologies can reveal 
differing results (Mostowy et al., 2017).  
 
Recombination was observed between multiple strains in all patients by the Gubbins 
analysis (Croucher et al., 2015). Although recombination direction cannot be 
determined by this method, the continuous red (recombination shared between multiple 
isolates within the dataset) blocks observed between all strains from each patient infer 
that both within and between niche recombination might occur (figure 5.5A). This 
suggests that the antrum and corpus strains naturally interact, providing opportunities 
to recombine.  
 
The Gubbins analysis for patient 439 (figure 5.5A) shows that while there appears to 
be shared recombination between strains from both the antrum and corpus (red blocks), 
this is mainly towards the end of the genomes. As Gubbins identifies regions of 
increased SNP densities between the genomes, the smaller contigs towards the end of 
the genome assembly are potentially more susceptible to variation due to the smaller 
contig sizes that usually have much higher average coverage from the de novo 
assembled genomes (an example of this can be observed in Chapter Four, figure 4.4). 
These contigs are likely of lower quality due to the artificial inflation of reads mapping 
to this region and potentially harbours more genetic variation. Therefore, the end of the 
genomes are likely to contain increased false positive detections of recombinant sites 
with this being a known limitation to this recombination detection methodology 
(Croucher et al., 2015). In consideration of this, there is a more defined antrum and 
corpus only strain recombination pattern, supporting the antrum and corpus strain 
division and inferring little between niche strain interaction (figure 5.5A). This is further 
supported by the fastGEAR analysis (figure 5.5B) where there is little to no inferred 
recombination between the lineages and between the antrum and corpus strains. The 
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only exception to this is one small blue antrum associated recombination block detected 
towards the end of the strain 439A7 (figure 5.5B).  
 
Surprisingly, strains isolated from patient 732 that were shown to have a defined core 
genome-based population structure was inferred to recombine with strains from the 
opposite niche. The fastGEAR recombination analysis of patient 732 (Appendix, figure 
10.5.16) indicates that there are shared recombination events between the antrum and 
corpus isolates identified by contaminating alternative lineage coloured blocks. These 
blocks are not defined towards the end of the genomes suggesting that they are not 
artefacts from genetic content contained in small contigs, providing evidence of 
between niche strain recombination (Appendix, figure 10.5.16). The flow of 
recombination seems to be mainly from corpus isolates (blue clade) to the antrum 
population (red clade). This observation perhaps shows corpus strain migration to the 
antrum is more common than antrum strain migration to the corpus. This might add to 
the findings of Ailloud et al. (2019), who found that 21% of migration events happen 
between the antrum and corpus.  
 
Strain 732A4 is also shown to harbour regions of recombination that have come from a 
strain outside the dataset (black blocks) by fastGEAR (Appendix, figure 10.5.16). These 
regions were not detected by the Gubbins analysis. This supports the dual 
recombination analysis approach and perhaps starts to explain why this strain is split 
on a different branch in the phylogeny (figure 5.2I; Appendix figure 10.5.16). 
 
Single colony isolates from patients 194, 326, 439 and 444 were all shown to recombine 
between niches, but evidence was only observed towards the end of the genome 
sequences (figures 11.5.9, 11.5.12, 5.5 and 11.5.13 respectively).  
 
Single colony isolates from the antrum and corpus were observed to recombine at 
genomic regions not defined towards the end of the genomes for patients 322, 565 and 
732. This provided strong evidence of between niche interaction of strains. A study by 
Cao et al. (2015), investigated within niche microevolution of 18 strains taken from a 
single antral biopsy and found that recombination between clades representing a mixed 
strain infection was better identified than recombination between within-clade strains. 
This could suggest that patients 322, 565 and 732 hold a mixed strain infection.  
 
No between niche recombination of isolates were observed for patients 295 and 495. 
 169 
Figure 5.5 Recombination detection by Gubbins and fastGEAR – patient 439 single colony isolates 
 
A) Recombination detected by Gubbins as described in the materials and methods (section 5.2.9). The genomic scale bar is depicted at the top of the figure with 
blue markings highlighting genes along the genome. The core genome phylogeny is depicted to the left followed by coloured blocks differentiating antrum (purple) 
and corpus (green) isolates. The reference strain is coloured orange. Figure centre depicts sites of recombination. White space (no recombination sites), blue blocks 
(single site of recombination) and red blocks (shared site of recombination). B) Recombination detected by fastGEAR as described in the materials and methods 
(section 5.2.9). Lineages detected by fastGEAR are colour coded and have been ordered to match the strain locations in the Gubbins analysis for ease of cross 
comparisons. Grey blocks represent recombination sites within lineages while black blocks represent recombination from an outside strain. Coloured blocks within 
lineages infer direction of recombination events between lineages. Results for all other samples can be found in the Appendix (figures 11.5.9 – 11.5.16). 
A) B) 
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5.3.6. Cross comparing the single colony identified SNPs with the deep 
sequenced population detected minor allele variants 
 
The isolation of single colony isolates from the populations that were deep sequenced 
provided a unique opportunity to compare the minor allele population variants (Chapter 
Four, section 4.3.4) to the SNPs identified between the single colony isolates and the 
population consensus genome assembled from the deep sequencing data. This allows 
for the interrogation of results obtained from the minor allele calling pipeline to 
determine how well the data generated from each approach agree with each other.  
 
If the minor allele calling pipeline was calling population variants as intended, then the 
majority of the single colony isolate variants should, in theory, be well captured. 
However, since the minor allele calling pipeline was designed with highly stringent 
criteria to reduce the false positive calling of variant sites, it is likely that the false 
negative rate was increased as a resulting trade-off. Therefore, it is important to 
evaluate the performance of this pipeline using real population data in the form of single 
colony isolates.  
 
A total of 152 allelic variants were detected by the deep sequencing pipeline (table 5.4; 
Chapter Four, section 4.2.1.1) for the antrum population in patient 439 (Chapter Four, 
table 4.3). Mapping the single colony reads to the population consensus genome 
resulted in a range of isolate specific SNP counts (0 – 89 SNPs) (table 5.4). In total, 
328 SNPs were detected by the minor allele calling pipeline, leaving only 39 SNPs 
across all 12 single colony isolates that were not picked up by this methodology (table 
5.4). For this specific sample, this equated to an 89.37% detection of all single colony 
isolate SNPs by the deep sequencing minor allele calling pipeline. In terms of uniquely 
identified single colony variants across the six isolates, the minor allele calling pipeline 
missed 29 variants, equating to a detection rate of 83.98% (33% of unique variants 
detected by the minor allele calling pipeline only; 16.02% of variants missed by the 
minor allele calling pipeline; 50.28% of variants detected by both single colony and deep 
population analysis pipelines) (table 5.4). 
 
While this was an impressive detection rate, it was not known to what extent the SNP 
counts were inflated due to appearing across multiple single colony isolates. For 
example, a total of 328 single colony SNPs were identified as concordant to the minor 
allele calling pipeline, but only 152 allelic variants were captured suggesting that this 
 171 
detection rate might be different when duplicate SNPs were removed across the single 
colony isolates. This would allow for a more accurate detection as well as providing the 
proportion of low population allelic variants that were potentially filtered out of the allele 
calling pipeline.  
 
Figure 5.6A represents the unique SNPs identified from the single colony isolates to the 
population consensus genome, compared with the minor allele variants detected by the 
population deep sequencing. There is a very good concordance between the two 
methodologies, validating the data generated using the different approaches. 
Approximately 50% of all detected SNPs were detected by both methodologies. 
However, only 16% of the SNPs were uniquely identified by the single colony isolate 
method while 34% were detected uniquely by the population deep sequencing 
methodology. This suggests that while there is good detection by both methods, the 
population deep sequencing identifies a much larger proportion of the population 
diversity than the single colony approach. Furthermore, as the number of single colony 
isolates increases the number of uniquely identified SNPs would likely decrease due to 
the rarer allelic variant positions within the population. However, the deep sequencing 
pipeline is more likely to capture the population as a whole, providing a more accurate 
snapshot of genetic diversity at population level.  
 
The corpus population could not be interrogated for the 439C population due to no 
SNPs being detected by the single colony isolates (figure 5.6B). However, this is still 
an interesting observation, mainly because the single colony method would have 
suggested that there was no genetic diversity in this population. But, the deep 
sequencing of the population proves that this is incorrect. Furthermore, it highlights the 
limitations of sequencing single colony isolates from a clinical sweep. Successful 
isolation of single colony isolates, and representative sampling of the population is 
challenging and can only be judged after sequencing because most colonies look 
identical on the culture medium. Even then, it is still not possible to know how well the 
population was sampled. Whereas, a population deep sequencing approach, whilst also 
having its own limitations, relies less on the separation of single colony isolates and 
sequencing of the whole population allows for a potentially more accurate snapshot of 
population diversity. The random sampling of single colony isolates, and the return of 
no SNPs might also indicate that the pipelines used within this study are consistent and 
accurate. This result might indicate that there is little to no ‘background’ SNP variation 
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as a result of data handling (genome assembly and variant calling pipelines) validating 
the SNPs detected in the other samples as a result.  
 
The better approach would be a culture independent sequencing approach. However, 
such a method would be difficult to apply to H. pylori populations colonising the human 
gastric mucosa. There would be ethical implications of sequencing directly from human 
tissue samples. Furthermore, as biopsy samples are usually pulled through the oral 
cavity, contamination by other bacteria is not uncommon, complicating the subsequent 
bioinformatics analysis.  
 
The unique single colony SNP data for all single colony isolates were pooled and a 
combined detection percentage was calculated and depicted in figure 5.7. Samples 
from 565C were excluded due to the potential multiple H. pylori strain contamination of 
isolates 565C1 and 565C6. Of all uniquely identified SNPs by both methodologies, an 
average of 68.69% (95% CL: 59.13% – 78.25%) were detected only by the population 
deep sequencing, 8.13% (95% CL: 4.83% – 11.43%) by the single colony isolate 
analysis and 23.18% (95% CL: 14.93% – 31.43%) were concordant between the 
methodologies. Again, this suggests that the deep sequencing allelic calling pipeline 
worked well with only 8.13% of all identified SNPs not picked up in the population with 
a good overall concordance.  
 
The deep sequencing methodology is superior in capturing the snapshot of population 
genetic diversity compared to a single colony approach and has many advantages. The 
main advantage is in better understanding of the genetic diversity within the population, 
which has implications in driving future research on key variable genes. Furthermore, 
in understanding this diversity, a suitable vaccine target might be identified as 
population variable genes would not be a good target. This analysis might help explain 
how H. pylori is able to colonise the human host as a life long chronic infection.  
 
However, single colony analysis is still relevant and useful to provide insights where a 





Table 5.4 Concordance of single colony variants and variants detected by the deep population sequencing minor allele calling pipeline for 
patient 439A 
 
Method Sweep / isolate Total variants Single colony unique variants Concordant variants 
Population deep 
sequencing 
439A 152 N/A N/A 
Single colony 
sequencing 
439A1 89 6 83 
Single colony 
sequencing 
439A4 87 6 81 
Single colony 
sequencing 
439A5 30 16 14 
Single colony 
sequencing 
439A6 78 4 74 
Single colony 
sequencing 
439A7 0 0 0 
Single colony 
sequencing 




All single colony isolates and deep 
sequenced antrum population 181 29 91 
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Table displaying the total number of variants, single colony unique variants and concordant variants identified by the single colony (section 5.2.10) and deep 
population variant calling pipelines (Chapter Four, section 4.2.1.1). All variant sites detected within the single colony isolates were compared (‘vcf-isec’) to identify 
the single colony uniquely identified variants due to potential unique variant call duplication across the strains (as described in section 5.2.10). Further results of all 





Figure 5.6 Comparison of detection rates from the minor allele deep population and single colony variant calling pipelines for patient 439 
            
Figure depicting and denoting the proportion of uniquely identified deep population minor allele variants (blue), uniquely identified single colony variants (pink) 
and concordantly identified variants (pink/blue cross section). Figure A represents the antrum while figure B represents the corpus datasets. Venn diagrams for other 
patient samples used within this study are presented in the Appendix figures 11.5.17 – 11.5.26. 
 
61 2991 98 0
A) B) 
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Figure 5.7 Total SNP detection rate between the minor allele deep population and single colony variant calling pipelines across all samples 
from all patients 
 
Figure depicting and denoting the proportion of uniquely identified deep population minor allele variants (blue), uniquely identified single colony variants 
(pink) and concordantly identified variants (pink/blue cross section). Sample 565C was excluded from this analysis (n=19) as both single colony and 
population variants were exceptionally high, with single colony variants being substantially higher than population variants and are thus outlier results. The 
average detection rate is depicted. Deep sequencing minor allele only detection (average) = 68.69% (95% CL: 59.13% – 78.25%), Single colony variant 
detection only (average) = 8.13% (95% CL: 4.83% – 11.43%), shared methodology detection = 23.18% (95% CL: 14.93% – 31.43%) (GraphPad Prism, 
version 8.2.0). This figure was constructed by the R statistical software version 3.5.1 (R Core Team, 2018). 
68.69 8.1323.18 %  %  %  
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5.4. Future work 
 
While the deep population sequencing of H. pylori clinical sweeps was novel, the 
combination of deep population sequencing and single colony isolate sequencing was 
particularly powerful. This combination of approaches allowed a comprehensive 
investigation of the within patient and between patient genetic diversity and dynamics 
of H. pylori patient colonisation. However, only 5-6 single colony isolates were taken 
from each population providing insight but perhaps not complete depth of analysis. 
Therefore, an increased single colony sample size would have benefitted this project, 
particularly for the cross comparisons of the single colony and deep population 
methodologies and the population structure analysis between niches.  
 
The GWAS lacked resolution/power due to the low number of samples, further 
suggesting that a bigger sample size would be highly beneficial to future studies. 
However, genes with high sensitivity and specificity from strains associated with the 
antrum or corpus should be investigated further to understand their importance in niche 
adaptation. For example, gene knockout mutants of H. pylori could be compared to 
wildtype strains to further investigate colonisation patterns across the stomach using 
mouse models and phenotypic assays.  
 
This study investigated the gene differences between strains taken from individual 
patients and compared results to those presented in Chapter Four. However, gene 
expression levels were not investigated. Future studies might include expression of 
genes from different niches of the stomach. This could provide further information of 
between niche diversity of H. pylori strains and/or populations.  
 
The two presumptive mixed strain contaminated samples 565C1 and 565C6 should be 























The collection of sequential H. pylori samples from the same patient over time is 
relatively rare due to the clinical practice of treating H. pylori infection with an eradication 
therapy regime in H. pylori positive patients. Furthermore, not all patients who present 
with H. pylori infection symptoms undergo gastric endoscopy and subsequent bacterial 
culture. The primary method of both initial diagnosis of H. pylori infection and 
confirmation of successful eradication are determined through the 13C urea breath test 
(European Helicobacter pylori Study Group, 1997). Therefore, relatively few patients 
undertake gastric endoscopy and fewer patients still return for gastric endoscopy after 
eradication therapy because a positive 13C urea breath test would usually be enough 
to prompt a second course of eradication therapy. Further still, antimicrobial 
susceptibility testing of H. pylori infection is rarely carried out (Dang and Graham, 2017). 
This hinders the effective tailoring of eradication therapies to clear H. pylori infections 
and limits the surveillance of antimicrobial resistance.  
 
Despite this, there have been a number of studies involving sequential isolates. For 
example, the natural mutation rate of H. pylori has been determined from studies that 
used sequential isolates inferred by the number of observable mutations between the 
different sampling time points (Falush et al., 2001b; Morelli et al., 2010; Didelot et al., 
2013). These same studies also determined the natural recombination rate between H. 
pylori strains. Other sequential H. pylori studies have investigated the size of 
recombination imports, that have been found to range from 261 – 3,853 bp (Kennemann 
et al., 2011; Kulick et al., 2008; Falush et al., 2001b).  
 
Other studies have investigated H. pylori infection in families and populations where 
sequential samples were obtained (Nell et al., 2014; Kennemann et al., 2011; Morelli et 
al., 2010). The study by Morelli et al. (2010), investigated the within and between host 
evolution of H. pylori sequentially isolated strains by sequening 78 genes (total – 39,300 
bp) from these strains. They calculated recombination rates of famillial isolated strains 
and sequential strains to determine the effect recombination had on these infections. 
Kennemann et al. (2011), used whole genome sequencing of sequential isolates from 
four patients to investigate the SNPs between the different time points and to 
investigate the recombinational imports and their relative lengths. They used this 
information to highlight specific genes of interest such as an increased recombinational 
imports and mutations within genes associated with adhesion. Another study 
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investigated within host evolution of the H. pylori Lewis b adhesion gene babA through 
sequentially isolated strains of H. pylori (median interval of 1.8 years; one strain 
sampled at two time points), and found that that in 12 out of 16 patients the babA gene 
was effected by recombination and/or mutation (Nell et al., 2014). These studies 
showed how sequential sampling can be used to track changes over time and can 
highlight genes of interest that could be involved in specific processes such as bacterial 
adhesion.  
 
Some studies have followed H. pylori infected individuals over a period of time, taking 
sequential samples during the course of infection. For example, Kraft et al. (2006), 
investigated sequential isolates taken from an infected individual ranging from three to 
48 months. They observed specific strain differences between time points across 
virulence associated genes, housekeeping genes, insertion elements and restriction-
modification systems. These genetic changes associated with a range of genes over a 
relatively short period of time show how the H. pylori infection within a single host can 
change and develop during chronic infection. While this was an important study, it was 
based around whole-genome DNA microarrays and hybridisations modelled from the 
H. pylori reference genomes 26695 (Alm et al., 1999) and J99 (Tomb et al., 1997). 
Therefore, it is likely that only genes shared with strain 26695 were analysed, potentially 
missing out accessory genes in the strain isolated from the patient. Furthermore, DNA 
microarrays do not capture the whole target genome, only the coding genes. Therefore, 
intergenic regions and promoter regions are ignored in this type of analysis. 
 
Krishna et al. (2016), investigated an archival J99 strain taken from the patient that 
provided the first sample six years prior to refusing eradication therapy (Alm et al., 
1999). While these strains were not compared by whole genome sequencing, 
phenotypic acid tolerance differences were observed between strains taken from 
different time points. Deletion and reconstituted mutants confirmed that mutations in the 
arsS gene were responsible for the increased acid survival and this was further 
confirmed by the sequencing of these genes. The authors speculated that such genetic 
changes during chronic infection may result in niche migration from the less acidic 
antrum to the oxyntic corpus and might increase the risk of gastric cancer. 
 
A longer term study of chronic infection by H. pylori was conducted by Liu et al. (2015), 
in a primate (rhesus macaque) model over ten years. Gastric biopsies were taken at 3-
month intervals and cultured to collect ten single colony isolates from both the antrum 
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and corpus niches at each time point from 12 rhesus macaques. Whole genome 
sequencing was not carried out on any single colony isolates at any of the time points. 
Instead, DNA fingerprinting and comparative genomic microarray-based hybridisation 
was used to investigate the genetic differences between strains at the varying time 
points. The authors found that H. pylori single strain infection remained identical after 
one year of infection. However, after five years the single colony isolates had started to 
change genetically. This allowed the authors to identify the babA gene and conclude 
that it was under strong selection pressure potentially relating to colonisation of the 
host. 
 
A second study using a primate (rhesus macaque) model took an opposite approach to 
that of Liu et al. (2015), and investigated the short term, acute infection phase of H. 
pylori infection (Linz et al., 2014). Linz et al. (2014), extracted antral gastric biopsies 
from seven days and one, two and three months after innoculating a single primate with 
H. pylori and used whole genome sequencing on the cultured isolates to compare them 
to the original infecting strain. The authours complimented the rhesus macaque model 
with two human volunteers who re-infected themselves with their previously infecting 
H. pylori cultures (cured through eradication therapy) and had gastric biopsies of the 
antrum taken at 20 days and 44 days after infection confirmation (urea breath test). The 
authors found that there was an increased mutation rate during acute infection that was 
ten times higer than during chronic infection. They termed this a ‘mutational burst’ 
during acute phase infection. This result was in direct conflict with the previous study 
by Liu et al. (2015), who did not observe genetic changes until after one year of 
infection. However, as previously mentioned, this result might have been limited by the 
analysis methodology employed (DNA fingerprinting and comparative genomic 
microarray-based hybridisation), whereas Linz et al. (2014), used whole genome 
sequencing that is more sensitive to SNP variation.  
 
Taking these studies together, it is clear that sequential samples are rarely obtained 
from naturally infected patients with H. pylori. It is also clear that even fewer studies 
have utilised the information available within the datasets by undertaking whole genome 
sequencing and using whole genome comparative genetics techniques. Despite this, 
they have been used to generate some interesting and important findings in regard to 
how H. pylori infection develops during acute and chronic phases of infection. 
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To the best of this author’s knowledge, sequentially isolated samples have not yet been 
tested for their sensitivity to antibiotics at different time points. Furthermore, 
characterisation of sequential H. pylori samples taken before and after failed eradication 
therapy within naturally infected humans has yet to be published within the literature. 
Therefore, this study provides a novel insight into how H. pylori infections might change 
once challenged by eradication therapy that subsequently fails to eradicate the 
infection. Both population deep sequencing and single colony isolate sequencing 
techniques were used in this study to comprehensively study two patients where 
sequential samples were taken both before and after failed eradication therapy. 
 
6.2. Materials and methods 
 
Sample selection, DNA extraction, whole genome deep sequencing, sequencing read 
curation, contamination detection, whole genome assembly, assembly curation and 
genome annotation were conducted as described in Chapter Two.  
 
Antibiograms were carried out as described in Chapter Three section 3.4.2. 
 
Single colony isolation and subsequent whole genome sequencing were carried out as 
described in Chapter Five section 5.2.1. 
 
6.2.1. Samples used within this study 
 
For two patients, sequential samples were taken before and after failed eradication 
therapy (table 6.1). However, due to patient confidentiality surrounding medical records, 
it was not possible to obtain information on the antibiotics prescribed in each case.  
 
A H. pylori population sweep was taken from the corpus biopsy of patient 249 with a 
second population sweep taken from the antrum approximately 44.9 months (1,366 
days) after the initial sampling and designated the patient ID 537. These samples are 
referred to as sequential set 1 (table 6.1). It is not known why paired antrum and corpus 
biopsies were not available. It is possible that the H. pylori sweep was not viable from 
the missing biopsy cultures or was simply a decision taken by the health practitioner at 
time of endoscopy to not take paired biopsies. Whilst Chapters Four and Five show 
there are antrum and corpus population differences, this data was still considered 
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important due to the rarity of sequential human samples and are therefore described 
here.  
 
A second patient underwent H. pylori population culture from biopsies taken from both 
the antrum and corpus referred to as patient 295. This same patient had a second 
antrum and corpus biopsy taken approximately 4.9 months later with the patient 
identifier 326. This sample set is referred to as sequential set 2 (table 6.1). 
 
The population sweeps were deep population sequenced as described in Chapter Two 
sections 2.6 and 2.8. Single colony isolates were also collected from each population 
(Chapter Five, section 5.2.1) and six of these were sequenced per population, as 
described in Chapter Two section 2.7 – 2.8.  
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Table 6.1 Patients and samples used within this study 
Deep population 
sequenced samples 
List of single colony isolate 





249C1, 249C3, 249C6, 249C8, 
249C10, 249C16 
1 
Initial biopsy taken at time point 0 from patient 249. Only the 
corpus sample was available. 
537A 
537A1, 537A3, 537A4, 537A5, 
537A7, 537A8 
1 
Second/sequential biopsy taken 1,366 days after the initial biopsy. 
Only an antral sample was available. 
295A 
295A1, 295A2, 295A3, 295A4, 
295A5, 295A6 
2 Initial biopsy taken from the antrum at time point 0. 
295C 
295C1, 295C2, 295C4, 295C6, 
295C7, 295C8 
2 Initial biopsy taken from the corpus at time point 0. 
326A 
326A22, 326A23, 326A24, 
326A25, 326A26, 326A27 
2 
Second/sequential biopsy taken 148 days from the antrum after 
the initial antral biopsy. The population sweep, 326A, was 
contaminated as shown in Chapter Four table 4.1. However, none 
of the single colony isolates were contaminated (Chapter Five 
section 5.3.1). 
326C 
326C1, 326C2, 326C3, 326C4, 
326C5, 326C6 
2 
Second/sequential biopsy taken 148 days from the corpus after 
the initial corpus biopsy. 
 
Samples used within this study including population sweeps and single colony isolates. Further patient, sampling and H. pylori samples details are denoted.
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6.2.2. Patient reference genome for sequential samples  
 
The reference genomes are described in each figure and analysis due to the use of 
multiple different references in this study. However, a consistent approach was taken 




Antibiotic resistance assays were carried out on the population sweeps for patient 
numbers 249, 295, 326 and 537 as described in Chapter Three section 3.4.2. Briefly, 
frozen cultures were thawed from -80 °C and plated onto a blood agar base #2 culture 
plate supplemented with 7.5% defibrinated horse blood which was incubated (37°C) 
under microaerophilic conditions for 48 – 72 hours. After incubation, a rapid urease test 
(Chapter Two, section 2.3) was used to confirm presence of H. pylori and bacterial edge 
growth was used to inoculate three additional culture plates and incubated for a further 
16 – 24 hours under the same conditions (Chapter Two, section 2.2). Bacterial edge 
growth was taken from multiple culture plates (if required) and made up to a McFarland 
2.8 ±0.1 in 0.85% saline using a densitometer (Chapter Three, section 3.4.2). Six MHA 
plates supplemented with 7.5% defibrinated horse blood were inoculated with the 
McFarland 2.8 cultures. Antibiotic disks containing 15 µg clarithromycin, 10 µg 
amoxicillin, 5 µg rifampicin, 1 µg levofloxacin, 30 µg tetracycline or 5 µg metronidazole 
were placed in the centre of the culture plates, one antibiotic disk per plate. These plates 
were incubated for 96 – 120 hours and zones of inhibition recorded.  
 
Each antibiotic resistance assay was repeated in triplicate.  
 
6.2.4. Deep population sequencing analysis of sequential samples 
 
The antrum and the corpus populations were deep sequenced at time points 0 and 1 
respectively for sequential set 1 (patient IDs 249 and 537). Both the antrum and corpus 
populations were sequenced at time points 0 and 1 for sequential set 2 (patient IDs 295 
and 326) (table 6.1). 
 
The minor allele detection pipeline was used on all datasets as described in Chapter 
Four section 4.2.1.1. Briefly, the sequencing reads from each population were 
assembled into a sample/niche consensus genome and the population reads were 
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mapped back to identify sites of allelic variation within each population. Duplicate reads 
were removed as they were likely to be PCR duplications. A read mapping quality score 
of Phred 34 and a base quality score of Phred 30 was used. To call minor allelic variant 
positions, variants with less than 3% of reads supporting a suspected allelic position 
were removed. 
 
This data was then converted into a heatmap of variable/allelic genes. 
 
6.2.4.1. Minor allele frequency determination 
 
The minor allelic calling pipeline does not output minor allele frequency (MAF) statistics 
primarily due to the exclusion of this in FreeBayes (Garrison and Marth, 2012). 
 
Minor allele frequencies were manually calculated by extracting minor allelic calls within 
the VCF output files output from the minor allele calling pipeline (Chapter Four, section 
4.2.1.1). Next, the minor allelic positions within ‘hypothetical protein’ and ‘outer 
membrane protein’ were removed as these were excessively numerous and already 
described as genetically diverse within Chapters Four and Five. It was decided that 
removing these calls would potentially highlight other genes of interest.  
 
The info field ‘AD’ (Number of observation for each allele – reference and alternative) 
within the VCF files were imported into Microsoft Excel (version 16.16.6) and added 
together for each separate minor allelic position to determine the total number of reads 
mapping to each position. Finally, the number of reads supporting the minor allele call 
were divided by the total number of reads mapping to that position, providing the MAF.  
 
The VCF files were annotated as described in Chapter Two section 2.14.  
 
6.2.5. Single colony isolate genetic variation before and after failed eradication 
therapy 
 
To investigate the genetic variation of single colony isolates, isolate reads were mapped 
to the patient reference genome at time point 0. The following command was used: 
 
snippy --cpus {user specified CPU/thread/core number} --report -
-minfrac 0.9 --mincov 6 --mapqual 34 --basequal 30 --ref {patient 
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reference at time point 0 consensus genome. GenBank annotation 
file} --outdir {user specified output directory} --R1 {path to 
forward/mate pair 1 of a single colony isolate} --R2 {path to 
reverse/mate pair 2 of a single colony isolate} 
 
Snippy (Seemann, https://github.com/tseemann/snippy) was enacted whereby 90% of 
reads had to support an alternative base call to be classed as a variant position between 
the isolate and the reference genome. A Phred 30 cut off score was used as this 
increases the base calling accuracy to the equivalent of 99.9%. Similarly, a Phred 34 
mapping score was used to increase mapping accuracy equivalent to 99.96%. For a 
base to be considered polymorphic, it had to have at least 6 reads aligning to this 
position.  
 
Output VCF files were processed as described in Chapter Two section 2.14 to annotate 
the genes in which the SNPs were found.  
 
6.2.6. Whole genome alignments of the sequential samples 
 
Taking a similar approach to that described in Chapter Four (section 4.2.2.3) and 
Chapter Five (section 5.2.6) all sequential single colony isolates were comparatively 
analysed using BLASTN to the patient consensus genome (Chapter Five, section 5.2.3) 
at time point 0.  
 
Briefly, the assembled genomes were filtered to remove contigs of <500 bp in length. 
The single colony isolates isolated before and after failed eradication therapy for 
sequential set 1 were compared by BLASTN (upper 99% lower 96% nucleotide identity) 
to the population deep sequenced consensus genome assembly of patient 249C. A 
patient consensus genome was not created for sequential set 1 as there was no 
population data for the antral niche. The single colony isolates from sequential set 2 
were compared against the patient (295) consensus genome where all population 
antrum and corpus reads were pooled and assembled by SPAdes (Chapter Two, 
section 2.11).  
 
This method does not allow for the direct comparison of site-specific allelic variants or 
alignment SNPs to the comparative niche after failed eradication therapy. However, it 
does allow for a visualisation of all samples together facilitated by the patient reference 
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genome at time point 0. As previously mentioned (Chapter Five, section 5.2.6), the 
exact SNP locations could not be displayed because a different reference was used for 
the population minor allele detection and single colony read mapping methodologies. 
Therefore, to better depict the cross comparisons of the single colony variation and the 
minor allele population variants, genes that were detected as allelic within the 
population but not variable by the single colony read mapping to the respective 
reference genomes were highlighted as teal coloured gene labels. Genes observed to 
be variable by the single colony read mapping to the respective reference and not by 
the population minor allele detection pipeline were coloured as black gene labels. 
Finally, where both single colony read mapping and minor allele population gene 
variants matched by gene name, they were highlighted as red gene labels in the BRIG 
plot. 
 




The single colony isolates from sequential set 1 and 2 were used to create a 
phylogenetic tree to infer genetic relationships. A read mapping approach was used 
where the sequencing reads from the single colony isolates were mapped against the 
patient reference genomes at time point 0 for each sequential dataset. This method 
was identical to that described in Chapter Five section 5.2.4. 
 
Briefly, single colony isolate reads were mapped to the reference via Snippy (Seemann, 
https://github.com/tseemann/snippy) whereby 90% of reads had to align to an 
alternative base call to be called as variant. A minimum base coverage of 6 was also 
required, providing a higher alternative calling accuracy. Phred 30 and 36 scores were 
required for base quality and mapping quality, respectively.  
 
Next, the regions of recombination were removed by Gubbins (Croucher et al., 2015) 
and sites of variation were output in relation to the reference sequence. This SNP 
alignment was run through FastTree to create a phylogenetic tree by approximately-
maximum-likelihood (Price, Dehal and Arkin, 2010).  
 
Phylogenies were drawn and manually labelled using the interactive tree of life (Letunic 
and Bork, 2007). 
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The alignment files were manually inspected to calculate the number of SNPs between 




Regions of homologous recombination were investigated between all strains within 
sequential set 1 and 2 both before and after eradication therapy. This method is as 
previously described in Chapter Five section 5.2.7.  
 
Briefly, all single colony isolate genomes from sequential set 1 and 2 were separately 
aligned to the time point 0 patient reference genome using Mugsy (Angiuoli and 
Salzberg, 2011) and alignments were filtered to remove alignment gaps that were 
observed in > 50% of the genomes. Two different recombination detection 
algorithms/programs were run, Gubbins (Croucher et al., 2015) and fastGEAR 
(Mostowy et al., 2017), to identify regions of recombination.  
 
As previously described, Gubbins identifies substitution clusters within similar datasets 
that are flagged as outliers inferred through phylogeny whereas fastGEAR locates 
similar genetic segments from diverse clusters and uses these to infer recombination. 
FastGEAR does not depend on a phylogenetic reconstruction while Gubbins does. 
Analysis by two different methodologies allows for a better insight into regions of 
homologous recombination. 
 
6.3. Results and discussion 
 
6.3.1. Antibiograms before and after failed eradication therapy  
 
Eradication therapy consists of two antibiotics, usually a combination of clarithromycin, 
amoxicillin and metronidazole coupled with a proton pump inhibitor (Cameron et al., 
2004). It is common practice for a H. pylori infection to be prescribed eradication therapy 
without knowing the sensitivity profile of the infection. There are many reasons for this. 
For example, not all cases of H. pylori infection are identified through gastric endoscopy 
and subsequent histological and culture analysis. In the UK, the carbon-13 urea breath 
test is primarily used for H. pylori infection diagnosis (Shirin et al., 2001; Israeli et al., 
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2003) and H. pylori are not routinely cultured for identification and sensitivity testing. 
The fastidious nature of H. pylori and the high risk of contamination due to the 
endoscopy passing through the oral cavity also make routine culturing difficult. 
Furthermore, there are currently no nationally recognised antibiotic typing profiles for 
sensitivity and resistance for H. pylori by disc diffusion. For example, the EUCAST only 
provide clinical MIC breakpoints and no guidance on breakpoints for disk diffusion 
based methodologies (EUCAST, 2019). 
 
6.3.1.1. Sequential set 1 
 
The antibiograms before and after failed eradication therapy were similar for sequential 
set 1 (figure 6.1). This is perhaps a surprising result considering treatment with 
antibiotics should, in theory, clear the infection or potentially have some notable impact 
on the infection. However, it is clear from the antibiograms that this patient was infected 
with a clarithromycin resistant H. pylori strain before eradication therapy was attempted. 
Clarithromycin resistance in H. pylori was recorded at around 5% from a study 
investigating resistance rates between the years 1991 and 2001 in the UK (Cameron 
et al., 2004). Although the resistance rates are potentially higher today, attributed to the 
increasing global trend of antimicrobial resistance, resistance to clarithromycin in the 
UK is thought to be low compared to other countries (Megraud et al., 2013). Despite 
the low level of clarithromycin resistance in the UK, a more recent European study into 
resistance found levels of resistance equivalent to 17.5% across European countries 
and 8% in the UK (Megraud et al., 2013). These results were attained through 
susceptibility testing via Etest strips. Due to the alarming increase of resistance to 
clarithromycin, a first line antibiotic in the triple therapy, the World Health Organisation 
(WHO) has recently placed H. pylori in the top ten pathogens of global concern where 
research and development are needed for new antibiotics (Savoldi et al., 2018).  
 
Furthermore, the sequential set 1 time point 0 population was also resistant to 
metronidazole and rifampicin, making this a multi-drug resistant H. pylori infection 
(Chapter Three, table 3.5). Considering first line metronidazole and clarithromycin 
resistance, it is perhaps not surprising that this patient presented little change in 
resistances to the six antibiotics tested in this study. It is not known what combination 
of drugs were prescribed to this patient due to patient confidentiality restrictions. 
However, as the populations became slightly more sensitive to amoxicillin post 
antimicrobial therapy (figure 6.1) it might indicate that amoxicillin was not prescribed as 
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higher resistance to this antibiotic might be expected if resistant populations were 
present at time point 0. Due to suspected sensitivity to amoxicillin (Chapter Three, table 
3.5) at time point 0, it would not be unreasonable to suggest that had amoxicillin been 
prescribed, it might have resulted in population clearance or reduction of H. pylori 
burden. 
 
Resistance to rifampicin is another surprising observation for sequential set 1. This is 
because a 2009 study reported resistances as less than 1% in the UK and highlighted 
rifampicin as a potential antibiotic for use in first line drug resistant infections (Chisholm 
and Owen, 2009). Therefore, based on the recommendation of that study, treatment 
with rifampicin for this patient would likely be futile. Therefore, there is the desideratum 
to standardise the methodology for H. pylori antimicrobial resistance reporting.  
 
Helicobacter pylori resistance to metronidazole in the UK was observed to be around 
31.7% as identified in the aforementioned study by Cameron et al. (2004), suggesting 
that resistance is much higher for this antibiotic than for clarithromycin and rifampicin 
resistance. However, there is little reference to multi-drug resistant H. pylori infections 
in UK studies and within the EU generally, suggesting that the prevalence of such 
infections is not fully understood. (Megraud et al., 2013). This is supported by the 
observation of a three-drug resistant population in sequential set 1.  
 
It must also be noted that only two notable studies on the antimicrobial resistance 
profiles of UK infections with H. pylori have been published (Cameron et al., 2004; 
Megraud et al., 2013). Megraud et al. (2013) commented on a surprisingly low number 
of clinical H. pylori representatives sampled from the UK in their study (including 
Germany, Italy and Poland). Therefore, there is perhaps the need for a current review 
into the antimicrobial resistance profiles of H. pylori infections in the UK today.  
 
It is clear then, that the sequential set 1 patient holds a potentially difficult to treat (with 
first line triple therapy) multi-drug resistant H. pylori infection. This observation might 
have been missed without the antibiograms conducted in this study.  
 
6.3.1.2. Sequential set 2 
 
Contrary to sequential set 1, sequential set 2 exhibited changes in antibiotic resistance 
profiles after failed eradication therapy in both the antrum and corpus populations. This 
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striking difference between sequential set 1 and 2 is likely due to the differences in 
sensitivities of the H. pylori infections at time of eradication therapy. While sequential 
set 1 was resistant to two of the first line antibiotics before eradication therapy began, 
sequential set 2 was only resistant to one, metronidazole (figure 6.2A-B). Therefore, 
any combination of the three, first line antibiotics would most likely have an effect on 
the H. pylori infection. This provides a unique opportunity to investigate what might 
happen during and after a failed eradication regime.  
 
It must also be noted that the patient of sequential set 2 held a multi-drug resistant H. 
pylori population due to metronidazole and rifampicin resistance (figure 6.2A-B; Chapter 
Three, table 3.5). Again, while metronidazole resistance is relatively high in the UK (~ 
31.7%), rifampicin resistance was surprising considering previous studies finding that 
fewer than 1% of strains were rifampicin resistant (Cameron et al., 2004). Despite the 
multi-drug resistance of sequential set 2, this study is assuming that at least the first 
line drug therapy was attempted.  
 
It should be further noted that the antrum population sweep at time point 0 for sequential 
set 2 (sample 326A) was most likely contaminated with an unknown contaminant 
(Chapter Four, table 4.1). Although the bacterial growth on the agar plates appeared 
uniform and consistent with the appearance of H. pylori, the antibiotic resistance assays 
for this population may be incorrect because the contaminant population that was 
detected by deep population sequencing could be contributing to the resistance profiles 
observed. However, the corpus population was not contaminated (Chapter Four, table 
4.1) thus is a reliable data set and is the focus of the analysis presented here. 
 
Excluding the antrum population (326A) at time point 0 for sequential set 2, it is clear 
that there are antibiotic resistance differences before and after failed eradication 
therapy. Of particular note is rifampicin that was significantly higher at time point 0 than 
time point 1 (p-value 0.015) (figure 6.2B). There were also slight increases in resistance 
of the H. pylori population to metronidazole and tetracycline following failed eradication 
therapy. Sensitivity to amoxicillin and clarithromycin was slightly higher while 
levofloxacin zones of inhibition were identical. 
 
The antrum and corpus sensitivity profiles were also different post eradication failure, 
suggesting that the antibiotics had varying effects dependant on the niche. This could 
be down to differences in the delivery and/or effectiveness of the antibiotics between 
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these niches. Alternatively, H. pylori population/strain differences could be driving these 
differences in sensitivity to antibiotics. This observation highlights the need for 
standardisation of biopsy sampling location for antimicrobial resistance surveillance.  
 




Time point 0 represents population sweep 249C while time point 1 refers to the population sweep 
537A. Antibiograms were carried out as described in Chapter Three section 3.4.2. Triplicate 
results were averaged, and the standard deviation is plot with red error bars. This figure was plot 
using GraphPad Prism (version 8.2.0). Amx = amoxicillin, clr = clarithromycin, lvx = 
levofloxacin, mtz = metronidazole, rif = rifampicin, tet = tetracycline. A paired t-test was 
performed on each antibiotic triplicate data at each time point to investigate statistically different 
resistance between the timepoints by size of the inhibition zone. There were no statistically 










Figure A depicts the sequential set 2 antrum population antibiograms at sampling timepoints 0 
(295A) and 1 (326A). Figure B depicts the sequential set 2 corpus population antibiograms at 
timepoints 0 (295C) and 1 (326C). Antibiograms were carried out as described in Chapter Three 
section 3.4.2. Triplicate antibiogram results were averaged where error bars represent the 
standard deviation. Amx = amoxicillin, clr = clarithromycin, lvx = levofloxacin, mtz = 
metronidazole, rif = rifampicin, tet = tetracycline. A paired t-test (unpaired with Welch’s 
correction) was performed on each antibiotic triplicate data for each time point to investigate 
statistically different resistance between the timepoints by size of the inhibition zone. Antibiotics 
with statistically significant (P value < 0.05) differences between zones of inhibition at different 





6.3.2. Deep population minor allelic variation of sequential samples before and 
after failed eradication therapy 
 
6.3.2.1. Sequential set 1 
 
There were five more allelic genes after failed eradication therapy for sequential set 1 
(figure 6.3). This was a surprisingly low increase in population genetic diversity, 
especially considering the sampling time gap of approximately 1,366 days. With the 
high mutation rate and recombination rate, a much higher level of population diversity 
might be expected after more than three years of chronic infection. Such low genetic 
diversity might suggest that the H. pylori population within this patient’s stomach was 
very clonal and not of a mixed infection. This would limit opportunities for homologous 
recombination between genetically diverse strains. Furthermore, this infection appears 
to be successful with little change in genetic diversity. This is an interesting observation 
as high genetic diversity is thought to aid in the persistence of infection (Liu et al., 2015).  
 
The most variable gene(s) in terms of the number of uniquely called allelic variants 
harboured within them, both before and after failed eradication therapy in sequential 
set 1, were the outer membrane protein genes (figure 6.3). Outer membrane protein 
variation is thought to aid in chronic infection due to differences in adhesion and 
recognition by the host immune system, preventing immune clearance (Liu et al., 2015; 
Huang et al., 2016b). The low overall genetic diversity between the time points 
combined with the high diversity observed within these genes, suggests an important 
role for outer membrane proteins in the persistence of chronic infection.  
 
The most variable gene(s) in terms of called allelic variants with supporting alternative 
reads mapping to the alternative base call, encoded for outer membrane genes. These 
were shown to have a MAF > 0.125 pre-eradication therapy (table 6.2). These relatively 
high frequencies could suggest that these variant positions are starting to become 
elevated within the population, potentially moving towards fixation. Alternatively, these 
higher frequencies could be representative of a cluster of strains within the population. 
 
In terms of the number of allelic variants with a MAF > 0.125 there were more observed 
post eradication (table 6.3). As observed in sequential set 1 (table 6.2), only three genes 
containing allelic positions > MAF 0.125 remained from before and after failed 
eradication therapy (HP1409, HP1177 and HP0725). This switch of genes with high 
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MAF variant positions potentially reflects genes with allelic variants being selected for 
at the different time points of infection. A study by Lieberman et al. (2014), found that 
when a strong selection pressure is acting on a gene, multiple gene mutations can 
occur but no specific adaptive mutation fixes within the population. This, they say, 
provides a genetic record of past selection events.  
 
Diversity of OMP genes could be how this infection has been able to persist between 
the two sample points, perhapse preventing immumo recognition and clearance.  
 
Despite there being little variation in the total number of allelic genes (figure 6.3) post 
eradication therapy in sequential set 1 compared to pre-therapy, there were changes in 
the number of minor alleles with frequencies > 0.125 within the populations (table 6.2). 
Post eradication therapy, ten genes were observed with very high (> 0.25 MAF) MAFs 
compared to only four genes with MAFs >0.25 pre-eradication therapy. This change 
might reflect minor allelic positions within genes that are moving towards fixation due 
to positive selection pressures. It is probably an over-simplification to suggest this could 
be due to antimicrobial treatment, because these samples were taken over three years 
apart.  
 
6.3.2.2. Sequential set 2 
 
In sequential set 2, there were comparable levels of genetic diversity between the 
antrum and corpus at time point 0. At time point 1 (after failed eradication therapy) there 
was a dramatic increase in overall diversity and there were more allelic genes within 
the antrum population compared to the corpus. The contaminated antrum population 
(Chapter Four, table 4.1), was not thought to be interfering with the minor allele 
detection pipeline results presented in figure 6.4 for four reasons. Firstly, the GC 
content of the contaminated assembled contigs were much higher to those that were 
aligned to the uncontaminated corpus dataset (Appendix, figures 11.4.45A-B). 
Therefore, the contaminated reads were likely to be distinct and less likely to map to 
the H. pylori genomic sequence. Secondly, any allelic positions that were identified 
within the non- H. pylori genome were manually filtered out. Thirdly, the high mapping 
quality score likely prevented contaminated reads from mapping to the H. pylori genome 
sequences. Finally, most of the genes that were found to be allelic were annotated as 
‘HP’ reference genes. 
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The dramatic increase in the number of allelic genes after failed eradication therapy 
was surprising because we expected that antibiotic treatment would cause an 
evolutionary bottleneck. Such bottlenecks are thought to enhance the effects of genetic 
drift whereby strain extinction, fixation and sweeping events are increased (Didelot et 
al., 2016).  
 
The increase in the number of genes harbouring allelic variation could be due to a 
number of factors. One theory could align with a study carried out by Linz et al. (2014), 
who observed a mutational burst during acute phase infection of humans and rhesus 
macaques after just 44 days of infection. Perhaps what happened after eradication 
therapy in this patient was similar to an acute phase infection, with antibiotic treatment 
clearing the chronic phase H. pylori infection, subsequently allowing a more acute 
phase type of infection with a mutational burst. This theory is supported by the MAFs 
of the genes observed within the populations after eradication therapy (tables 6.2 and 
6.3). Out of 735 of the allelic positions between samples 326A and 326C at time point 
1 (sequential set 2) there were 282 allelic variants with a MAF < 0.04 (i.e. < 4%). This 
MAF is very close to the minimum alternative fraction filter used to call minor allele 
variants, of ³ 3% (Chapter Four, section 4.2.1.1). These low frequency allelic variants 
might be detected due to an increased mutation rate of the H. pylori strains within the 
populations inflating the observed genetic diversity within the populations.  
 
An alternative possible explanation for increased genetic diversity after failed 
eradication therapy relies on the concept of prior within population diversity and 
heteroresistance. Population diversity as a result of a mixed H. pylori strain infection or 
a population that has split into sub-populations/quasispecies due to mutation and 
homologous recombination during chronic infection, could present strains within the 
population that harbour higher antimicrobial resistance phenotypes. When challenged 
with the eradication therapy, it is possible that the previously dominant sensitive 
population is cleared, leaving behind heteroresistant H. pylori strains that are very 
closely related to the original population, but are ultimately more resistant to the 
antimicrobial challenge. If multiple sub-strains/quasispecies had acquired higher 
natural resistance, then it is possible that the observed increase in genetic diversity 
following failed eradication therapy is a result of outgrowth of these diverse resistant 
strains. How these resistant strains would develop back into a chronic infection is 
unknown. However, it could be speculated that over time, a genetically fitter strain is 
likely to then become the most dominant strain within the population, following genetic 
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drift and positive selection. It would also be possible for the cycle to repeat again, if 
challenged by another ineffective combination of prescribed antibiotics. Failed 
eradication therapy as a consequence could drive an increase in antimicrobial 
resistance in H. pylori infections. The caveat to this theory is that a sufficient level of 
population diversity would need to be present to increase the likelihood of multiple sub-
strains harbouring naturally mutated resistance phenotypes. Such genetic diversity, 
resulting in an increased risk of eradication therapy failure, might therefore be limited 
to patients who have held a chronic H. pylori infection for many years, or patients with 
a potentially mixed H. pylori strain infection.  
 
The last theory described here to potentially explain the increase of genetic diversity 
post eradication therapy failure refers to the triple therapy itself. First-line standard triple 
therapy consists of two antibiotics coupled with a PPI (Urgesi, Cianci and Riccioni, 
2012). Proton pump inhibitors increase the gastric pH by reducing acid secretion within 
the stomach (Sachs, Shin and Howden, 2006). Furthermore, PPIs increase the efficacy 
of antibiotics against the H. pylori infection (Peterson, 1997; Yang, Lu and Lin, 2014). 
However, what is not well understood is the effect of PPIs on the H. pylori populations 
where eradication therapy fails. It is possible that by increasing the gastric pH, PPIs 
could reduce the environmental pressures acting on the H. pylori populations. The relief 
of acid stress on the bacterial population could drive further genetic variation within the 
populations due to less fit bacteria being able to survive the more neutral pH conditions. 
This could potentially drive the expansion in genetic diversity observed after eradication 
therapy failure.  
 
To determine which, if any, of these hypotheses is true would require further 






Figure 6.3 Heat map of minor allelic gene products before and after eradication 




Heat map of all minor allelic variant genes/gene products within sequential set 1 samples 249C 
(time point 0 – T0) and 537A (time point 1 – T1). Genetic diversity can be compared by looking 
between samples. Number of different polymorphic genes/associated gene products can be 
identified per sample. Colour intensity indicates a higher number of polymorphic positions 
within these genes/associated genes by product. This approach tries to keep together observed 
polymorphic diversity within genes by gene name and where no gene name is provided (by 
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Figure 6.4 Partial heat map of minor allelic gene products before and after 
eradication therapy failure in patient 295/326 (sequential set 2) 
 
Heat map of all minor allelic variant genes/gene products within sequential set 2 samples 295A 
plus 295C (time point 0 = T0) and 326A plus 326C (time point 1 = T1). Genetic diversity can 
be compared by looking between samples. Number of different polymorphic genes/associated 
gene products can be identified per sample. Colour intensity indicates a higher number of 
polymorphic positions within these genes/associated genes by product. This approach tries to 
keep together observed polymorphic diversity within genes by gene name and where no gene 
name is provided (by PROKKA) a unique gene number for each patient sample is provided. 
Only the most diverse genes across all samples (Chapter Four, figure 4.6) are displayed in this 
figure due to the very high number of allelic genes within sequential set 2 time point 1 
populations. Where there was no allelic variation within the genes depicted in Chapter Four 
figure 4.6, they were removed. A full version of this heat map of allelic genes can be observed 
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Table 6.2 Sequential set 1 genes harbouring alleles with minor allele frequencies 
12.5% or greater 
 Sample ID (time point) 
Gene product (gene abbreviation) 249C MAF (T0) 
537A MAF 
(T1) 
537A_00946_hypothetical protein N/A 0.445 
HP0057_Hypothetical protein HP0057 0.174 N/A 
HP0181_Membrane protein required for colicin V 
production 
N/A 0.302 




HP0725_Sialic acid-binding adhesin SabA 0.279 N/A 
HP0725_Sialic acid-binding adhesin SabA 0.422 N/A 
HP0771_Hypothetical protein HP0771 0.138 N/A 
HP1102_6-phosphogluconolactonase 0.176 N/A 
HP1177_Outer membrane protein HopQ 0.230 0.290 
HP1177_Outer membrane protein HopQ 0.388 0.391 
HP1177_Outer membrane protein HopQ 0.379 0.385 
HP1177_Outer membrane protein HopQ N/A 0.173 
HP1177_Outer membrane protein HopQ N/A 0.143 
HP1251_Oligopeptide ABC transporter permease 
OppB 
N/A 0.477 
HP1314_50S ribosomal protein L22 N/A 0.326 
HP1322_Hypothetical protein HP1322 N/A 0.431 
 
Table showing genes that harboured allelic positions with a minor MAF ³ 0.125 (i.e. 12.5% of 
reads supporting a minor allele variant at that position). Genes with multiple instances refer to 
different allelic positions. Genes with allelic positions < 0.125 were filtered out to reduce table 
length and display of most significant frequency changes post eradication therapy. T0 = time 
point 0, T1 = time point 1. N/A refers to the specific allelic position not observing a MAF ³ 




Table 6.3 Sequential set 2 genes harbouring alleles with minor allele frequencies 
12.5% or greater 
 Sample ID (time point) 








295A_01271_hypothetical protein 0.455 N/A N/A N/A 
326A_00310_hypothetical protein N/A N/A 0.151 N/A 
326A_00311_hypothetical protein N/A N/A 0.171 N/A 
326A_02270_hypothetical protein N/A N/A 0.269 N/A 
326A_02270_hypothetical protein N/A N/A 0.375 N/A 
326A_02270_hypothetical protein N/A N/A 0.125 N/A 
326C_00844_hypothetical protein N/A N/A N/A 0.125 
ccpA_Catabolite control protein A N/A N/A 0.138 N/A 
HP0162_Probable transcriptional regulatory 
protein HP0162 
0.174 N/A N/A N/A 
HP0207_ATP-binding protein Mpr N/A N/A N/A 0.133 
HP0349_CTP synthetase PyrG N/A N/A N/A 0.143 
HP0379_Alpha1,3-fucosyltransferase FutA N/A 0.214 N/A 0.155 
HP0379_Alpha1,3-fucosyltransferase FutA N/A N/A N/A 0.210 
HP0379_Alpha1,3-fucosyltransferase FutA N/A N/A N/A 0.167 
HP0394_UDP-2,3-diacylglucosamine hydrolase N/A N/A 0.273 N/A 
HP0466_Hypothetical protein HP0466 0.242 N/A N/A N/A 
HP0527_CagY protein N/A N/A 0.250 N/A 
HP0543_CagF protein N/A N/A N/A 0.137 
HP0544_CagE protein N/A N/A 0.209 N/A 
HP0559_Acyl carrier protein AcpP N/A N/A 0.232 N/A 
HP0734_Ribosomal protein S12 
methylthiotransferase RimO 
N/A N/A N/A 0.155 
HP0738_D-alanine--D-alanine ligase N/A N/A N/A 0.170 
HP0746_Hypothetical protein HP0746 N/A N/A 0.180 N/A 
HP0807_Iron(III) dicitrate transport protein FecA 0.153 N/A N/A N/A 
HP0953_Hypothetical protein HP0953 N/A N/A N/A 0.127 
HP1041_Flagellar biosynthesis protein FlhA 0.213 N/A N/A N/A 
HP1057_Hypothetical protein HP1057 N/A N/A 0.192 N/A 
HP1110_Pyruvate flavodoxin oxidoreductase 
subunit alpha PorA 
N/A N/A N/A 0.128 
HP1177_Outer membrane protein HopQ 0.148 0.345 N/A 0.155 
HP1177_Outer membrane protein HopQ N/A 0.427 N/A N/A 
HP1177_Outer membrane protein HopQ N/A 0.516 N/A N/A 
HP1177_Outer membrane protein HopQ N/A 0.389 N/A N/A 
HP1192_Secreted protein involved in flagellar 
motility HP1192 
N/A N/A N/A 0.125 
HP1243_Blood group antigen binding adhesin 
BabA 
N/A N/A 0.366 0.463 
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HP1243_Blood group antigen binding adhesin 
BabA 
N/A N/A 0.357 0.407 
HP1243_Blood group antigen binding adhesin 
BabA 
N/A N/A 0.279 0.264 
HP1243_Blood group antigen binding adhesin 
BabA 
N/A N/A 0.272 0.272 
HP1243_Blood group antigen binding adhesin 
BabA 
N/A N/A 0.648 0.531 
HP1243_Blood group antigen binding adhesin 
BabA 
N/A N/A 0.607 0.529 
HP1243_Blood group antigen binding adhesin 
BabA 
N/A N/A 0.605 0.522 
HP1243_Blood group antigen binding adhesin 
BabA 
N/A N/A 0.388 0.326 
HP1243_Blood group antigen binding adhesin 
BabA 
N/A N/A N/A 0.153 
HP1424_Hypothetical protein HP1424 N/A N/A N/A 0.180 
HP1431_Ribosomal RNA small subunit 
methyltransferase A 
N/A N/A N/A 0.161 
smc_Chromosome partition protein Smc N/A N/A N/A 0.176 
smc_Chromosome partition protein Smc N/A N/A N/A 0.149 
smc_Chromosome partition protein Smc N/A N/A N/A 0.169 
smc_Chromosome partition protein Smc N/A N/A N/A 0.137 
 
Table showing genes that harboured allelic positions with a MAF ³ 0.125 (i.e. 12.5% of reads 
supporting a minor allele variant at that position). Genes with allelic positions < 0.125 were 
filtered out to reduce table length and display only the most significant frequency changes post 
eradication therapy. T0 = time point 0, T1 = time point 1. N/A refers to the specific allelic 
position not observing a MAF ³ 0.125 at the denoted time point. Genes were annotated by 
PROKKA (Chapter Two, section 2.13). Some gene products / genes are displayed more than 
once due to multiple allelic positions with a MAF ³ 0.125.  
 
6.3.3. Comparing the single colony isolates from sequential sets 1 and 2 to their 
respective patient reference genomes before and after failed eradication 
therapy using the nucleotide basic local alignment tool  
 
6.3.3.1. Sequential set 1 
 
The single colony isolates from sequential set 1 were compared by BLASTN and 
visualised by BRIG (figure 6.5A) (Alikhan et al., 2011). The comparisons indicate that 
a similar pattern of 100% BLASTN identity and gaps can be observed for strains pre- 
and post- eradication therapy. This observation was also true for isolates taken from 
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the antrum and corpus of other patients (Chapter Five, figure 5.3; Appendix figures 
11.5.1 – 11.5.8). Despite these groups of isolates being taken from patient 249/537 
1,366 days apart, they are remarkably similar. There is very little genetic variation 
between colonies isolated before and after eradication therapy and the variable genes 
appear to be spread evenly across the genome. 
 
6.3.3.2. Sequential set 2 
 
Sequential set 2 antrum and corpus isolates before and after failed eradication therapy 
also appear to be genetically related (>96 % BLASTN identity), with time point specific 
patterns of BLASTN identity (figure 6.5B). This suggests that all of the isolates 
originated from the same infecting strain. There was a dramatic increase in genetic 
diversity after failed eradication therapy and the variable genes are labelled on the 






Figure 6.5 Nucleotide identity comparison between sequential set 1 and set 2 isolates 
 
Sequential set 1 A) 
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B) Sequential set 2 
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BLAST Ring Image Generator (BRIG) plots of sequential set 1 (figure A) and sequential set 2 (figure B) single colony genome assemblies constructed as described 
in section 6.2.6. The rings are denoted in the legend to the right of each figure in the order they are described. The green concentric ring represents the strains isolated 
from the antrum where the purple represents the corpus strains. Genes were colour coded as follows; black = identified as variable gene(s) by mapping single colony 
reads to patient reference consensus genome only, teal = identified allelic genes by the deep sequencing minor allele pipeline only, red = identified by both 
methodologies (Chapter Five, section 5.2.6). An upper BLASTN identity threshold of 99% and lower identity of 96% were used (section 6.2.6). The legend was 
removed in figure B to improve visualisation. Figure B concentric rings from the inner most green ring to the outer purple ring depict the following strains: 295A1, 
295A2, 295A3, 295A4, 295A5, 295A6, 326A22, 326A23, 326A24, 326A26, 326A25, 326A7, 295C1, 295C2, 295C4, 295C6, 295C7, 295C8, 326C1, 326C2, 326C3, 





6.3.4. Phylogenetic analysis of sequential data sets 
 
6.3.4.1. Sequential set 1 
 
Sequential set 1 single colony isolates split into two clades (figure 6.6A). These clades 
definitively split into pre- and post- eradication therapy clusters. Despite this, there were 
very few genetic differences between the individual isolates with only 18 SNPs 
separating the longest branch tip to tip distance between isolates (249C and 537A4/7). 
This indicates that there was very little genetic divergence between the sampling points 
(1,366 days). The eradication therapy had very little effect on the H. pylori population. 
Considering the spontaneous mutation rate of H. pylori of 3 x 10-5 mutations per site per 
year (Björkholm et al., 2001), the patient reference genome (249C) size of 1.63 Mbp, 
would equate to an expected number of mutations over 3.74 years of ~20 SNPs. The 
expected number of SNPs by natural mutation is thus very similar to that observed 
between the longest phylogenetic branches. This further suggests that recombination 
was not driving diversification, but natural mutation was.  
 
The limited diversity observed between the two time points is much lower than expected 
when considering the challenge of eradication therapy. The observed genetic diversity 
from single colony sequencing was consistent with the results obtained by the deep 
population sequencing analysis as previously discussed (section 6.3.2). Pulling 
together all of the genetic and phenotypic evidence, it is likely that this patient held a 
low diversity H. pylori infection before eradication therapy that was already completely 
resistant to the prescribed therapy. Under these circumstances, the drugs did not exert 
a selection pressure on the bacterial population, which remained essentially unchanged 
after treatment.  
 
6.3.4.2. Sequential set 2 
 
Sequential set 2 did not split into pre- and post- eradication therapy clusters (figure 
6.6B). However, all antrum and one corpus strains post eradication therapy clustered 
away from all other strains. Five out of six corpus strains clustered with the majority of 
the pre-eradication therapy samples. This suggests that the corpus population strains 
underwent very little genetic change between the sampling points. This is somewhat 
contradictory to that observed by the population deep sequencing results (figure 6.4). 
The contradiction could be explained by inadequate single colony isolation, where a set 
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of very similar strains were taken that do not reflect the true population diversity. 
Alternatively, these results could suggest that while the corpus population is more 
genetically diverse after failed eradication therapy, there are strains from pre-therapy 
that are still abiding. If this is correct, it could suggest that the corpus strains are more 
naturally adapted to resist eradication therapy, despite being closely related to the 
antral strains. Furthermore, it is thought that antibiotics may degrade due to low pH, 
suggesting a possible reason why the H. pylori infection showed little genetic change, 
potentially attributed to antibiotic degradation in the oxyntic corpus niche (Vallve et al., 
2002). 
 
The antrum strains post eradication therapy were substantially different to the antrum 
strains isolated before therapy (figure 6.6B). Despite the big genetic differences 
between these strains, they were not thought to be from a re-infection event. The 
reasoning behind this focuses on the pan-genome of these isolates. In Chapter Five 
figure 5.4, the pan-genome clustering of all strains of sequential set 2 clustered almost 
indistinguishably with one another. Due to the big differences in pan-genomes between 
different strains and populations, a new or re-infection of H. pylori post eradication 
therapy would presumably change the genes clustering within the pan-genome 
(Chapter Four, figure 4.13; Chapter Five, figure 5.4). Therefore, this is strong evidence 
against a re-infection hypothesis. Furthermore, figure 6.5B shows that all the isolates 
from sequential set 2 share a close relationship to the patient reference genome with a 
BLASTN identity > 96% covering most of the genome with very few gaps.  
 
The highly diverse antral strains post eradication therapy in sequential set 2 (figure 
6.6B) compliment the analysis by the deep population dataset (figure 6.4). Not only is 
there a substantial increase in genetic diversity within the population post eradication 
therapy (figure 6.4), there is also a big increase in genetic diversity between the core 
genomes and population structure at a single colony resolution (figure 6.5B; figure 
6.6B). Again, this suggests that while there were some persistent strains, the 








Population structure of single colony isolates from before and after eradication therapy. Figure 
A shows the phylogeny of isolates taken from sequential set 2 while figure B shows isolates 
from sequential set 2. Phylogenetic trees were constructed as described in section 6.2.7. 
Phylogenetic trees were constructed and visualised by the interactive tree of life (iTOL) where 
they were rooted by the midpoint (Letunic and Bork, 2007). Sample labels were colour coded 
by their location (antral isolates = green, corpus isolates = purple). A colour strip was added to 
ease in the visualisation of isolates from the different time points (pre-eradication therapy / T0 
= blue, post-eradication therapy / T1 = red).  
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6.3.5. Recombination detection between strains before and after failed 
eradication therapy 
 
6.3.5.1. Sequential set 1 
 
There was little observable recombination between isolates from sequential set 1 (figure 
6.7A1-2). Where recombination was detected it was confined towards the end of the 
isolate genomes. As previously discussed in Chapter Five section 5.3.5, recombination 
observed towards the ends of the genomes might not be an accurate representation 
due to smaller contigs towards the end of the genomes that are usually of much higher 
sequencing depth, suggesting a region of the genome that was not well assembled. As 
a result, this could inflate the number of allelic variants in these segments. However, 
recombination is observable between isolates and from outside sources in both 
methodologies. The fastGEAR analysis highlighted one region of recombination 
between isolates 249C6 and 249C8 which was not detected by Gubbins, suggesting 
that the fastGEAR methodology is able to detect additional recombination events.  
 
The low level of recombination for sequential set 1 is unsurprising, given the low level 
of genetic variation within the population (figure 6.3; figure 6.5A; figure 6.6A).  
 
6.3.5.2. Sequential set 2 
 
There were more recombination events detected between the sequential set 2 isolates 
(figure 6.7A-B). Recombination was not observed between the smaller clade and the 
larger clade of isolates. However, recombination was observed between isolates taken 
before and after eradication therapy by the fastGEAR analysis (figure 6.7B2). This 
suggests that single colony isolates were recombining during and/or after eradication 
therapy.  
 
Due to the lack of evidence of between clade recombination (blue bars) and 
recombination from an outside source (black bars) in the divergent smaller clade (red 
lineage containing strains 326A22-27 and 326C1), it could be argued that the genetic 
diversity of this clade was not a result of extensive recombination (figure 6.7B2). Such 
an observation could suggest that this diversity is more a result of natural random 
mutation of sub-strains/quasispecies within the population. If true, this observation 
could support the aforementioned second theory designed to explain the increased 
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observation of genetic diversity post failed eradiation therapy (section 6.3.2). In short, 
this theory centres around the idea of within patient genetic diversity resulting in sub-
populations/quasispecies prior to eradication. These sub-populations might be present 
in low abundance but may hold higher phenotypic resistance to antimicrobials due to 
random genetic mutation. These sub-population holding higher phenotypic resistance 
to antimicrobials might persist within the gastric niche but not fix due to competition from 
the dominant population. Lieberman et al. (2014), observed that Burkholderia dolosa 
intra-sample mutants coexist within the population and rarely sweep to fixation, 
supporting this theory, alongside the within patient genetic diversity observed in 
Chapter Four figure 4.6. Upon antibiotic challenge, the dominant H. pylori population 
that is sensitive would be cleared, leaving behind multiple small sub-populations of H. 
pylori with higher natural resistance to the eradication therapy drugs. Subsequent 
outgrowth of these populations could cause the observed increase in population genetic 
diversity after eradication therapy (figure 6.4). Since these low abundance sub-strains 
did not interact substantially with the dominant population prior to eradication therapy, 
little evidence of recombination between strains before and after eradication therapy 
was detected (figure 6.7B1-2). Recombination events were only observed between the 






















Recombination detected by Gubbins (figures A1 and B1) and fastGEAR (figures A2 and B2) as described in section 6.2.8. Figures A1 and A2 show sequential set 
1 while figures B1 and B2 relate to sequential set 2. The genomic scale bar is depicted at the top of each figure with blue markings highlighting genes along the 
genome. The core genome phylogeny is depicted to the left followed by coloured blocks differentiating antrum isolates (purple), corpus isolates (green) and reference 
(orange). The centre of figures A1 and B1 depict sites of recombination. White space (no recombination sites), blue blocks (single site of recombination) and red 
blocks (shared site of recombination). Figures A2 and B2 represent recombination detected by fastGEAR as described in section 6.2.8. Lineages detected by 
fastGEAR are colour coded and have been ordered to match the strain locations in the Gubbins analysis for ease of cross comparisons. Grey blocks represent 
recombination sites within lineages while black blocks represent recombination from an outside strain. Coloured blocks within lineages infer direction of 
recombination events between lineages.  
B1) B2) 
Sequential set 2 
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6.4. Future work 
 
Determining the antibiotics provided to the patients would greatly help in the 
interpretation of both sequential set 1 and 2 results. Understanding of this would help 
to draw better conclusions of the effect of these drugs on the H. pylori population 
proceeding failed eradication therapy. 
 
Genes observed to have higher MAF post eradication therapy would be good targets 
for mutagenesis experiments to observe their phenotypic effects on the antibiotic 
susceptibility and virulence of H. pylori, and to see if they contribute to eradication 
therapy failure. If so, these genes could be further targeted for improved eradication 
therapy or in diagnosis to highlight patients at risk of treatment failure.  
 
Although ethically problematic, continued sampling after failed eradication at additional 
time points could further the understanding of how the H. pylori populations continue to 
change and adapt after failed eradication therapy, specifically in the context of 
sequential set 2.  
 
This study only investigates sequential samples from two patients, one of which only 
had samples available from opposite niches of the stomach at the different time points. 
Ideally, additional patients should be identified where antrum and corpus samples are 
available for analysis before and after eradication therapy. Expanding the dataset would 
help provide a better picture of what happens to the H. pylori infection before and after 
eradication therapy.  
 
Further investigations into the theories presented in this study regarding the possible 
reasons for increased genetic diversity after failed eradication (sequential set 2) is 


















The prevailing aim of this thesis was to investigate the within niche and between niche 
genetic diversity of H. pylori populations taken from the same stomach. Secondary aims 
developed during the course of the thesis included between patient H. pylori population 
comparisons, antimicrobial resistance assay development with a focus on 
standardisation. 
 
With increasing global antimicrobial resistance to virtually all clinically relevant bacteria, 
including H. pylori with a particular concern for clarithromycin resistance, it is perhaps 
past time to improve antimicrobial susceptibility testing for this bacterial infection. While 
antimicrobial susceptibility testing at initial diagnosis of H. pylori infection would be 
preferable, it is perhaps ethically more acceptable to implement susceptibility testing 
after the first unsuccessful eradication therapy attempt as a carcinogen and the invasive 
nature of culture collection. As it stands today, eradication failure triggers a second line 
eradication therapy attempt. It could be argued that in the era of increasing eradication 
therapy failure, screening for antimicrobial susceptibility is perhaps a way to slow the 
trend of increasing antibiotic resistance and provide better, more patient specific 
eradication therapy regimes. This might help preserve the efficacy and continued use 
of antibiotics in the eradication of H. pylori for generations to come.  
 
However, limited understanding of within patient H. pylori antimicrobial susceptibility in 
terms of testing guidelines and how intra-strain diversity might affect phenotypic 
susceptibility has perhaps hampered culture-guided eradication therapy. These were 
addressed in Chapter Three, where a standardised antimicrobial resistance assay was 
presented, and a review of the literature identified potential breakpoints for an 
inexpensive but powerful (able to identify resistant colonies and second zones of 
inhibition) antimicrobial disk diffusion susceptibility assay. It was found that antrum and 
corpus antimicrobial susceptibility profiles can vary within individual patients. In terms 
of eradication therapy, these differences could be the difference in determining a H. 
pylori infection as sensitive or resistant suggesting that culture-guided eradication 
therapy is best informed from cultures taken from multiple gastric biopsy sites. 
However, future studies should investigate if there are intra-niche antimicrobial 
sensitivity differences, which might provide further guidance on which areas of the 
stomach should be selected for culture-guided eradication therapy.  
 
Extensive genomic diversity is a hallmark of H. pylori infection both globally, locally and 
within infected patients. To date, all studies have investigated genomic diversity using 
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DNA fingerprinting techniques, gene specific analysis and more recently, using whole 
genome sequencing of multiple single colony isolates obtained from individuals, family 
members and animal models of infection. This has progressed our understanding of H. 
pylori genetic diversity and its potential role in host adaptation, disease development 
and persistence. However, these studies are limited by sample size, thus the true H. 
pylori diversity is yet to be elucidated at a population level.  
 
In Chapter Four, a novel deep population sequencing method was applied to H. pylori 
clinical sweeps cultured from clinical biopsies. A novel read mapping approach was 
used to identify ‘common’ and ‘minor’ population allelic diversity. The former was used 
to identify alleles of high frequency while the latter was used to identify low frequency 
alleles. This novel approach presented a more accurate snapshot of population 
diversity, supporting observations from other studies of diverse genes and highlighted 
novel genes with allelic diversity.  
 
A total of 585 and 4,872 polymorphic sites were detected across all samples (excluding 
sample 565C; n=32) by common and minor allelic calling pipelines respectively. 
Excluding hypothetical proteins, the most polymorphic genes across all patient samples 
were: OMP (26/32), Glutamyl-tRNA synthetase (17/32), OMP assembly factor YaeT 
precursor (17/32), Methyl-accepting chemotaxis gene tlpA (16/32), vacA paralog 
(14/32), Type III restriction-modification system methylation subunit (13/32), Methyl-
accepting chemotaxis protein (12/32), Lipopolysaccharide biosynthesis protein (12/32), 
Type I restriction-modification system subunit R (12/32), Tetratricopeptide repeat family 
protein (11/32), Adenine specific DNA methyltransferase (10/32), Glutathione-regulated 
potassium-efflux system protein KefB (10/32) and Type I restriction-modification system 
subunit S (10/32). This study revealed that within niche polymorphic diversity was not 
preferably selected for or against within one niche to the other in relation to the antrum 
and the corpus. However, this study did reveal more nonsynonymous aligned fixed 
SNPs between the antrum and corpus than synonymous SNPs suggesting that 
selection pressures are potentially acting between these niches of the human stomach 
but presumably over a longer timescale. No associations between disease severity and 
total number of nonsynonymous mutations were found.  
 
The results obtained from this study have important implications in vaccine rational 
design as genetically diverse antigens would not make good vaccine targets. This study 
further elucidates the within patient, between patient, within niche and between niche 
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genetic diversity of H. pylori populations by combining a multitude of genetic 
bioinformatics analysis methodologies. This novel approach provides further insights 
into H. pylori host and niche adaptation as well as how this pathogen is able to persist 
as a chronic infection. Furthermore, this author presents a rich resource of population 
gene diversity for other researchers to use and potentially follow up on. Finally, this 
study highlights important bioinformatics limitations. For example, so called ‘fixed’ SNPs 
identified by comparative whole genome alignments can often still be polymorphic at 
the SNP site, suggesting that these positions are not truly ‘fixed’ within the populations 
where polymorphic variation might hold insights into past selection pressures, as first 
suggested by Lieberman et al. (2014).  
 
The methods and analysis presented in Chapter Four acted as a proof of concept for 
the capture of population diversity at single time point of infection. Future studies might 
benefit from this population method in sequential samples to observe how selection 
acts on specific genes over time.  
 
By comparing within niche genetic diversity of single colony isolates using a read 
mapping approach to a reference genome, it was possible to validate the deep 
population minor allelic calling pipeline (Chapter Four). This revealed a good fit between 
the two sequencing methodologies suggesting that the population deep sequencing 
minor allele pipeline presented in Chapter Four was accurate.  
 
The findings of Chapters Four and Five highlighted many genes that appear to be 
genetically diverse across numerous patient samples. While there was good agreement 
between the two different approaches in many instances, PCR-based validation could 
also be carried out. Furthermore, while genetic diversity is clear, gene expression levels 
are not. Therefore, DNA microarrays and/or reverse transcription PCR could be used 
to investigate the effects allelic diversity might have on gene expression. Additionally, 
while allelic diversity of specific genes might infer biological significance, the biological 
effect is less clear. In order to test this, more conventional studies would need to follow 
such as site directed mutagenesis of wild type strains and the comparison to wildtype 
strains through phenotypic assays.  
 
Chapter Six consisted of a unique dataset of sequential H. pylori cultures taken before 
and after failed eradication therapy. Sequential set 1 showed little change in 
antimicrobial sensitivity before and after eradication therapy. Furthermore, the genetic 
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diversity between the different timepoints remained comparable. This suggests that the 
eradication therapy followed in this patient had little to no effect on the H. pylori 
population. This was potentially due to pre-existing resistance to the prescribed 
eradication regime. However, the sampling timepoints were ~3.7 years apart which 
might not be representative of changes during or immediately following eradication 
therapy. 
 
Conversely, sequential set 2 showed antimicrobial sensitivity differences after failed 
eradication therapy ~4.9 months after the first sampling timepoint. High within niche 
population genetic diversity was observed post failed eradication therapy. This 
contradicted previous observations by other studies of restricted genetic diversity and 
suggested that failed eradication therapy might be a driver of genetic diversity. 
Increased diversity might drive additional resistance phenotypes to other antibiotics, 
resulting in further eradication therapy failures. However, further studies will be required 
to follow up these results to understand the implications of these findings as well as a 
more extensive sequential sample set from additional patients.  
 
Deep population sequencing and analysis proved to be an effective method to 
investigate within population genomic diversity of H. pylori. However, this read mapping 
approach relied on de novo consensus assemblies of the population from short read 
sequencing data. This was useful in the analysis of population variation (due to 
extensive genetic diversity rendering popular reference genomes unsuitable). While 
advantageous, this method had its own limitations. Of particular note is that genomes 
are almost never complete, with contig breaks around areas of the genome that could 
not be resolved. This has implications in read mapping where reads might not align 
correctly in this region. Furthermore, Illumina short read sequencing (by synthesis) is 
prone to errors in repetitive sequences.  
 
A comprehensive approach for the future might be to take a single colony isolate from 
the population to be studied, for sequencing on both the Illumina short read and Oxford 
Nanopore Technologies long read MinION platforms. This would provide an accurate 
representative ‘reference’ genome from the population to compare against. The 
population should then be deep sequenced as described in Chapter Four and the minor 
allele calling pipeline executed by mapping the population reads to this population 





This thesis presents many novel H. pylori analysis techniques and findings. Entire H. 
pylori populations from single biopsies were studied, something that has not been 
presented before. This has contributed to further novel insights into H. pylori host 
adaptation and persistence. Deep sequencing of sequential samples taken before and 
after failed eradication was also novel and suggested that failed eradication therapy 
could be a driver of genetic diversity, with potential implications in eradication therapy.  
 
It is hoped that this thesis will act as a useful platform to guide future research into 
allelically diverse genes detected within H. pylori populations (Chapter Four), within and 
between different niches of the human stomach (Chapter Four and Five) and from H. 
pylori populations after eradication therapy failure (Chapter Six). The development and 
standardisation of an internationally recognised H. pylori antimicrobial disk diffusion 
assay is needed, as is a better understanding of the H. pylori antibiotic resistance within 
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